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Summary 
Sleep loss may act as a trigger or early warning sign of manic episodes in individuals with 
bipolar disorder (BD) but the nature of this relationship remains unclear. The aim of this 
thesis was to explore the relationship between sleep disruption and mania in individuals with 
BD. 
The datasets used in this thesis were obtained from the Bipolar Disorder Research Network 
(BDRN), an ongoing research programme of over 6000 individuals with mood disorders 
recruited from across the UK. Psychiatric diagnoses were determined using a semi-structured 
diagnostic research interview and case notes. 
First, in 3140 BDRN participants with bipolar-I disorder (BD-I) or bipolar-II disorder (BD-II), I 
found that 20% of participants reported that sleep loss had triggered episodes of high mood. 
This was more commonly reported by individuals with BD-I than those with BD-II, and more 
commonly reported by women than men.  
Second, I found that women were more likely to have experienced episodes of mania or 
psychosis after childbirth (termed postpartum psychosis, PP) if sleep loss had triggered 
episodes of high mood. This effect suggested that a tendency for sleep loss to trigger 
episodes of high mood might be associated with vulnerability to PP. 
Third, in BDRN participants who had used an online mood monitoring system to track 
symptoms of mania and depression, I found that participants could be grouped into three 
classes based on their trajectories in symptoms of insomnia prior to episodes of high mood. 
Finally, I designed and conducted a pilot study using actigraphy to measure perinatal sleep in 
pregnant women at high risk of developing PP. I found that this methodology was challenging 
to implement in this population but can produce detailed information on sleep during the 
perinatal period.  
The findings of this thesis could help inform clinical practice by expanding current knowledge 
on how sleep loss affects individuals with BD.  
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1 INTRODUCTION 
Reported in part by (Lewis et al. 2016) 
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For doe but consider what an excellent thing sléepe is: It is so inestimable a Jewell, that if a 
Tyrant would give his crowne for an houres slumber, it cannot be bought… yea so greatly 
indebted are we to this kinseman of death, that we owe the better tributary, halfe of our life 
to him: and thers good cause why we should do so: for sleepe is that golden chaine that ties 
health and our bodies together. Who complaines of want? of woundes? of cares? of great 
mens oppressions? of captivity? whilest hée sléepeth? Beggers in their beds take as much 
pleasure as Kings: can we therefore surfet on this delicate Ambrosia? can we drink too much 
of that whereof to tast too little, tumbles us into a Church-yard, and to use it but indifferently, 
throwes us into Bedlam? (Dekker 1609 p.10)  
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1.1 Background 
Bipolar disorder (BD) is a psychiatric condition characterised by severe episodes of mood 
instability that range from depression to mania (extreme elation or irritability). Mania is the 
defining feature of BD that distinguishes it from other mood disorders such as major 
depressive disorder, and can include psychotic symptoms such as hallucinations and 
delusions. These recurrent episodes of mood instability result in significant impairment to 
personal, social and occupational functioning (Simon 2003), with associated costs to health 
services and the economy (Kleinman et al. 2003; Young et al. 2011). The primary goal for 
health care professionals, therefore, is to ensure prompt and effective treatment of mood 
episodes and, if possible, to prevent episodes from occurring (Leboyer and Kupfer 2010; 
National Institute for Health and Care Excellence, NICE, 2017). To inform these efforts, we 
must better understand what factors cause or signal the onset of mood episodes in 
individuals with BD. 
Current evidence suggests that a myriad of environmental and genetic factors may increase 
risk of BD (Craddock and Sklar 2013), and mood episodes may be precipitated by a variety of 
bio-psycho-social factors (Alloy et al. 2005). However, increasing evidence suggests that sleep 
disturbance, itself a symptom of both depression and mania, could provide valuable insight 
into the causes and early signs of mood episodes. If so, sleep patterns could be an easily 
monitored, non-pharmacologic target for intervention. 
In this chapter, I will first outline the characteristics of BD and current knowledge of its 
aetiology. Second, I will describe the systems governing the sleep-wake system and the 
physical and psychological consequences of disrupting these systems. Third, I will discuss 
evidence that research on sleep disturbance can provide valuable insight into the aetiology of 
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BD. Fourth, I will expound on the sleep-reduction model of mania, which informs the central 
focus of this thesis, that measuring sleep reduction could provide a valuable means for 
predicting episodes of mania in BD. The chapter will conclude with limitations in current 
knowledge of how sleep is involved in the pathway to mania, followed by a description of the 
aims for this thesis. 
1.2 Bipolar Disorder 
The modern concept of BD as a distinct entity derives from 19th and early 20th century 
psychiatry (Angst and Sellaro 2000; Angst and Marneros 2001).  In 1851, the French 
psychiatrist Jean-Pierre Falret described an illness characterised by episodes of mania, 
depression and euthymia, which he termed ‘folie circulaire’ (Pichot 1995; Angst and 
Marneros 2001). Subsequently, in the 1890s, Emil Kraepelin built upon the concept of ‘folie 
circulaire’ to devise the concept of ‘manic-depressive insanity’, which encompassed both 
bipolar and unipolar mood disorders and distinguished them from dementia praecox (i.e. 
schizophrenia) (Kraepelin 1893; Kraepelin 1896; Kraepelin 1899; Angst and Sellaro 2000). This 
categorisation prevailed until the 1950s, when Karl Leonhard distinguished between unipolar 
and bipolar affective disorders (Leonhard 1957), a distinction which is now used in modern 
diagnostic systems (Grande et al. 2015). As will be described in the following section, the 
defining feature of BD is mania. 
1.2.1 Modern Diagnosis of Bipolar Disorder 
At present, the two most widely acknowledged diagnostic classification systems are the 
International Classification of Diseases (ICD) (World Health Organisation,WHO, 1992) and the 
Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric 
Association 2013), currently in their 10th and 5th editions, respectively.  
 5 
This thesis uses the DSM criteria for BD diagnosis, which is centred on a set of operationalized 
criteria for mania. The fifth edition of the DSM (American Psychiatric Association 2013) 
defines manic episodes as distinct periods of (i) high mood or irritability and (ii) increased 
goal-directed activity or energy, which are accompanied by symptoms such as inflated self-
esteem or pressurised speech (see Table 1-1 for full list of symptoms). The episodes must 
cause marked impairment in important areas of functioning, such as occupational or social 
activities and persist for at least one week. Manic episodes are also diagnosed if the duration 
criterion is not met but there are psychotic symptoms (hallucinations and delusions) or the 
symptom severity warrants hospitalisation. 
Episodes that do not meet the duration or severity criteria but last for at least 4 days are 
termed ‘hypomanic’. Hypomanic episodes are not of sufficient severity to result in 
hospitalisation and do not cause marked impairment in social or occupational functioning. 
However, the symptoms must be observable by others and represent a marked change from 
typically functioning mood. Table 1-1 outlines DSM-5 criteria for manic and hypomanic 
episodes.
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Table 1-1. DSM-5 criteria for manic and hypomanic episodes (American Psychiatric Association 2013).  
Symptoms Duration criteria Impairment criteria 
A distinct period of abnormally and persistently 
elevated, expansive, or irritable mood and persistently 
increased goal-directed activity or energy*, that is 
accompanied by at least three (if the mood is high) or 
four (if the mood is irritable) of the following symptoms: 
1. Inflated self-esteem or grandiosity 
2. Decreased need for sleep (e.g. feeling rested 
after only 3 hours of sleep) 
3. More talkative than usual or pressure to keep 
talking 
4. Flight of ideas/subjective experience that 
thoughts are racing 
5. Distractibility (i.e. attention too easily drawn to 
unimportant or irrelevant external stimuli) 
6. Increase in goal-directed activity (socially, at 
work/school, sexually) or psychomotor agitation 
7. Excessive involvement in pleasurable activities 
that have a high potential for painful 
consequences (e.g. engaging in unrestrained 
buying sprees, sexual indiscretions, or foolish 
business investments) 
Mania: 
At least 1 week (or any 
duration if 
hospitalization 
necessary). 
Mania: 
Any of the following: 
 Marked impairment in occupational or social functioning. 
 Necessitates hospitalisation to prevent harm to self or others. 
 Includes psychotic features. 
Hypomania: 
At least 4 days (mood 
change must also be 
clearly different from the 
usual non-depressed 
mood). 
Hypomania: 
 Unequivocal change in functioning that is uncharacteristic of 
the person when not symptomatic. 
 Disturbances in mood and change in functioning are 
observable by others. 
The episode is not severe enough to cause marked impairment in 
social or occupational functioning, or to necessitate hospitalization, 
and there are no psychotic features. 
*Goal-directed activity was added as a core symptom of mania in the 5th edition of the DSM. All other criteria are consistent with DSM-IV (American 
Psychiatric Association 2000).
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1.2.2 Differences Between DSM-5 and DSM-IV Criteria for Manic and Hypomanic Episodes 
Most of the data available for this thesis were collected prior to the release of the DSM-5 in 2013, 
therefore Chapters 3-5 in this thesis rely on DSM-IV criteria for BD (American Psychiatric 
Association 2000). As shown in Table 1-1, DSM-IV and DSM-5 criteria for (hypo)manic episodes 
are consistent except for the addition of increased goal-directed activity or energy as a core 
symptom of mood change. A recent analysis on the dataset used in this thesis (described in 
Chapter 2) suggests that this new criterion does not result in substantial changes to existing DSM-
IV diagnoses, with 94% of 3993 cases with a lifetime DSM-IV diagnosis of BD meeting DSM-5 
criteria for BD (Gordon-Smith et al. 2017).  
1.2.3 Bipolar Disorder Subtypes 
There are a number of subtypes of bipolar disorder, which are summarised in Table 1-2. Bipolar-I 
disorder (BD-I) is diagnosed when individuals meet criteria for experiencing at least one manic 
episode. In contrast, bipolar-II disorder (BD-II) is diagnosed where individuals have experienced 
hypomanic (rather than ‘manic’) episodes and requires a history of at least one major depressive 
episode (criteria shown in Table 1-3). Although traditionally considered a milder form of bipolar 
disorder, BD-II is actually associated with high rates of recurrence, high rates of psychiatric 
comorbidities, and recurrent suicidal behaviours that impair quality of life (Vieta and Suppes 
2008). 
Additional variations in diagnosis (summarised in Table 1-2) include cyclothymic disorder and 
bipolar disorder ‘not otherwise specified’. These categories are part of the ‘bipolar 
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spectrum’(Ghaemi et al. 2002) whereby an individual does not meet full criteria for BD but 
presents with a condition that appears to be related to BD.  
Table 1-2. Summary of DSM-5 diagnostic criteria for bipolar disorder (American Psychiatric 
Association 2013). 
Disorder Manic Symptom Criteria Depressive Symptom Criteria 
Bipolar-I 
disorder 
 Manic episodes  Not required for diagnosis 
Bipolar-II 
disorder 
 One or more episodes of 
hypomania 
 No manic episodes 
 Major depressive episodes 
Cyclothymic 
disorder 
 Hypomanic symptoms 
present for at least 2 years 
 Periods of depressive 
symptoms that do not meet 
criteria for a major depressive 
episode 
Bipolar disorder 
not otherwise 
specified 
 Presence of manic 
symptoms that do not 
meet criteria for bipolar-I, 
bipolar-II or cyclothymic 
disorder 
 Not required for diagnosis 
Both BD-I and BD-II can exhibit a ‘rapid-cycling’ course of illness, where at least four (hypo)manic 
or depressive episodes occur within a year (each episode separated by either partial or full 
remission or by switching to an opposite polarity episode) (American Psychiatric Association 
2013). The lifetime prevalence of rapid-cycling BD has been estimated at 25-43% and is 
associated with an earlier age at illness onset, more illegal drug and alcohol abuse, and increased 
suicidality (Carvalho et al. 2014). In addition, DSM-5 criteria state that mood episodes in BD-I and 
BD-II can present with ‘mixed features’, whereby episodes of (hypo)mania or depression occur 
simultaneously with at least three symptoms of the opposite polarity (American Psychiatric 
Association 2013). This is in contrast to DSM-IV criteria, which instead describes ‘mixed episodes’. 
These are only present in BD-I and occur when an episode of mania simultaneously presents with 
full symptom criteria for a major depressive episode (American Psychiatric Association 2000).  
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Table 1-3. DSM-5 criteria for major depressive episodes (American Psychiatric Association 
2013). 
Symptom criteria Duration and Impairment criteria 
Five or more of the following symptoms (at least 
one symptom must be either depressed mood or 
anhedonia). 
 Depressed mood 
 Anhedonia 
 Weight change (>5% increase or decrease 
in body weight) or change in appetite 
 Insomnia/hypersomnia 
 Psychomotor agitation/retardation 
 Fatigue/loss of energy 
 Feelings of worthlessness/excessive guilt 
 Poor concentration/ability to make 
decisions 
 Recurrent thoughts of death, suicidal 
ideation, attempts or plans for committing 
suicide 
Duration: 
Symptoms must be present nearly every 
day (except suicidal thoughts) for a 2-
week period 
 
Impairment: 
Clinically significant distress/impairment 
in social, occupational or other 
important areas of functioning that 
represents a change from previous 
functioning. 
 
1.2.4 Epidemiology and Importance of Understanding Aetiology 
The onset of BD is usually in late adolescence or early adulthood, with the median age of onset 
estimated at 17.5 years (Kupfer et al. 2002) and symptom onset most common between the ages 
of 15 and 19 years of age (Weissman et al. 1996). 
Estimates of the lifetime prevalence of BD vary across studies, ranging from 0.3 to 2.4% for BD-I, 
and 0.3 to 4.8% for BD-II (Weissman et al. 1996; Kleinman et al. 2003; Waraich et al. 2004; Pini et 
al. 2005; Benazzi 2007; Merikangas et al. 2011). The estimates of lifetime prevalence for broader 
definitions of BD (e.g. that include cyclothymia) range from 0.8 to 13.5% (Benazzi 2007). Variation 
in estimates may reflect different assessment methods and criteria for generating diagnoses. 
However, evidence suggests that, due to under-identification and misdiagnosis (Goldberg et al. 
2001; Hirschfeld et al. 2003; Baca-Garcia et al. 2007; Berk et al. 2007), true prevalence is 
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underestimated. Such factors may contribute to the 5-10 year intervals between initial onset of 
illness and first treatment (Suppes et al. 2001; Baldessarini et al. 2003).  
With respect to sex differences, BD is equally prevalent among men and women (Lloyd et al. 
2005; Wells et al. 2006) but analysis of bipolar subtypes suggests that although BD-I is equally 
prevalent between genders, BD-II is actually more common in women than men (Di Florio and 
Jones 2010; Nivoli et al. 2011).  
In addition to the impairment caused directly by mood episodes, BD has a chronic course of 
illness that is associated with high rates of physical and psychiatric comorbidities (Angst 1998; 
Fiedorowicz 2008), substance misuse (Angst 1998), and higher rates of mortality compared to the 
general population (Angst et al. 2002). In addition, BD has been associated with neurocognitive 
deficits during mood episodes and periods of remission (Martínez-Arán et al. 2004; Martinez-
Aran and Vieta 2015) as well as enduring psychosocial impairment that worsens with increasing 
number of episodes experienced (Rosa et al. 2012). 
BD also has a considerable economic impact. When examining the effect of common physical and 
mental health disorders on productivity in 24 countries, Alonso et al. (2011) found that BD was 
associated with the most days completely out of role in the workplace. Furthermore, Das Gupta 
and Guest (2002) estimated the total annual cost of BD on UK society at £2 billion in 1999/2000 
prices. A more recent study estimated that the direct annual costs of BD to the UK healthcare 
system are £342 million at 2009/2010 prices, with hospitalizations accounting for 60% of this cost 
(Young et al. 2011).  
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The debilitating effects of BD on psychological, physical and occupational functioning, combined 
with substantial delays between the first manifestations of illness and diagnosis, mean that a 
primary goal of research is to inform efforts to improve early identification and intervention 
strategies (Bauer et al. 2008). One method of achieving this is to understand risk factors for BD 
(Correll et al. 2007). Before discussing the aetiology of BD in general I am going to discuss the role 
of childbirth – another area in which the effects of BD can have a significant impact on individuals 
and their families. 
1.2.5 Bipolar Disorder and the Perinatal Period 
Women with BD are at high risk of affective psychoses (i.e. mania, mixed1 episodes and psychotic 
depression) in the postpartum period (Jones et al. 2014). These episodes have traditionally been 
labelled as ‘postpartum psychosis’ (PP). The nosology of PP remains under debate (Chaudron and 
Pies 2003; Robertson et al. 2005) but evidence suggests that the majority of episodes have a 
sudden onset, typically occurring within the first two postpartum weeks (Brockington et al. 1981; 
Heron et al. 2007). In addition to the main symptoms of mania described previously in Table 1-1, 
PP is characterised by symptoms such as hallucinations, delusions and lability of mood (Jones et 
al. 2010).  
There is substantial evidence to suggest a relationship between PP and BD. In the general 
population, PP affects approximately 1 in 1000 parous women (Kendell et al. 1987). In contrast, 
PP affects 20-30% of parous women with a history of bipolar disorder (Jones and Craddock 2001; 
                                                          
1 In DSM-IV, a ‘mixed’ episode refers to an episode of mania or hypomania that simultaneously presents 
with full symptom criteria for a major depressive episode (American Psychiatric Association 2000).  DSM-5 
replaced ‘mixed episodes’ with ‘manic/hypomanic episode with mixed features’ in which subsyndromal 
depressive symptoms are present in (hypo)manic episodes (American Psychiatric Association 2013). 
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Di Florio et al. 2013; Wesseloo et al. 2016). This, combined with evidence that episodes of PP 
typically have a manic presentation(Brockington et al. 1981) and evidence that PP can be a 
marker for a more familial form of BD (Jones and Craddock 2002) suggests that PP may be best 
conceptualised as a bipolar diathesis combined with a vulnerability to a puerperal (i.e. childbirth-
related) trigger.  
Women with BD are also at high risk of experiencing major affective episodes in general during 
the postpartum period (Brockington, 1996), with estimates of relapse as high as 52% (Viguera et 
al. 2011). These findings persist even when accounting for potential changes or interruptions in 
medication around this time (Viguera et al. 2000). This suggests that specific aspects of childbirth 
trigger bipolar illness and that identifying these factors could provide useful information on the 
aetiology of BD in general. 
Due to the temporal proximity of mood episodes to childbirth, usually within two weeks of birth 
(Heron et al. 2007), researchers have endeavoured to identify which aspects of childbirth are 
responsible for triggering such episodes. To date, researchers have examined a variety of 
variables, which include delivery complications, gender of the baby, changes in medication, 
hormonal changes, psychosocial risk factors, immunological abnormalities, genetic vulnerabilities, 
and neurological factors (Robertson Blackmore et al. 2006; Spinelli 2009; Jones et al. 2014). To 
date, the most promising factors implicated in the aetiology of PP include primiparity, 
dysregulation of immune system function, and genetic factors (Jones et al. 2014; Bergink et al. 
2016). One under-researched area within this line of research is the role of sleep loss in triggering 
PP. This will be discussed in further detail in section 1.5.  
 
 13 
1.2.6 Aetiology: Current Knowledge 
The aetiology of BD is currently not clearly established but evidence to date suggests that the 
cause is multifactorial, involving a complex interaction between genetic and environmental 
factors (Craddock and Sklar 2013). A number of research avenues have examined biological, 
psychological and social factors that could be involved in the aetiology of BD. The following 
subsections provide a brief overview of this research. 
Genetics 
A detailed discussion of the genetic findings for BD is beyond the scope of this thesis and what 
follows is a brief summary (for more comprehensive reviews, see Craddock and Sklar, 2013, 
Maletic and Raison, 2014, Heyes et al. 2015). 
A wealth of evidence implicates a genetic component to BD. An individual’s likelihood of 
developing BD is greater if they have an identical twin or first-degree relative who also has the 
disorder (Goodwin and Jamison 1990; Lichtenstein et al. 2009), with an estimated heritability of 
60-90% (Smoller and Finn 2003; Craddock and Sklar 2013). 
Genome wide association studies (GWAS), which aim to identify single nucleotide polymorphisms 
(SNPs) within the genes of people with BD have suggested that genetic factors that increase risk 
for BD overlap largely with those associated with other psychiatric disorders (Cross-Disorder 
Group of the Psychiatric Genomics Consortium 2013), particularly schizophrenia (Lee et al. 2013; 
Stahl et al. 2017). GWAS using large samples with well-defined bipolar phenotypes (e.g. only 
patients with bipolar-I diagnoses) have replicated results for genes such as CACNA1C, ODZ4, and 
ANK3, which are involved in brain-specific functions such as neuronal signalling (Psychiatric GWAS 
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Consortium Bipolar Disorder Working Group 2011; Mühleisen et al. 2014; Stahl et al. 2017). 
However, these studies also unveil that the pattern of inheritance is complex, involving multiple 
genes which each confer only a small increase in risk for the disorder (Craddock and Jones 1999). 
The influence of genes on BD is further complicated by the fact that the environment may exert 
changes on gene expression via epigenetic changes (Machado-Vieira et al. 2011). 
Neurochemistry and Neuroendocrinology 
Research investigating the role of neurotransmitter functioning suggests that neurotransmitter 
imbalances or abnormal neurotransmitter receptors may be involved in the genesis of manic or 
depressive states. These include dopamine, noradrenaline and serotonin (Vawter et al. 2000; 
Shastry 2005; van Enkhuizen et al. 2014; Lin et al. 2014). Neuroendocrine abnormalities have also 
been implicated, such as hyperactivity in the hypothalamic-pituitary-adrenocortical (HPA) axis 
(Duffy et al. 2012) and abnormalities in indices of immune system functioning, such as pro-
inflammatory cytokines (Kauer-Sant’Anna et al. 2009). 
Brain Structure and Function 
Some studies suggest that individuals with BD have abnormalities in brain areas involved in 
emotion regulation (Houenou et al. 2007; Phillips et al. 2008). Imaging studies report structural 
abnormalities in individuals with BD compared to healthy controls, such as enlarged amygdala 
(Altshuler et al. 1998; Strakowski et al. 1999), and abnormalities in white matter structure in 
prefrontal-limbic-cortical areas (Strakowski et al. 2005; Maletic and Raison 2014). BD has also 
been associated with abnormal processing of emotional information and abnormal activation in 
areas of the brain involved in emotion regulation during emotion-processing tasks (Yurgelun-
Todd et al. 2000; Foland et al. 2008; Phillips et al. 2008; Pan et al. 2009; Townsend and Altshuler 
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2012). However, the cross-sectional nature of these studies means it is difficult to determine 
whether abnormalities in cortical and subcortical areas are precursors or merely a result of 
deterioration due to the illness and/or medication use (Drevets 2000).  
Psychosocial Factors 
Genetic predispositions cannot fully explain the onset and ongoing presentation of BD – 
evidenced by the fact that heritability estimates are less than 100% – and must therefore interact 
with environmental factors to produce the bipolar phenotype. Environmental and psychosocial 
factors proposed to trigger initial onset and recurrence of BD include stressful life events, alcohol 
or substance abuse, parenting styles and history of maltreatment (Johnson and Miller 1997; 
Frank and Thase 1999; Strakowski and Delbello 2000; Leverich et al. 2002). However, the 
evidence for parenting styles and maltreatment history is less conclusive than that for life events 
and alcohol or substance misuse (Alloy et al. 2005). 
Further research has explored the potential mechanisms by which environmental factors may 
trigger manic or depressive episodes. One theory is that individuals with BD have cognitive styles 
that result in overly high affect following positive life events (e.g. goal attainment) and overly 
negative affect following negative life events (Depue and Iacono 1989; Leboyer and Kupfer 2010; 
Hamlat et al. 2016). This ‘emotional reactivity’ has been supported by evidence from functional 
and structural brain imaging studies, in which BD patients show abnormal processing of 
emotional information and (as mentioned above) abnormalities in brain areas involved in 
emotion regulation (Houenou et al. 2007; Phillips et al. 2008). 
Another mechanism, proposed by Ehlers et al. (1988), is that life events which disrupt social 
rhythms subsequently disturb sleep and circadian rhythms, with the resultant biological 
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consequences culminating in relapse. This explanation is discussed in further detail in section 
1.3.4. 
 
Summary 
In summary, a number of bio-psycho-social factors could be involved in the aetiology of BD, and 
the likelihood is that such factors interact to contribute to illness onset and recurrence. The 
relationship between sleep disruption and BD has primarily been considered only insofar as sleep 
disruption is a symptom of mania. However, there is compelling evidence that disruption to the 
sleep-wake cycle also plays a role in the aetiology of BD. This will be explored in the following 
section in which I will outline how sleep disruption could be an additional paradigm through 
which we can understand more about the aetiology of BD.  
 
1.3 Sleep and Bipolar Disorder 
Emil Kraepelin was one of the first psychiatrists to document an association between abnormal 
sleep patterns and poor mental health (Kraepelin 1883), and in modern diagnostic systems (e.g. 
DSM-IV, DSM-5 and ICD-10) sleep disruption is a symptom of mania (a reduced need for sleep) 
and depression (hypersomnia and/or insomnia) (WHO 1992; American Psychiatric Association 
2000; American Psychiatric Association 2013). 
Disrupted sleep, although not a mandatory symptom for diagnosing manic or depressive 
episodes, is commonly reported by individuals with BD during episodes of depression and mania 
(Harvey 2008b), which has been verified using objective measures of sleep (de Maertelaer et al. 
1987; Hudson et al. 1988; Hudson et al. 1992). 
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Before discussing the role of sleep disruption in the aetiology of BD, the following section will 
outline the systems governing the sleep-wake cycle in humans. 
1.3.1 Regulation of the Sleep-Wake Cycle  
At a behavioural level, sleep is characterised by reduced movement and poor responsiveness to 
external stimuli (Bonnett 2011). This is accompanied by distinctive patterns in brain activation as 
a result of differential patterns in neurotransmitter release (Pace-Schott and Hobson 2002). A 
brief summary of these processes is as follows. Throughout wakefulness, a pressure to sleep 
develops due to the accumulation of adenosine in brain areas such as the basal forebrain. This 
results in the production of GABA (γ-aminobutyric acid) and galanin, which in turn inhibit arousal-
promoting systems within the brainstem, midbrain and basal forebrain, resulting in the onset of 
sleep. Once sleep is initiated, further variations in neurotransmitters serve to divide sleep into 
REM (rapid eye moment) and non-REM (NREM) sleep, which can be distinguished according to 
variations in electroencephalographic (EEG) oscillations (Wulff et al. 2010). NREM is characterised 
by inhibition of all aminergic and cholinergic neurotransmitters, as well as inhibition of the 
neuropeptide orexin. In contrast, in REM sleep orexin is released in addition to acetylcholine from 
the brainstem, midbrain and basal forebrain neurons (Peplow 2013). 
The alternating periods of sleep and wakefulness are known as the sleep-wake cycle, which in 
humans lasts approximately 24-hours. Patterns of behaviour or physiology that conform to a 24-
hour period are collectively termed circadian rhythms, from the Latin ‘circa diem’ meaning ‘about 
a day’. An individual’s propensity to sleep is thought to be an interaction of circadian rhythms in 
arousal (also known as Process C) and a homeostatic ‘sleep pressure’ (i.e. Process S) which 
increases the longer that someone is awake and then dissipates upon sleeping (Borbély 1982). 
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The interaction between Process S and Process C is demonstrated in Figure 1-1. This figure 
demonstrates that sleep onset is most likely at the time in the day when there is the largest 
difference between Process S and Process C. 
 
Figure 1-1. Interaction between the circadian drive for arousal (Process C) and the 
homeostatic sleep drive (Process S) (Borbély 1982).  
Aside from theories regarding adenosine accumulation in the brain, little is known about the 
physiology of Process S. In contrast, more research has been conducted on the generation and 
control of circadian rhythms. Multiple physiological processes throughout the body (such as 
hormone secretion, body temperature and blood pressure) display circadian rhythms (Foster and 
Kreitzman 2014) and serve to align various aspects of human behaviour (e.g. eating, sleeping, 
activity) to the changing requirements of the day. For example, in anticipation of sleep, body 
temperature and blood pressure decrease and levels of melatonin increase (Foster and Wulff 
2005).  
Circadian rhythms are generated by a collection of neurons in the anterior hypothalamus called 
the suprachiasmatic nuclei (SCN), also referred to as the ‘master clock’ (Foster and Kreitzman 
2014). Under constant conditions, the human sleep-wake cycle runs at approximately, but not 
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exactly, 24 hours (Harvey et al. 2011), therefore the SCN acts as a pacemaker to align the sleep-
wake cycle with the 24-hour day. This process is known as ‘entrainment’, which is achieved 
through zeitgebers (a German term meaning ‘time-giver’). The primary zeitgeber is the external 
light-dark cycle of the earth. Light levels detected by the eyes are relayed via a 
retinohypothalamic tract to the SCN, which then signals via multi-synaptic pathways to other 
areas of the brain. Activation of these brain areas then serves to coordinate the ‘peripheral 
clocks’ present within cells and tissues throughout the body. In turn, emerging evidence shows 
that peripheral clocks are able to entrain the SCN via non-photic information such as 
temperature, social cues, feeding or physical activity (Mistlberger et al. 2000). Therefore the 
circadian system is complex and constantly adapting to environmental factors that may or may 
not be due to human volition (e.g. staying awake due to long-haul travel or shift-work).  
1.3.2 The Physiological Effects of Sleep Disruption 
The processes governing the onset, maintenance and control of sleep interact with numerous 
processes in the body such as hormone release, metabolism, digestion, immune system 
functioning, and cognition. Thus, disruptions to sleep and circadian regulatory systems have 
widespread effects throughout the body.   
There is a burgeoning literature examining the associations between sleep disruption and poor 
health. For example, epidemiological studies find that individuals who are exposed to sleep and 
circadian disruption through shift work are at an increased risk of obesity (Gangwisch et al. 2005), 
cardiovascular mortality (Harrington 2001), cancer (Schernhammer et al. 2003), and poor 
reproductive health (Nurminen 1998; Zhu et al. 2004). Proposed mechanisms include disrupted 
metabolic processes (Knutson et al. 2007) and effects on immune system functioning (Irwin 
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2002). The physiological effects of sleep disruption have been further confirmed in studies of 
gene expression following mistimed sleep, with a study by Archer and colleagues finding that the 
function of genes involved in inflammation and immunity were affected when human subjects 
slept at times at odds with their circadian clock (Archer et al. 2014). 
1.3.3 The Effects of Sleep Disruption on Mental Health 
The physiological effects of sleep disruption also have implications for mental health, and 
emerging research suggests that the neural mechanisms underlying sleep and mental health 
overlap, therefore disruption to one pathway results in dysfunction in the other (Wulff et al. 
2010; Harvey et al. 2011; Foster and Kreitzman 2014). Numerous observational studies indicate 
that disrupted sleep precedes the onset of poor mental health (Kahn-Greene et al. 2007; Morphy 
et al. 2007; Ritter et al. 2011) and abnormalities in sleep architecture (e.g. increased REM density) 
have been identified as risk factors for developing affective disorders (Modell et al. 2003). In 
addition, sleep disorders are highly comorbid with the majority of psychiatric disorders (Harvey 
2011). 
However, the relationship between sleep disruption and mental health can be difficult to 
disentangle as disrupted sleep is often a core symptom of psychiatric disorders (Harvey 2008a; 
American Psychiatric Association 2013), with 80% of patients with depression or schizophrenia 
experiencing sleep problems (Wulff et al. 2010). As shown in Figure 1-2, the consequences of 
psychiatric illness, such as medication use, may also increase the risk of sleep disruption. This 
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makes it difficult for researchers to determine whether sleep disruption is a trigger, prodrome2, 
or an early symptom of impending illness. More convincing evidence that disrupted sleep could 
have a causal role in the development of mental illness are provided by sleep deprivation 
protocols, in which healthy subjects are kept awake under experimental conditions. These studies 
find that sleep deprivation results in impaired cognition and mood (Scott et al. 2006; Acheson et 
al. 2007; Banks and Dinges 2007; McKenna and Eyler 2012). In addition, animal studies find that 
disrupting the function of circadian genes disrupts mood regulation, increases anxiety, and 
moderates responses to reward (McClung 2011). 
Currently, the exact mechanisms by which sleep disruption results in poor mental health are 
unclear. However, the theory that has received the most attention proposes that disruptions to 
sleep (and the circadian rhythms underlying it) are associated with psychiatric illness via common 
overlapping mechanisms (Figure 1-2). 
     
                                                          
2  Changes in behaviour, affect and cognition that precede illness onset or relapse (Bustillo et al. 1995; 
Jackson et al. 2003).  
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Figure 1-2. Hypothesised relationship between sleep and circadian disruption and psychiatric 
illness (Wulff et al. 2010). 
The main common overlapping mechanism proposed is that, as sleep and circadian systems 
affect numerous neurotransmitter systems throughout the brain, perturbations in these systems 
due to sleep disruption results in widespread effects on other processes that rely on these 
systems for healthy functioning, such as mental and physical health (Wulff et al. 2010). More 
specifically, sleep disruption may affect mood via a mismatch between sleep and circadian 
systems. An example of how this may occur is in jet lag, whereby travelling across multiple time 
zones results in major variations in light exposure, activity and eating patterns. This information 
results in the peripheral clocks of the body becoming misaligned with the master clock, as the 
SCN, although entrained by light, takes multiple days to completely entrain to external light 
patterns.  
The abnormal phase relationship between the sleep and circadian systems is thought to produce 
the aberrations in neurotransmitter and neuroendocrine functions (e.g. stress axis activation) 
that lead to dysregulated mood and poor cognition (Murray and Harvey 2010; Wulff et al. 2010). 
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This theory has been supported by the effectiveness of therapies involving a combination of sleep 
deprivation, light therapy and imposed sleep schedules, which are thought to work by resetting 
the mismatched sleep and circadian systems (Wirz-Justice and Van den Hoofdakker 1999; 
Benedetti et al. 2007). Further evidence for an overlap between circadian systems and psychiatric 
disorders is derived from studies finding that genes that govern the generation and regulation of 
circadian systems have been associated with mood disorders, anxiety disorders, and 
schizophrenia (Serretti et al. 2003; Lamont et al. 2007; Partonen et al. 2007; Partonen 2012; 
Pritchett et al. 2012). 
However, Figure 1-2 also highlights that there are other factors associated with psychiatric 
disorders, abnormal neurotransmitter release, and sleep/circadian rhythm disruption. These 
include addiction or substance abuse and medication. This can make it difficult to determine 
whether sleep and circadian rhythm disruption is a cause or a result of psychiatric illness. 
In summary, there is considerable evidence that sleep disturbance could play a role in psychiatric 
illness beyond being merely a symptom. However, like the aetiology of psychiatric disorders in 
general, the relationship is complex and involves multiple interacting bio-psycho-social factors. In 
the next section, I will discuss the role of sleep disruption in the aetiology of BD in particular. 
1.3.4 The Role of Sleep Disruption in the Aetiology of Bipolar Disorder 
The evidence I have described so far suggests that sleep disruption could play an important role 
in the aetiology of mood disorders. As previously discussed, sleep disturbance is a symptom of 
episodes of depression and mania. However, in this section I will focus on the evidence that sleep 
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disruption plays a role in the aetiology of BD.  There are four main lines of evidence supporting 
this theory: 
1. Sleep disruption is a trait marker for BD – sleep disruption is evident in individuals with 
BD during periods of euthymia and prior to illness onset. 
2. There are plausible biological mechanisms through which sleep disruption could affect 
mood in BD, specifically mania. 
3. Treating sleep disruption in individuals with BD appears to improve illness outcomes. 
4. Sleep deprivation imposed under experimental settings triggers mania (e.g. total sleep 
deprivation therapy) 
In this section, I will outline the evidence for each of these statements. Following this, in section 
1.4 I will focus on the specific role of sleep as a pathway to mania in BD. This is the primary 
manner in which sleep has a different relationship with BD compared to other psychiatric 
disorders, and it is this which forms the central theme of this thesis. 
1. Sleep Disruption as a Trait Marker for BD 
Disrupted sleep precedes the onset of BD (Ritter et al. 2011) and persists during periods of 
euthymia. For example, numerous studies using objective indices of sleep, such as actigraphy (a 
method of measuring sleep using activity monitors), have found that individuals with BD show 
disrupted sleep-wake schedules when euthymic (Jones et al. 2005; Salvatore et al. 2008; Gershon 
et al. 2012; Kaplan et al. 2012). There is also evidence that euthymic BD individuals show 
abnormalities in the architecture of sleep, such as increased REM density (Eidelman et al. 2010). 
Furthermore, children of individuals with BD show more disturbed sleep than those whose 
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parents have no history of mood disorders (Duffy et al. 2010), suggesting that sleep disruption 
could be an endophenotype of the disorder.  
Sleep disorders during euthymia are also common in BD. For example, compared to the general 
population, individuals with BD are more likely (during euthymic periods) to experience sleep 
disorders such as obstructive sleep apnoea, insomnia, hypersomnia, and circadian rhythm sleep 
phase disorders (Plante and Winkelman 2008; Soehner et al. 2013; Kanady et al. 2015; Bradley et 
al. 2017). 
In addition to perturbed sleep-wake cycles, there is evidence that a variety of circadian rhythms 
(which, as discussed in section 1.3.1, are pivotal to the regulation of the sleep-wake cycle) such as 
general activity and temperature rhythms, are disrupted in BD (Kripke et al. 1978; Pflug et al. 
1982; Jones et al. 2005)). This evidence suggests that BD is associated with an underlying 
instability in circadian rhythms. This has been supported by studies showing that greater 
instability in circadian rhythms is associated with symptom severity (Gonzalez et al. 2014) and risk 
of relapse (Jones 2001) in BD. 
Further evidence for a role of circadian influence in BD derives from research on chronotype. 
Chronotype refers to the time of day at which individuals prefer to do particular activities 
(including but not limited to sleep), and has been correlated with a number of physiological 
parameters implicated in BD, such as catecholamine and hormone secretion, temperature 
rhythms, and arousal (Akerstedt and Fröberg 1976; Liu et al. 2000; Duffy et al. 2001; Kudielka et 
al. 2006). Preliminary data suggest that BD patients are more likely to show an evening 
chronotype (i.e. a preference for performing activities during the evening) than healthy 
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participants (Mansour et al. 2005; Ahn et al. 2008; Wood et al. 2009). However, it is unclear 
whether such studies are confounded by other factors such as medication and social schedules.  
2. Biological Mechanisms 
There are plausible biological mechanisms that could account for the association between BD and 
sleep disruption. Of note is that many of these mechanisms have been independently implicated 
in the aetiology of BD. Therefore sleep disruption may be a unifying mechanism through which 
these biological effects are involved in the pathogenesis of BD. 
One proposed mechanism for these findings is that circadian rhythm abnormalities in BD are due 
to abnormalities in the genes governing circadian rhythms, otherwise referred to as ‘clock genes’ 
(Shi et al. 2008). The literature on this is still in its early stages, however a number of candidate 
gene studies have found associations between polymorphisms in clock genes and BD (Mansour et 
al. 2006; Lamont et al. 2007; M. Ha et al. 2009; Kripke et al. 2009; McGrath et al. 2009; Wulff et 
al. 2010; Benedetti and Terman 2013; Gonzalez 2014; Geoffroy et al. 2015). Other studies have 
found that clock genes are associated with course of illness, such as early onset and response to 
lithium treatment (Benedetti et al. 2004; Rybakowski et al. 2014). Finally, there is evidence that 
pharmacological treatments for BD, such as lithium and valproic acid, restore rhythmicity in clock 
genes (Johansson et al. 2011; Osland et al. 2011; McCarthy et al. 2013).  
Monoamines implicated in BD, such as serotonin and dopamine, have also been found to display 
circadian rhythms in their release, suggesting that they are under circadian control (McClung 
2007). In addition, some theories propose that the pathology of BD might be due, in part, to 
abnormal circadian rhythms in the production of melatonin (Pacchierotti et al. 2001). To date, 
findings are mixed, however there is preliminary evidence that BD patients show blunted 
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circadian rhythms in melatonin (Nurnberger et al. 2000) and overactive melatonin secretion in 
response to light (Lewy et al. 1985). Additional evidence for the involvement of the melatonergic 
system comes from research on the melatonin receptor agonist agomelatine which is reported to 
affect sleep architecture and circadian rhythms (Zupancic and Guilleminault 2006), as well as 
preliminary evidence that it could be an effective treatment for BD patients (De Berardis et al. 
2015). 
Sleep disruption may also perturb neuroendocrine functions that have been implicated in BD, for 
example via the abnormal activation of the HPA axis (Morris et al. 2012) and increases in 
proinflammatory cytokines (Imeri and Opp 2009). Of interest is that alterations in peptides 
involved in feeding and metabolism have been shown to be arrhythmic in Clock knockout mice, 
who also show increased weight gain and symptoms similar to those seen in metabolic syndrome 
(Turek et al. 2005). This may provide a potential mechanism to explain why individuals with BD 
have an increased risk of obesity and metabolic syndrome (Fiedorowicz 2008). 
Mood episodes display a seasonal pattern in some individuals with BD, with depressive episodes 
more common in winter months and manic episodes more common in summer months (Hardin 
et al. 1991; Silverstone et al. 1995; Cassidy and Carroll 2002; Hakkarainen et al. 2003). The DSM-5 
includes a seasonal specifier for course of mood variation to reflect this (American Psychiatric 
Association 2013). It has been hypothesised that this seasonal variation is due to the effects of 
varying light-exposure on the circadian system, which will, in turn, disrupt mood regulation 
(McClung 2007; Gonzalez 2014). This theory is further supported by results that light therapy can 
be used as an effective treatment for bipolar depression (Colombo et al. 2000; Benedetti et al. 
2005), and dark therapy for mania (Wirz-Justice et al. 2009).  
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3. Treating Sleep Disruption Improves Illness Outcomes 
If sleep disruption is involved in the aetiology or pathology of BD, then improvements in sleep 
should lead to improvements in symptoms of the illness as well as functioning and prognosis. 
Preliminary evidence supports this theory, as interventions that aim to restore regularity in 
circadian rhythms in BD have been associated with positive outcomes. For example, the central 
tenet of interpersonal and social therapy (IPSRT) (Frank et al. 2000) is that bipolar episodes result 
from disruption to circadian rhythms (Ehlers et al. 1988). IPSRT aims to stabilise circadian rhythms 
through maintaining schedules in social interaction, eating patterns, work patterns as well as 
sleep patterns. To date there is preliminary evidence that this form of therapy may be a beneficial 
complement to pharmacotherapy, and may be associated with a reduced rate of relapse (Frank 
et al. 2005), however there is still currently a lack of randomised-controlled trials to corroborate 
its efficacy (Haynes et al. 2016). 
An emerging treatment for insomnia, CBT-I (cognitive behavioural therapy for insomnia) has been 
adapted for use in psychiatric populations, with preliminary results suggesting that it could be 
effective for reducing psychotic symptoms in patients with schizophrenia (Freeman et al. 2013; 
Freeman et al. 2015). To date, there has been one randomised controlled trial (RCT) assessing the 
efficacy of CBT-I as a treatment in BD; in a pilot RCT, Harvey and colleagues compared 
psychoeducation to CBTI-BP (CBT-I adapted for use in patients with BD) and found that CBTI-BP 
was associated with a reduced risk of relapse over a 6 month follow-up period (Harvey et al. 
2015). 
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4. Sleep Deprivation Imposed Under Experimental Settings Triggers Mania 
The final line of evidence that sleep plays a role in the aetiology of BD stems from findings that 
experimentally-imposed sleep deprivation (i.e. when individuals are intentionally deprived of 
sleep for research or therapeutic purposes) is associated with mania (Colombo et al. 1999). The 
theory of sleep disturbance acting as a trigger or pathway to mania, and its implications for our 
understanding of BD, are discussed fully in the next section.   
1.4 Sleep Disturbance as a Pathway to Mania 
In this section, I will focus on the role of sleep disruption as a pathway in the aetiology of BD, 
specifically manic episodes. This will be followed by a discussion of current limitations in this area 
of research, concluding with the aims of the thesis. This literature review was conducted using 
online databases (e.g. MEDLINE, EMBASE, Web of Science, Scopus) using the terms  “prodrome”, 
“trigger”, “early warning sign”, “precipitant”, “precedent”, “predictor”, “mania”, “hypomania”, 
“high mood”, “bipolar”, “mood”, “sleep”, “insomnia” and “circadian”. This was complemented by 
studies cited within the identified literature that did not appear in online searches (e.g. case 
reports and older reviews). This literature review should be considered in light of limitations such 
as publication bias (e.g. grey literature was not reviewed) and a reliance on studies published in 
English language studies. 
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1.4.1 The Sleep-Reduction Model of Mania 
In 1987, Thomas Wehr and colleagues proposed that sleep disruption may be a ‘final common 
pathway in the genesis of mania’ (Wehr et al. 1987). This hypothesis was initially based on 
observations from case studies (Wehr et al. 1982; Wehr et al. 1987; Wehr 1989) in which Wehr 
observed that some patients appeared to have experienced sleep deprivation prior to the onset 
of manic episode. Selected examples are provided below: 
Example 1: An attorney with no previous history of mental illness: 
‘The attorney was working on a difficult and important case. A trial date had been set, 
and as it approached, he realized that he did not have enough time to prepare in his usual 
thorough manner. Therefore, the night before the trial he decided to go without sleep and 
continue his preparations through the night. The next morning…he became increasingly 
manic, the police were called, and he was hospitalised involuntarily.’ (Wehr 1989 p.11)  
Example 2:  Dr A, a bipolar patient who had been mildly depressed during the final year of medical 
school: 
‘During the first 2 months of his internship, he was on call at the hospital every third night. 
When on call, he was unable to obtain more than a few hours of sleep during the night. 
Each day after the on-call night Dr A became hypomanic; he became euthymic on the 
second day and mildly depressed on the third. Thus he developed a rapid-cycling course of 
manic-depressive illness that was driven by external factors regulating his sleep schedule.’ 
(Wehr et al. 1987 p.202)  
Example 3: Ms D 
‘Ms. D, a 50-year old woman who had been depressed for several months, took an 
overnight transatlantic flight from the United States to Europe to visit her family. Like 
many passengers, she slept very little (if at all) during the flight and by the time of her 
arrival the following morning she had switched into her first hypomanic episode.’ (Wehr 
et al. 1987 p.202) 
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These case studies, in combination with other evidence (described in more detail below), led 
Wehr and colleagues to propose that: 
‘Diverse psychological, interpersonal, environmental and pharmacological factors that 
appear to trigger the onset of mania could act via their capacity to cause sleep 
deprivation...Since mania in turn causes insomnia, the development of mania is 
potentially self-reinforcing and could become autonomous after being initiated by 
precipitating factors.’ (Wehr et al. 1987 p.201) 
The initial model proposed by Wehr and colleagues is shown in Figure 1-3.  
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Figure 1-3. Proposed model of the relationship between sleep disruption and mania (Wehr et 
al. 1987). 
As shown in Figure 1-3, Wehr et al. (1987) proposed multiple mechanisms (biological, 
psychological and environmental) by which an individual might experience a reduction in sleep. 
The model incorporates the possibility that the symptoms of mania result in further sleep 
disruption, thus providing a potential explanation for rapid escalation of manic episodes as well 
as drawing attention to the fact that mania can be both a symptom and cause of sleep disruption.  
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1.4.2 Supporting Evidence 
In 1991, Wehr presented additional evidence to support the sleep-reduction model of mania 
from prospective observations of an inpatient over 16 weeks, shown in Figure 1-4 (Wehr 1991). 
Nurses monitored the patient’s mood twice a day and the patient’s sleep every 30 minutes. 
During the 16 weeks, the patient experienced five manic episodes. The first three episodes were 
preceded by reduced sleep, which Wehr proposed was the result of the stress of being admitted 
(first episode), and medication withdrawal (second and third episode). Following this, Wehr 
attempted to experimentally induce sleep deprivation by asking the patient to stay awake 
overnight on two separate occasions. On both of these occasions, the patient switched into 
mania the day after sleep deprivation, which was followed by depression once she had slept. 
Wehr concluded that, ‘Although other interpretations are possible, the sleep-deprivation 
hypothesis appears to provide a parsimonious, unitary explanation for the patient’s responses’ 
(Wehr 1991 p.578). 
 
Figure 1-4. Longitudinal 16-week record of sleep duration and mood in 59 year old woman 
with bipolar illness (Wehr 1991). 
 34 
Additional observational evidence has supported this model, with reports of mania following 
substance abuse, medications, long-haul travel, and bereavement (Hollender and Goldin 1978; 
Jauhar and Weller 1982; Rosenman and Tayler 1986; Wehr 1991; Young 1995). However, this 
evidence is limited by an inability to determine whether the observed sleep disruption is an early 
symptom of mania. For example, in a systematic review of prodromes, Jackson and colleagues 
(2003) concluded that sleep loss was one of the most common prodromes of manic episodes, 
reported by 77% of patients. Furthermore, sleep disruption may also be an epiphenomenon of 
other factors associated with manic episodes 
However, more compelling evidence that sleep disturbance can trigger mania derives from the 
findings of (1) animal studies, (2) total sleep deprivation studies in healthy human populations, 
and (3) studies of bipolar patients undergoing total sleep deprivation therapy for depression. 
Animal studies 
Some researchers have reported manic-like behaviours in rats following enforced sleep-
deprivation as produced by use of the ‘platform method’ (Jouvet et al. 1964) in which the rat is 
suspended on a small platform above water that it will fall into if it sleeps. For approximately 30 
minutes after the protocol has ended, researchers have reported symptoms in the rats that 
mimic mania, such as hyperactivity, irritability (stimulation-induced aggression), hypersexuality 
and decreased need for sleep (Morden et al. 1968; Albert et al. 1970; Hicks et al. 1979; Fratta et 
al. 1987). In addition, Gessa and colleagues found that these symptoms could be alleviated 
following administration of lithium (Gessa et al. 1995).  
Additional evidence for the role of sleep in the aetiology of mania is derived from mouse models 
in which researchers have induced mutations in genes involved in regulating circadian rhythms. 
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For example, Roybal and colleagues found that mice with a mutation in the Clock gene displayed 
manic-like behaviours, such as hyperactivity, decreased sleep, and increased value for rewards, 
which were alleviated following administration of lithium (Roybal et al. 2007). However, as noted 
in Section 1.3, the circadian system governs multiple processes throughout the body in addition 
to the sleep-wake cycle. Therefore mutations in circadian rhythm genes could incite manic 
symptoms via other processes. 
Total Sleep Deprivation Studies in Healthy Human Populations 
Total sleep deprivation (TSD) experiments in healthy participants have noted that some 
participants display manic-like behaviour such as euphoria, distractibility and disinhibited 
behaviour (Bliss et al. 1959; Kollar et al. 1966; Horne 1993). These findings have been 
corroborated by neuroimaging studies. For example, Gujar et al. (2011) found that TSD was 
associated with increased reactivity toward pleasure-evoking stimuli, with corresponding 
increases in mesolimbic reward brain networks. 
 
Total Sleep Deprivation Therapy in BD Patients 
Additional support for the mania-inducing effects of sleep loss derives from accounts of mood 
changes following sleep deprivation therapy (Wehr 1992). During sleep deprivation therapy, 
depressed patients are kept awake for either the entire night (total sleep deprivation, TSD, 
comprising at least 36 hours wakefulness) or half of the night (partial sleep deprivation). Sleep 
deprivation therapy has been used as a treatment for depression since the 1970s due to its 
antidepressant effects (Pflug 1972; Pflug 1976; Benedetti 2012). However, there are accounts of 
some patients with BD becoming manic or hypomanic following this treatment (Wehr 1989; Wu 
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and Bunney 1990; Kasper and Wehr 1992). Wu and Bunney (1990) reviewed the findings of 10 
sleep deprivation studies (published from 1974 to 1982) and calculated that approximately 30% 
of the bipolar depressed patients had switched into mania. Table 1-4 includes the studies 
reported by Wu and Bunney (1990) in addition to subsequently published studies that have 
reported the percentage of BD inpatients who have become manic or hypomanic following TSD.
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Table 1-4. Rates of mania and hypomania in BD inpatients following total sleep deprivation therapy for depression. 
Study Sample  Sleep Deprivation Protocol Mood Measure N (%) who became 
manic or 
hypomanic 
Bhanji and Roy 
(1975) 
 2 BD-II 
 Male (100%) 
 Age 59 and 52 
 1 night TSD therapy. 
 Medication kept constant. 
 
Mood measured by clinical observation 
and self-rated depression scale (Snaith et 
al. 1971) 
1 (50%) ‘mildly 
hypomanic’ 
 
Cole and Muller 
(1976)  
 3 BD  
 Gender and age not 
reported specifically 
for BD participants. 
 36-hour TSD therapy under supervision 
of treating physician. 
 Treatment with antidepressant. 
medication in “most cases”. 
Hamilton Rating Scale for Depression 
(Hamilton 1960) and clinical notes. 
1 (33%) manic 
Colombo et al. 
(1999) 
 206 BD 
 70 Male (34%) 
 Mean age 46.4 
 3 cycles of TSD alone or in combination 
with supplemental medication. 
Mania and hypomania defined according 
to DSM-IV criteria with exception of 
temporal criterion for mania.  
10 (4.85%) manic 
12 (5.83%) 
hypomanic 
 
Dessauer et al. 
(1985) 
 
 4 BD  
 Gender and age not 
reported specifically 
for BD participants. 
 1 night partial sleep deprivation (5 sleep 
deprivation treatments in the second 
half of the night from 01.30h at 5-day 
intervals). 
Bojanovsky-Chloupkova mood rating scale 
(Bojanovsky and Chloukova 1966) by 
examiner and patient self-report using 
Luria (1975) visual analogue mood scale. 
1 (25%) manic  
1 (25%) hypomanic  
 
Gerner et al. 
(1979) 
 14 BD-I 
 Gender and age not 
reported specifically 
for BD participants. 
 1 night TSD therapy (40 hours awake) 
monitored by nursing staff. 
 Medication-free for at least three weeks 
prior to study. 
Mood ratings every 2 hours by trained 
nurses or psychologists using Bojanovsky 
and Chloukova (1966) rating scale. 
No patients became 
manic or 
hypomanic. 
Larsen et al. 
(1976) 
 3 BD  
 2 Male (66%) 
 2 < 60 years old 
 1 > 60 years old 
 1 night TSD therapy from 11pm until 
5pm the following day, with supervision 
from medical student. 
 Medication-free 36 hours before sleep 
deprivation protocol. 
Bjørum and Lindberg Scale (reference not 
provided) rated by two psychologists. 
No patients became 
manic or 
hypomanic. 
King et al. (1982)  3 BD 
 Male (100%) 
 Mean age 39 (range 
28-50) 
 1 night TSD (36-42 hours). 
 Medication kept constant. 
Clinical notes (nurses and psychiatric 
resident) rated by independent raters. 
1 patient became 
‘euphoric’ (33%). 
 38 
Study Sample  Sleep Deprivation Protocol Mood Measure N (%) who became 
manic or 
hypomanic 
Pflug (1976) 
 
 12 BD 
 6 Male (50%) 
 Mean age 42 
 1 night TSD therapy Bojanovsky and Chloukova (1966) mood 
rating scale. 
1 (8%) manic 
Post et al. (1976)  7 BD-I, 2 BD-II 
 3 Male (33%) 
 Mean age 38 
 1 night TSD therapy for at least 39 hours 
with continuous monitoring by nursing 
staff. 
 Medication-free. 
Ratings of depression, mania, psychosis, 
anxiety, anger, talkativeness, restlessness, 
drowsiness, somatic complaints, 
grandiosity, elation, retardation, agitation, 
and sadness obtained every two hours 
throughout the day by a trained research 
staff nurse using a 15-point scale designed 
to measure short-term behavioural and 
somatic changes. 
1 (11%) ‘mild 
hypomanic state’ 
which lasted for two 
weeks. 
Svendsen (1976)  17 BD  
 Gender and age not 
reported specifically 
for BD participants. 
 1-6 treatments of 1-night TSD therapy 
with monitoring by nursing staff. 
 Medication kept constant. 
Mood rated by clinical observation and 
modified Cronholm-Ottosson rating scale 
(Cronholm and Ottosson 1960). 
No patients became 
manic, unknown 
whether any 
became hypomanic. 
Vovin et al. (1982)  7 BD  
 Gender and age not 
reported specifically 
for BD participants. 
 1-night TSD therapy (36 hours) every 2-3 
days for 2-3 weeks. 
 Medication (antidepressants) kept 
constant. 
Nurse observation every 2 hours. 1 (14%) manic, 
unknown whether 
any became 
hypomanic. 
Wehr et al. (1982)  9 rapid-cycling BD (3 
BD-I, 6 BD-II) 
 1 Male (11%) 
 Mean age 39 
 1-night TSD therapy (40 hours) with 
monitoring every 30 minutes by nursing 
staff. 
 Medication-free. 
Twice daily ratings of mania and 
depression by nurses using Bunney-
Hamburg scale (Bunney and Hamburg 
1963). 
4 (44%) manic  
3 (33%) hypomanic  
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Study Sample  Sleep Deprivation Protocol Mood Measure N (%) who became 
manic or 
hypomanic 
Yamaguchi et al. 
(1978) 
 Sample of 
depressed patients 
(number with BD 
not reported) 
 Gender and age 
not reported 
specifically for BD 
participants. 
 1 night TSD therapy with close 
supervision by at least one psychiatrist. 
 Medication kept constant  
Clinical observation (specific measure not 
reported). 
1 manic  
Zimanova and 
Vojtechovsky 
(1974) 
 Sample of 
depressed patients 
(number with BD 
not reported) 
 Age and gender of 
BD patients not 
reported. 
 28 nights TSD therapy with nurse 
observation  
 Medication: tricyclic antidepressants 
Questionnaire and self-rating mood scale 
(von Zeerson scale, references not 
provided). 
1 manic  
1 hypomanic 
TSD, total sleep deprivation (i.e. at least 36 hours wakefulness); BD, bipolar disorder; BD-I, bipolar-I disorder; BD-II, bipolar-II disorder. 
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As shown in Table 1-4, in studies where the number of BD patients have been reported, the rate 
of switch into (hypo)mania varies widely from 0-44% for mania, and 0-50% for hypomania. 
However, these TSD studies are limited in a number of respects. First, apart from the study by 
Colombo et al. (1999) most of the studies have small sample sizes (ranging from 2 to 17 BD 
patients, with a median of 7 patients), thus they are underpowered and of insufficient 
representativeness to ascertain the rate of switch into (hypo)mania.  Second, samples vary 
considerably in age, medications, and other clinical characteristics such as the presence of rapid-
cycling and non-rapid cycling3 BD. Third, in all studies reviewed in Table 1-4, sleep deprivation 
therapy was administered to bipolar patients when they were depressed, therefore sleep loss 
may be more likely to trigger mania in euthymic bipolar patients (Plante and Winkelman 2008). 
Finally, characteristics of the sleep deprivation protocols may have influenced the rate of switch 
into mania. For example, in the study conducted by Svendsen (1976), the sleep deprivation 
protocol was described as follows, “The night’s social gathering comprises coffee parties, walks, 
music, card-playing, and various occupations according to the patients’ desires and skills. These 
activities are optional” (p.185). Although none of the patients in this study became manic, this 
raises the question of whether sleep deprivation protocols introduce additional factors that could 
incite mania, such as caffeine consumption and stimulating activities. Furthermore, patients were 
often fully aware of the purpose of these sleep-deprivation studies, thus any effects observed 
may have been a placebo effect. 
                                                          
3 The ‘rapid-cycling’ specifier for BD is described in section 1.2.3.  
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In light of these methodological limitations, the most robust study of rate of switch into mania 
was by Colombo et al. (1999), due to the relatively larger sample size and consideration of 
medication, which the authors concluded was not significantly associated with the rate of 
switches into mania. In this study, the rate of switching into mania was considerably lower than 
reported in the other studies (5-6%). However the authors concede that these rates could be 
higher in euthymic bipolar patients. Nevertheless, despite having a larger sample size than other 
studies available, the sample size in this study is still relatively small and had considerable 
heterogeneity in medications taken by patients, thus making it difficult to assess the true rate of 
switch into mania following sleep deprivation.   
Prospective Studies of Sleep and Mood in BD 
The findings outlined above prompted some researchers to examine the longitudinal relationship 
between sleep duration and mood in participants with bipolar disorder. Specifically, if sleep 
deprivation can trigger mania, then reduced sleep duration should predict subsequent increases 
in manic symptoms (Plante and Winkelman 2008). If so, clinicians and patients may be able to use 
this information to manage the condition. Some prospective studies have supported this 
hypothesis. For example, Wehr et al. (1982) reported that 13 out of 15 rapid-cycling patients 
experienced mania or hypomania following nights in which they could not sleep. In addition, 
Leibenluft et al. (1996) examined associations between sleep length and mood in a sample of 8 
rapid-cycling bipolar patients over 18 months, finding that a decrease in sleep duration predicted 
a subsequent increase in manic symptoms the following day. Similarly, Bauer et al. (2006) 
examined associations between sleep and mood in 59 bipolar patients over a minimum of 100 
days, finding that a 3 hour change in bed-rest predicted increased manic symptoms the following 
day.  Other studies that have investigated the longitudinal relationship between sleep and mania 
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are summarised in Table 1-5. The studies presented in this table all demonstrate associations 
between reduced sleep duration and subsequent high mood. However, these studies are also 
limited in a number of respects. First, there is wide variation in the period of monitoring sleep 
and mood across studies; with the monitoring period of some studies as short as three days, and 
others as long as 18 months. Second, the frequency at which data on sleep and mood were 
monitored also varied widely between studies, ranging from 30-minute to 4-week intervals. 
Second, some of the studies (Wehr et al. 1982; Barbini et al. 1996; Leibenluft et al. 1996) rely on 
very small sample sizes, thus limiting the representativeness of the samples. Furthermore, the 
prospective studies of sleep and mood also suffer the same limitations as the sleep deprivation 
studies; in which the methodology includes samples that vary in age, medication use, and clinical 
features such as the presence of rapid-cycling BD.  Finally, not all participants showed significant 
associations between reduced sleep and (hypo)mania. These issues will be discussed in further 
detail in section 1.6.  
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Table 1-5. Prospective studies between sleep and mania in participants with bipolar disorder. 
Authors N Bipolar 
Subtype 
Mood Measure Sleep Measure Monitoring Period and 
Frequency 
Findings 
[1] Bauer 
et al. 
(2006)  
59 37 BD-I 
22 BD-II 
 
Self-report 
Visual analogue mood scale (0-
100) 
Self-report 
Sleep diary 
(awake, sleep, 
bedrest) 
Daily measures of sleep and 
mood for 169 (mean) ± 59 
days per participant 
Decrease in sleep or bedrest 
followed by a shift towards 
mania/hypomania the next day 
in 59% of participants. 
[2] Bauer 
et al. 
(2008) 
101 64 BD-I 
37 BD-II 
Self-report 
Visual analogue mood scale (0-
100) 
Self-report 
Sleep diary 
(awake, sleep, 
bedrest) 
Daily measures of sleep and 
mood for 265 (mean) ± 103 
days per participant 
Decrease in sleep duration (sleep 
and bedrest) associated with 
shift towards mania/hypomania 
the next day in 39% of 
participants.  
[3] Barbini 
et al. 
(1996) 
34 BD-I Clinician-report 
Young Rating Scale for Mania 
(YRSM, Young et al. 1978). 
 
Nurses’ Observation Scale for 
Inpatient Evaluation (NOSIE, 
Honigfeld and Klett 1965). 
Clinician-report 
Nocturnal sleep 
duration and 
diurnal naps 
recorded by 
nursing staff. 
Over 3 consecutive days: 
 Sleep checked at 60-
minute intervals. 
 YRSM once daily at 
12:00 
 NOSIE twice daily at 
12:00 and 19:00 
Significant correlations between 
decreased sleep duration and 
increased manic symptoms the 
subsequent day. 
[4] Gruber 
et al. 
(2011) 
196  126 BD-I  
54 BD-II 
16 BD NOS 
Self-report/Clinician-report 
Clinical Monitoring Form (CMF, 
Sachs et al. 2002) 
Self-report 
Average number 
of hours slept 
and sleep 
variability over 
preceding week. 
Sleep and mood over 
preceding week reported at 
each routine psychiatric 
appointment over 12 
months.  
Shorter sleep durations 
associated with increased mania 
severity over 12 months. 
Greater sleep variability 
associated with increased mania 
and depression severity over 12 
months. 
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Authors N Bipolar 
Subtype 
Mood Measure Sleep Measure Monitoring Period and 
Frequency 
Findings 
[5] 
Houston et 
al. (2007) 
401  Not 
reported 
Clinician-report 
Young Rating Scale for Mania 
(YRSM, Young et al. 1978). 
 
Clinician-report 
Decreased need 
for sleep item of 
the Young Rating 
Scale for Mania 
(YRSM, Young et 
al. 1978). 
 
52 weeks 
Psychiatric appointments at 
4-week intervals. 
Decreased need for sleep item 
scores significantly predicted 
relapse in 7 participants. 
[6] 
Leibenluft 
et al. 
(1996) 
8* Not 
reported 
Self-report 
Visual analogue mood scale (0-
100) (Whybrow and Guylia 
1995) 
Self-report 
Sleep diary (wake 
onset, sleep 
onset) 
18 months 
Mood: twice daily 
Sleep: once daily upon 
awakening 
Increased sleep duration was 
associated with a decreased 
probability of being in a 
hypomanic or manic mood state 
the following day in 5 patients. 
[7] Wehr 
et al. 
(1982) 
15* Not 
reported 
Clinician-report 
Twice-daily mood rating by 
nurses using Bunney-Hamburg 
Scale (Bunney and Hamburg 
1963) 
Objective 
Actigraphy 
 
Clinician-report 
Nurse 
observation 
Exact monitoring period not 
reported. Authors report 
monitoring for 1 to 32 
“manic-depressive cycles”. 
 
Mood: twice daily 
Sleep: 
 Actigraphy: continuous 
 Nurse observation: 
every 30 minutes from 
21:00 to 07:00. 
 
13 patients experienced one or 
more nights of wakefulness (i.e. 
total sleep deprivation) when 
switching from depression into 
mania or hypomania.  
* rapid-cycling inpatients. BD-I, bipolar I disorder; BD-II, bipolar II disorder. 
 
  
1.4.3 Potential Mechanisms 
The mechanism by which sleep deprivation may precipitate episodes of mania remains 
unclear. However, current theories from neuroscience and chronobiology suggest that sleep 
deprivation may induce mania because: 
1. As discussed in section 1.3.3, there is an overlap between the physiological systems 
involved in regulating emotion and sleep, therefore perturbations in sleep will affect 
mood regulation, and vice versa.  
2. Individuals with mood disorders have an underlying instability in circadian rhythms 
that is ‘reset’ following sleep deprivation, resulting in increased positive affect 
(euthymia or mania). 
Sections 1.3.3 - 1.3.4 outlined how sleep disruption may perturb emotion regulation more 
broadly, therefore the following section outlines the research that relates specifically to how 
sleep loss might trigger mania. 
Neurophysiological Explanations 
As discussed in section 1.3, neurophysiological theories posit that the physiological effects of 
sleep deprivation (on the immune system, neuronal signalling, HPA-axis etc.) interact with 
systems in the brain involved in emotion regulation (e.g. serotonergic, dopaminergic systems) 
to disrupt functioning in areas of the brain involved in emotion regulation (Dahl and Lewin 
2002; Saper et al. 2005). This has been supported by behavioural and neurophysiological 
evidence from neuroimaging studies in healthy volunteers who are sleep deprived (Kahn et al. 
2013). For example, using functional magnetic resonance imaging, Gujar and colleagues 
(2011) found that sleep deprivation was associated with increased positive reactivity to 
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stimuli, which corresponded with activity in mesolimbic regions of the brain (involved in 
reward processing). Sleep deprivation has also been associated with increased neurochemical 
dopamine activity (Gillin et al. 2001) with evidence that this increase occurs in brain networks 
associated with reward processing (Volkow et al. 2009; Krause et al. 2017). Serotonergic 
systems in the brain have also been implicated as a potential mechanism by which sleep 
deprivation could have antidepressant (or euphorogenic) effects (Benedetti and Smeraldi 
2009; Harvey et al. 2011). This has been supported by animal studies which have found that 
sleep deprivation is associated with increased serotonin neurotransmission (Gardner et al. 
1997; Adrien 2002). 
 
The Social-Zeitgeber theory 
Many of the same mechanisms proposed to account for state and trait characteristics of sleep 
disruption in BD outlined in section 1.3.4 may also apply here. However, with developments 
in circadian research since Wehr et al.’s (1987) original model, other researchers have 
reconceptualised the model as the ‘social zeitgeber theory’ in which life events are thought to 
trigger mood episodes through disrupting biological rhythms (Grandin et al. 2006). According 
to this theory, individuals with mood disorders have a circadian system that is overly sensitive 
to physiological or environmental changes, thus culminating in mood episodes. This might 
explain the associations between mutations in circadian rhythm genes and manic-like 
behaviour in animal models described previously in section 1.4.2. In addition, one of the 
therapeutic targets of lithium (a common treatment for BD) is glycogen synthase kinase Beta 
(GSK3-B), which plays a key role in the regulation of circadian rhythms (Gould and Manji 
2005). Single-nucleotide polymorphisms in the GSK3-B promoter gene have been associated 
with response to sleep deprivation therapy (Benedetti et al. 2004; Benedetti et al. 2012). 
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However, lithium has several other targets, therefore the research in this area is still in its 
early stages (Jagannath et al. 2013). 
1.4.4 Implications for Clinical Practice 
The role of sleep disruption in relapse in BD has important clinical implications: 
1. If sleep loss is involved in the aetiology and pathogenesis of bipolar disorder, then it is 
possible that efforts to normalise sleep may be accompanied by improvements in 
illness course. This has been supported by evidence that interpersonal and social 
rhythm therapy (IPSRT), which aims to stabilise sleep and other circadian rhythms, 
has been associated with improved prognosis in some patients (Frank et al. 2005).  
2. If sleep loss triggers or precedes mania, sleep duration could be used as an indicator 
of when an individual is on-course to becoming unwell. With the advent of ‘e-
monitoring’ techniques in which patients are encouraged to track their symptoms 
and identify early warning signs of impending illness (e.g. Hidalgo-Mazzei et al. 2015; 
Miklowitz et al. 2012), sleep duration might represent a useful variable for illness 
prevention as well as management. 
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1.5 Sleep Disturbance as a Pathway to Mania: Implications for 
Postpartum Psychosis 
The sleep-reduction model of mania has important implications for our understanding of the 
causes of postpartum psychosis (episodes of mania or psychosis occurring in the postpartum 
period). As outlined in section 1.2.5, women with BD are at heightened risk of experiencing PP 
and the relationship between sleep loss and mania may explain this increased risk.  
Episodes of PP are more often characterised by manic symptoms than psychotic symptoms 
(Brockington et al. 1981), suggesting that PP is a manifestation of a bipolar disorder triggered 
by childbirth. If this is so, then factors involved in the pathway to mania could also be involved 
in the pathway to episodes of PP. Sleep deprivation has been proposed as one such factor 
(Sharma and Mazmanian 2003). In fact, Wehr et al. (1987) include childbirth in the sleep-
reduction model of mania (see Figure 1-3), stating that, ‘Many of the factors believed to play 
a role in inducing mania interfere with sleep…Sleep is often disrupted in the postpartum 
period by the demands of feeding and caring for a newborn infant’ (Wehr et al. 1987 p.201). 
Sleep disruption is a common complaint during the perinatal period (Okun and Coussons-
Read 2007; Reichner 2015), with the late third trimester and early postpartum period 
associated with the greatest sleep disruption (Hedman et al. 2002; Beebe and Lee 2007; 
Montgomery-Downs et al. 2010). This closely corresponds to the time that women are of 
greatest risk of developing PP, which, as mentioned in section 1.2.5, often emerges within the 
first few weeks of childbirth. A qualitative study of 13 women who had experienced PP 
reported that all women in the interviews discussed lack of sleep in the early stages of their 
illness (Engqvist and Nilsson 2013). In addition, in a study of 127 women who had 
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experienced PP, Heron et al. (2008) found that a lack of sleep was one of the most commonly 
reported early symptoms of PP, reported by 48% of women.  
To date, few studies have examined the association between perinatal sleep loss and PP 
(Lawson et al. 2015). A retrospective study of parous women found that those who 
developed PP had significantly longer labours and were more likely to give birth during the 
night (Sharma et al. 2004), suggesting that women with PP experienced greater sleep 
disruption in the perinatal period.  Furthermore, a case study of 3 women with a history of PP 
found that they became manic or hypomanic following experimentally-induced sleep 
deprivation (Strouse et al. 1992), suggesting that any sleep loss experienced during labour 
could have triggered the episodes of PP. However, in both of these studies, it was not known 
how long women had been kept awake prior to the onset of PP. 
Conversely, one of the few prospective studies on PP and perinatal sleep comparing the sleep 
of pregnant women with a history of BD or PP (i.e. a group at high risk of PP) to pregnant 
healthy controls found no significant differences in sleep/wake patterns during pregnancy 
between these groups (Bilszta et al. 2010). However, due to a small sample size, the authors 
were unable to compare the sleep of women who relapsed following childbirth to those who 
remained well. Thus it remains unclear whether women who develop PP experience greater 
sleep disturbance prior to episode onset. This study highlights that the comparison group is 
important in research in this areas, as in order to understand what makes some women with 
BD develop PP, we need to individualise risk. To do that, we need to compare characteristics 
of sleep within high-risk women. In addition, objective measures of sleep (such as actigraphy) 
are required to verify what level of sleep deprivation women experience.  
Another explanation for how sleep loss might trigger episodes of PP is that women who 
develop PP are more sensitive than average to the sleep disturbances that typify the perinatal 
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period. This hypothesis is plausible for two reasons. First, research examining responses to 
sleep deprivation finds that there is considerable variation within healthy populations, with 
some individuals showing more pronounced neurobehavioural sequelae than others (Rupp et 
al. 2012) and emerging evidence suggests that this might be moderated by genetic factors 
(Groeger et al. 2008; Kuna et al. 2012). Second, although it is thought that individuals with 
psychiatric disorders are more vulnerable to the negative effects of sleep disturbance than 
healthy populations, there is evidence of variation in response to sleep deprivation within the 
BD population. For example, Benedetti and colleagues have found that an antidepressant 
response to sleep deprivation in individuals with BD is associated with genetic factors 
(Benedetti and Smeraldi 2009; Benedetti et al. 2012). This variation within the BD population 
in how individuals respond to sleep loss may extend to women in the perinatal period, with 
some women with BD being more sensitive to perinatal sleep disturbance and therefore 
potentially more susceptible to PP. The role of individual differences in the tendency for sleep 
loss to act as a pathway to mania is discussed in further detail in the following section, and 
analysis of this forms a key part of this thesis. 
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1.6 Limitations in Current Knowledge of the Sleep Reduction Model 
As mentioned in section 1.4, there are a number of limitations in the body of literature that 
has been put forward to support the sleep reduction model of mania. These limitations 
include, small sample sizes (which are therefore of limited representativeness), heterogeneity 
in the use and dosages of medication, and a lack of information on other clinical features, 
such as bipolar subtypes. 
Additional limitations of studies utilising therapeutic sleep deprivation include: the fact that 
the majority of these studies were not designed to detect mania, therefore these studies do 
not consistently report on the characteristics of BD participants, and sometimes used 
antidepressants as an additional treatment. Authors of these studies often comment that 
participants were informed that sleep deprivation was a treatment for depression, and this, in 
combination with the fact the studies could not be designed so that participants were blind to 
whether they had received sleep deprivation therapy, increased the likelihood of a placebo 
effect.  
Additional limitations of prospective studies include variation in the frequency and length of 
the monitoring period, and variation in methods of measuring mood and sleep. It is also more 
difficult to ascertain causation from these studies, as observed associations between sleep 
and high mood could be the result of other triggering factors such as alcohol misuse, 
medications, stressors and other factors that may lead to circadian rhythm disruption, such as 
light exposure.  
In summary, therefore, there is limited evidence on whether sleep deprivation can, in fact, 
trigger mania in individuals with BD. Existing studies, while suggesting that there might be an 
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association, are limited by methodological issues, thus making it difficult to determine 
causation. 
Assuming that sleep deprivation can, in some cases, act as an early-warning sign or trigger of 
impending mood episodes, there are further limitations in our knowledge on this subject. 
These can be summarised as follows: 
1. Some evidence finds an association between reduced sleep and depression, 
Therefore, the nature of the association between sleep disruption and episode 
polarity is inconsistent (Gruber et al. 2011).  There is a need, therefore, to understand 
what factors may cause individuals with BD to become depressed rather than manic 
following sleep disruption. 
2. Not all individuals experience mood-elevating effects of sleep deprivation protocols 
(Benedetti and Smeraldi 2009), suggesting that some individuals have a lower 
threshold for the antidepressant effects of sleep loss compared to others. 
3. The duration of sleep deprivation that is required to trigger mania is still unknown, 
with varying estimates provided in different studies. 
These findings may be the result of (i) the type of sleep loss experienced (chronic vs. acute) 
and (ii) individual differences in the response to sleep disruption. 
1.6.1 Sleep Disruption and Depressive Symptoms 
Some studies find that reduced sleep is associated with increased depressive rather than 
manic symptoms. For example, Talbot et al. (2012) examined 49 patients with bipolar 
disorder over one week and found that decreased sleep predicted an increase in depressive, 
but not manic, symptoms the following day. Furthermore, Perlman et al. (2006), in a sample 
of 54 BD-I participants, found that reduced sleep duration predicted an increase in 
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depressive, but not manic, symptoms over a six-month follow-up period. This has also been 
noted in sleep deprivation therapy, where there are accounts of some patients becoming 
more depressed, rather than euthymic or (hypo)manic, following sleep deprivation (Wirz-
Justice and Van den Hoofdakker 1999). Alternatively, sleep reduction might cause a manic or 
depressive polarity depending on characteristics of the sleep loss, such as whether it is 
chronic or acute (Boland and Alloy 2013). 
1.6.2 Non-Manic Responses to Sleep Deprivation Protocols 
Not all studies have found associations between sleep and subsequent mood. For example, 
(Klein et al. 1992) compared the sleep (from actigraphy) of patients who did and did not 
relapse following lithium discontinuation, and did not find significant differences between the 
groups (although this study may have been underpowered to detect differences, due to the 
small sample size of 10 participants). Studies of patients undergoing TSD for depression have 
also reported that some individuals do not experience antidepressant effects of sleep 
deprivation (Pflug 1976; Bhanji et al. 1978; Wirz-Justice and Van den Hoofdakker 1999) and it 
has been estimated that the treatment is effective for 50-60% of patients (Wu and Bunney 
1990; Kasper and Wehr 1992). This further suggests that individuals vary in how they respond 
to sleep loss. 
The fact that not all individuals respond to TSD in the same way might explain the varying 
estimates of the proportion of individuals with BD who will become (hypo)manic following 
sleep deprivation. However, most earlier studies of TSD were not designed to investigate 
what proportion of BD individuals would switch into mania, therefore included patients with a 
variety of diagnoses (e.g. major depressive disorder, BD-I, BD-II) and did not always report 
whether any patients had become hypomanic (Plante and Winkelman 2008). This, in addition 
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to issues with small sample sizes and varying methods, might explain the wide range in the 
proportion of individuals who become (hypo)manic following TSD.  
1.6.3 How Much Sleep Loss Triggers Episodes? 
The studies that report positive associations between sleep deprivation and mood also differ 
in their estimates of how much sleep deprivation will cause shifts in mood, with estimates 
ranging from three (Bauer et al. 2006) to 48 hours (Wehr et al. 1982). As discussed previously, 
this might be due to methodology and sample characteristics. It is also possible that the type 
of sleep loss (acute vs. chronic) may affect the polarity of the episode that is triggered, with 
chronic sleep loss being more likely to trigger depressive episodes, and acute sleep loss (i.e. 
total sleep deprivation) increasing the likelihood of manic episodes (Wehr 1992). In addition, 
the time that the sleep deprivation occurs may also be important; partial sleep deprivation 
therapy, where patients are restricted to 4 hours of sleep per night (Kasper and Wehr 1992), 
is more effective when patients are sleep-deprived in the second half of the night (i.e. woken 
after 1am) than in the first half of the night (Goetze and Tolle 1981; Sack et al. 1985; Sack et 
al. 1988). 
1.6.4 Individual Differences In Response To Sleep Disruption 
A possible explanation for why these studies show inconsistent results is that there is 
individual variation in the response to sleep loss within individuals with bipolar disorder. 
Vulnerability to the negative cognitive and emotional effects of sleep loss has been studied 
more extensively in the general population. Research in this area suggests that the differential 
vulnerability to sleep loss is trait-like (Van Dongen et al. 2004; Rupp et al. 2012; Taniyama et 
al. 2015) with tentative evidence suggesting that this is heritable (Kuna et al. 2012), 
associated with chronotype (Selvi et al. 2007), and associated with polymorphisms in 
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circadian rhythm genes (Groeger et al. 2008; Drake et al. 2015). This, in addition to evidence 
that BD is a heterogeneous condition, with a multi-factorial aetiology and clinical 
presentation, suggests that individuals within bipolar populations will show variation in their 
vulnerability to sleep disruption.  
1.6.5 Summary 
Therefore, despite being widely acknowledged as an important factor in the presentation, 
management and pathophysiology of BD, there is inconsistent evidence that changes in sleep 
reliably predict manic symptoms and/or episodes. Furthermore, the literature review 
undertaken in this thesis was non-systematic, therefore did not examine grey literature and 
was limited to studies published (or translated into) English. This means that the reported 
literature was predominantly conducted in Western populations and could be subject to 
publication bias. 
The literature described in this section suggests that the role of individual differences in 
moderating the response to sleep disruption (e.g. polarity of response) requires further 
investigation, in addition to the characteristics of sleep loss that may influence whether it acts 
as a pathway to mania (e.g. duration, time in circadian night that sleep disruption occurs).  
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1.7 Aims and Structure of Thesis  
In summary, the evidence I have outlined above suggests that sleep disruption may be one 
factor involved in the aetiology and pathogenesis of BD. However, a number of questions 
remain unanswered about the relationship between sleep disruption and BD. This thesis has 
the following aims: 
Broad Aim: to examine the association between sleep disruption and mania in individuals 
with bipolar disorder.  
Specific Aims:  
1. To explore whether there is a subgroup of individuals who experience sleep 
disruption as a pathway to mania and, if present, to examine individual differences 
associated with this phenotype. 
2. To determine whether experiencing sleep disruption as a pathway to mania is 
associated with vulnerability to postpartum psychosis (PP).  
3. To conduct a pilot study using actigraphy to measure perinatal sleep in pregnant 
women at high risk of PP. 
4. Within aims 1 and 2, to compare results for sleep disruption as a pathway to mania to 
those examining sleep loss as a pathway to depression. 
I will address these aims using both retrospective and prospective data collected via the 
Bipolar Disorder Research Network (BDRN) (www.bdrn.org). In Chapter 3, I will examine the 
retrospective data on the tendency to report that sleep loss has triggered episodes of mania 
in a sample of 3,140 BDRN participants. In Chapter 4, I will examine data from 870 parous 
women to explore whether reporting that sleep loss has triggered episodes of mania is 
associated with experiencing PP. In Chapter 5, will utilise prospective data on symptoms of 
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insomnia and mania from 692 BDRN participants who monitored their mood using an online 
system. Finally, in Chapter 6, I conduct a pilot study using actigraphy to monitor sleep in a 
sample of pregnant women at high risk of PP. 
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2 GENERAL METHOD 
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2.1 Background 
This thesis uses data from participants recruited to the Bipolar Disorder Research Network 
(BDRN). This is an ongoing study of individuals with bipolar disorder recruited from across the 
UK by research teams based at Cardiff University and the University of Worcester. In this 
chapter, I describe the BDRN sample recruitment and assessments. I will describe the 
methods and sample characteristics specific to individual analyses at the relevant points in 
subsequent chapters.  
 
2.2 Sample Recruitment 
Data in this thesis was obtained from participants who were recruited to the Bipolar Disorder 
Research Network (BDRN) (www.bdrn.org), a large-scale, ongoing study investigating the 
clinical and molecular genetic determinants of mood disorders (Jones et al. 2015). 
Participants were recruited from across the UK, both systematically (via National Health 
Service, NHS, and Community Mental Health Teams) and non-systematically (via 
advertisements in local and national media and through patient support organisations, such 
as Bipolar UK). 
The study has UK NHS Research Ethics Committee approval (MREC/97/7/01) and local 
Research and Development approval in all participating NHS Trusts/Health Boards. All 
participants provided written informed consent. 
The study was funded by the Wellcome trust and Stanley Medical Research Institute. The 
principle investigators for this study are Professor Nick Craddock (Cardiff University), 
Professor Ian Jones (Cardiff University) and Professor Lisa Jones (University of Worcester).  
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2.3 Inclusion and Exclusion Criteria 
Participants recruited to the BDRN were at least 18 years of age and met DSM-IV criteria for a 
major affective disorder (American Psychiatric Association 2013). Participants were of UK or 
Irish white ethnicity as the initial focus of the BDRN was to discover genetic determinants of 
affective illness within a relatively homogenous sample. Exclusion criteria were (i) affective 
illness experienced only in relation to alcohol or substance dependence, (ii) affective illness 
secondary to physical illness or medication, or (iii) a lifetime diagnosis of intravenous drug 
dependency.  
2.4 Assessment Procedure 
After obtaining written, informed consent, trained research psychologists or psychiatrists 
interviewed all participants. This semi-structured interview included questions on key clinical 
and demographic variables and relevant sections from the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN, Wing et al. 1990). The SCAN questions were used to ascertain the 
presence of lifetime and worst-episode symptoms of mania, depression and psychosis. This 
information was then combined with case notes, and diagnostic and clinical ratings (such as 
age at illness onset and number of episodes of illness) were made based on all available 
information. Best-estimate lifetime diagnoses were made according to DSM-IV (American 
Psychiatric Association 2000), and ICD-10 (International Classification of Diseases, Tenth 
Revision; WHO, 1993) criteria. Diagnostic and clinical ratings were conducted for the majority 
of cases in this thesis prior to publication of the most recent edition of the DSM (DSM-5, 
American Psychiatric Association 2013), therefore DSM-IV (rather than DSM-5) criteria is used 
throughout this thesis.   
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In cases where there was doubt, diagnostic and clinical ratings were made by at least two 
members of the research team blind to each other’s rating and consensus was reached via 
discussion where necessary. The inter-rater reliability for DSM-IV diagnoses, for both lifetime 
and perinatal mood episodes, was high (κ = 0.85 and 0.92 respectively). The mean kappa 
statistics for other key clinical variables (e.g. age of onset of psychiatric disorder and the 
number of episodes of mania and depression) ranged from 0.81-0.99 (Gordon-Smith et al. 
2015). 
2.5 BDRN Data and Samples Used in this Thesis 
The sample of participants in the BDRN study with a DSM-IV diagnosis of BD-I or BD-II 
(n=5,742) were 66% female, 76% BD-I, and had an average age of 46 (range 18-89). The 
sample was also highly educated, with 41% having a level of higher education above A level 
standard. This sample may therefore differ from the population of individuals with BD as a 
whole, thus limiting the generalizability of results using these data.  
The BDRN has encompassed multiple waves of recruitment over time, each including 
different targets and methods. This thesis is focused on data collected from the BDRN that 
could be used to investigate the relationship between sleep and mood. This comprises three 
methods of data collection: 
1. Questions on whether sleep loss had triggered mood episodes, administered at 
original BDRN interview. 
2. Weekly mood questionnaires administered via an online mood monitoring system 
(‘True Colours’), which included questions on sleep disturbance (e.g. symptoms of 
insomnia symptoms). 
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3. Prospective estimates of sleep obtained via actigraphy during late pregnancy to early 
postpartum, combined with information on puerperal mood episodes. 
The following sections outline brief information on each of these assessment methods and 
the samples used in this thesis. Further information is provided in each of the subsequent 
chapters. 
2.5.1 Sleep Loss as a Trigger of Mood Episodes 
In November 2007, a semi-structured question on triggers of (hypo)mania or depression was 
added to the main BDRN interview, in which participants were asked whether they had 
noticed anything that had triggered their mood episodes (Appendix A).  
Interviewers highlighted to participants that the question related to triggers of mood 
episodes, rather than early signs or symptoms of a mood episode. In addition to the broad 
question on triggers, participants were also asked specifically whether sleep loss, physical 
illness, medication, non-prescription drugs, antidepressants or alcohol had triggered episodes 
of high or low mood. Participants responses were coded ‘Yes’, ‘No’, ‘Unsure’ or ‘Not 
applicable’ for each of the trigger options. The ‘Not applicable’ rating was used when 
individuals had not experienced the relevant mood episode or trigger (e.g. if a person with 
BD-I had never experienced a depressive episode, then questions relating to triggers of 
depressive episodes were rated ‘Not applicable’). If participants could not differentiate 
between a trigger and early warning sign/symptom, interviewers coded responses as 
‘Unsure’. 
Chapters 3 and 4 utilise the data derived from this measure. Chapter 3 examines responses to 
this question within 3,140 participants with a DSM-IV diagnosis of BD-I or BD-II. Chapter 4 
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examines responses to this question within a subsample of 870 parous women with a DSM-IV 
diagnosis of BD-I. 
2.5.2 True Colours Online Prospective Mood Monitoring 
True Colours is an online version of an SMS-based (Short-Message-Service/text message) 
symptom monitoring system developed by Professor John Geddes and colleagues at the 
University of Oxford Department of Psychiatry (Bopp et al. 2010). The True Colours system 
aimed to allow patients with BD to monitor mental wellbeing and aid illness management. 
The system was initially used by NHS patients within the Oxford Health Foundation Trust, and 
was adapted for use in research settings by the BDRN team from 2014-2015. From March 
2015, participants enrolled in the Bipolar Disorder Research Network were invited (via 
newsletters and emails) to enrol in the research-adapted version of True Colours 
(bdrn.org/research/true-colours/). 
Participants enrolled in the BDRN True Colours system were sent a weekly reminder email to 
complete two questionnaires on mood: the Altman Mania Scale (AMS) (Altman et al. 1997) 
and Quick Inventory of Depressive Symptoms (QIDS) scale (Rush et al. 2003) (Appendix B and 
C, respectively). These questionnaires included specific questions on sleep (e.g. insomnia).  
In Chapter 5, I use data collected from the BDRN True Colours mood monitoring system to 
explore changes in insomnia symptoms that occur prior to episodes of high and low mood 
within individuals with BD-I or BD-II. 
2.5.3 Prospective Sleep Monitoring in Pregnancy Study 
From November 2014 to February 2016, women at high risk of developing PP (i.e. those who 
had a lifetime diagnosis of BD or a history of PP) were recruited during pregnancy to 
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participate in a prospective study that examined mood changes during pregnancy and the 
postpartum period. Women enrolled in this study were given the option to monitor their 
sleep patterns using an actigraph from week 37 of pregnancy until postpartum week 2. In 
Chapter 6, I conduct a pilot study to explore whether actigraphy can be used to collect 
information on sleep during the perinatal period in women at high-risk of PP. 
2.5.4 Summary of Samples 
To summarise, the analyses in this thesis were conducted on three samples of participants 
from the BDRN (illustrated in Figure 2-1): 
Sample 1: BDRN participants who answered questions about sleep loss as a trigger of mood 
episodes as part of the interview assessment. Chapter 3 examines responses to these 
questions within participants with BD-I or BD-II (n=3140). Chapter 4 focuses on responses of 
parous women with BD-I (n=870). 
Sample 2: A sample of 692 BDRN participants with BD-I or BD-II who were enrolled in the 
True Colours mood monitoring system (Chapter 5). 
Sample 3: Actigraphy data from 10 pregnant women recruited to BDRN from 2014 as part of 
an ongoing project that examined pregnant women with a history of BD or PP (Chapter 6).  
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Figure 2-1. Diagram to illustrate the derivation of the samples used for each chapter of this 
thesis. 
Further detail on methodology will be provided in the relevant sections of Chapter 3, 4, 5 and 
6.  
2.6 Statistical Analysis 
I describe methods for statistical analysis in each of the relevant chapters to follow. Analyses 
in subsequent chapters were performed using SPSS version 20 (IBM 2011), Mplus version 7 
(Muthén and Muthén 2012), or R version 3.2.2 (R Core Team 2017). 
 
  
3 SLEEP LOSS AS A TRIGGER OF MOOD EPISODES IN BIPOLAR DISORDER: 
INDIVIDUAL DIFFERENCES BASED ON DIAGNOSTIC SUBTYPE AND GENDER 
Reported by (Lewis et al. 2017) 
 
 67 
3.1 Introduction 
In Chapter 1, I discussed the evidence that sleep loss is not only a symptom of mood episodes 
in BD, but can act as an early-warning sign of impending mood episodes (Jackson et al. 2003), 
and can trigger relapse, particularly mania (Wehr et al. 1982; Wehr et al. 1987; Gessa et al. 
1995). However, sleep loss does not appear to be a trigger for all individuals with BD, and 
those who are vulnerable to this trigger may also differ in whether sleep loss triggers mania 
or depression (Perlman et al. 2006; Talbot et al. 2012).  
In addition to aiding our understanding of the underlying mechanisms of bipolar illness, 
understanding what factors influence the relationship between sleep and mood episodes 
could (a) help clinicians predict which individuals are most likely to relapse following periods 
of sleep deprivation (e.g. due to long-haul travel or shift-work), and (b) inform self-
management techniques such as ‘e-monitoring’ (Hidalgo-Mazzei et al. 2015). 
In this chapter, I examine data on mood episodes triggered by sleep loss in a large sample of 
individuals with BD recruited to the BDRN (described in Chapter 2). In particular, I focus on 
whether sensitivity to sleep loss differs according to bipolar diagnostic subtype and gender. 
The reasons for comparing individuals on these characteristics are described in more detail 
below. 
 
Bipolar Diagnostic Subtypes  
As outlined in Chapter 1, bipolar-I disorder (BD-I) and bipolar-II disorder (BD-II) are subtypes 
of bipolar disorder that are distinguished via the presence of manic (BD-I) or hypomanic (BD-
 68 
II) episodes. Exploring whether there are differential reported effects of sleep disruption on 
mood episodes in BD-I and BD-II is important, given that they represent two well-defined 
diagnostic subtypes of BD with distinct clinical features, illness course, and physiology (T. H. 
Ha et al. 2009; Liu et al. 2010; Baek et al. 2011; Caseras et al. 2013). Furthermore, the 
majority of studies examining sleep and BD either include only BD-I participants, or do not 
distinguish between BD-I or BD-II, therefore it is unclear whether the effects of sleep loss are 
the same across the bipolar spectrum (Alloy et al. 2005). Of note is that one of the proposed 
mechanisms by which sleep loss affects emotion regulation is by disrupting emotion 
regulation systems in the brain (e.g. prefrontal and limbic areas) (Kahn et al. 2013). Recent 
neuroimaging studies have found that these same neurological systems vary between 
individuals with BD-I and BD-II, and correspond with behavioural differences in emotion 
regulation (Caseras et al. 2015). It is possible, therefore, that the effect of sleep loss on mood 
will also differ according to bipolar subtype.  
Gender 
The second characteristic I explore in this chapter is gender. There is evidence that the onset 
and presentation of bipolar illness differs between men and women, which may reflect 
different aetiology and pathology. For example, women are more likely to be diagnosed with 
BD-II rather than BD-I, spend less time well than men across their lifetime, and spend more 
time in the depressed polarity than men (Arnold et al. 2003; Benazzi 2006; Benazzi 2007; 
Altshuler et al. 2010; Di Florio and Jones 2010). In regards to mood episodes triggered by 
sleep loss, emerging evidence suggests that women are more prone to emotional 
dysregulation following sleep deprivation (Baglioni et al. 2010; Saunders et al. 2015; Short 
and Louca 2015) and more likely than men to experience insomnia (Mai and Buysse 2008). 
Women are also more likely to experience mood episodes following seasonal changes (Kerr-
Corrêa et al. 1998; Suhail and Cochrane 1998; Morken et al. 2002), suggesting that 
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perturbations to the circadian system (described in Chapter 1) may have a more pronounced 
effect on mood in women than men.  Only one study to date has examined gender 
differences in sleep loss triggering mood episodes in BD. Proudfoot and colleagues conducted 
an online survey of episode triggers in 198 individuals with (self-reported) BD (Proudfoot et 
al. 2012). They found that women were more likely than men to report that sleep loss had 
triggered episodes of depression than mania, whereas men were equally likely to report that 
sleep loss had triggered depression or (hypo)mania. However, these analyses were conducted 
on only 23 men, therefore may not be representative, and did not adjust for the total number 
of mood episodes experienced. In summary, the above evidence suggests that there could be 
a differential effect of sleep on mood between the genders, thereby warranting further 
investigation. 
Episode Polarity 
As discussed in Chapter 1, it is possible that inconsistent findings in observational studies are 
due to some individuals being more likely to experience depressive episodes in response to 
sleep loss, rather than manic episodes. Therefore, for each of the comparisons outlined 
above, I will compare the results for sleep loss triggering episodes of mania to sleep loss 
triggering episodes of depression.  
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3.2 Method 
3.2.1 Sample 
For further information on sample recruitment, see Chapter 2, section 2.2. The inclusion 
criteria for these analyses were that participants had a DSM-IV main lifetime diagnosis of 
bipolar disorder (BD-I or BD-II) and had been asked at interview about sleep loss triggering 
mood episodes.  A total of 3,140 participants met these criteria. 
3.2.2 Assessments 
As described in Chapter 2, information on whether sleep loss had ever triggered episodes of 
high mood or low mood was derived at interview, where participants were asked about 
specific past triggers of their mood episodes (Appendix A). Response options, in addition to 
sleep loss, included physical illness, medication, non-prescription drugs and alcohol. 
Participants responses were coded ‘Yes’, ‘No’, ‘Unsure’ or ‘Not Applicable’ for each of the 
trigger options. The ‘Not Applicable’ rating was used when individuals had not experienced 
the relevant mood episode or trigger (e.g. if a person with BD-I had never experienced a 
depressive episode, then questions relating to triggers of depressive episodes were rated not 
applicable).  
3.2.3 Statistical Analysis 
All analyses were performed using SPSS version 20. Initial analyses were calculated using chi-
squared (χ2) tests for independence to investigate associations between (i) bipolar subtype 
(BD-I vs. BD-II) and (ii) gender (male vs. female), and participant reports of sleep loss 
triggering episodes of (hypo)mania and major depression. Initial chi-squared tests for 
independence included all responses to the sleep trigger questions (i.e. ‘Yes’, ‘No’ and 
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‘Unsure’). Tests that revealed significant associations were followed by partitioned chi-square 
tests that examined only ‘Yes’ and ‘No’ responses.  
For analyses that were significant at the univariate level, I conducted a multivariate logistic 
regression analysis with bipolar subtype and gender as predictors and whether sleep loss had 
triggered mood episodes as the outcome. This enabled analyses to control for age, number of 
episodes of (hypo)mania or depression (depending on whether the outcome was sleep loss 
triggering episodes of high or low mood), and method of recruitment (systematic vs. non-
systematic). These covariates were chosen due to their potential relationship with the 
likelihood of reporting sleep loss as a trigger. All tests were two-tailed with a p <.05 criterion 
for statistical significance. 
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3.3 Results 
A total of 3140 individuals met the inclusion criteria described in section 3.2.1, of which 2075 
(66%) had a lifetime diagnosis of BD-I and 1065 (34%) had a diagnosis of BD-II. Of this sample, 
68% were female (n=2146), and the mean age at interview was 46.44 years (range 18-86, SD 
12.40). Additional demographic and clinical information is provided in Table 3-1. 
Table 3-1. Clinical and demographic information of participants with BD-I or BD-II who 
were asked about triggers of mood episodes. 
 
Sample Statistic  
(n = 3140) 
% Female 68.0 
Age at interview in years 
Mean (SD) 
Median (range) 
 
46.4 (12.4) 
46.00 (18-86) 
Age at illness onset 
Mean (SD) 
Median (range) 
 
22.1 (9.1) 
20.0 (4-68) 
Number of episodes of mania 
Mean (SD) 
Median (range) 
 
12.6 (17.0) 
7.0 (1 -300) 
Number of episodes of depression 
Mean (SD) 
Median (range) 
 
15.9 (18.9) 
10 (0 -200) 
Systematic recruitment, n (%) 806 (25.7) 
Highest educational achievement, n (%)* 
No secondary education qualifications  
CSE/O-level/GCSE  
A-level/AS-level  
Degree 
Postgraduate degree 
Unknown 
 
185 (5.9) 
708 (22.5) 
814 (25.9) 
864 (27.5) 
408 (13.0) 
161 (5.1) 
Highest occupational attainment, n (%) 
Professional 
Non-professional 
Never worked 
Unknown 
 
1534 (48.9) 
1367 (43.5) 
102 (3.2) 
137 (4.4) 
* Grades of UK secondary education are specified as GCSE, General Certificate of Secondary Education; 
O-level, ordinary level; A-level, advanced level; AS-level, advanced subsidiary level; BD-I, bipolar-I 
disorder; BD-II, bipolar-II disorder. 
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3.3.1 Prevalence of Sleep Loss Triggering Mood Episodes in Bipolar Disorder 
Within the total sample of 3140 individuals, 20% (95% CI 18.6-21.4%, n=627) of participants 
reported that sleep loss had triggered episodes of mania or hypomania. Of those who had 
experienced at least one major depressive episode (n=3064), 12% (95% CI 10.6-12.9%, 
n=359) reported that sleep loss had triggered episodes of depression. The rates of responses 
for other triggers are shown in Table 3-2. 
 
Table 3-2. Response frequencies of triggers of mood episodes of participants with bipolar 
disorder. 
Triggers of Mood Episodes, n (%) 
Mood 
episode 
Response Sleep Loss 
Physical 
Illness 
Alcohol 
Non-
Prescription 
Drugs 
Medication 
(Hypo)mania 
(n = 3140) 
Yes 627 (20.0) 82 (2.6) 231 (7.4) 175 (5.6) 114 (3.6) 
No 2325 (74.0) 2952 (94.0) 2706 (86.2) 2781 (88.6) 2881 (91.8) 
NA/Unsure 188 (6.0) 106 (3.4) 203(6.5) 184 (5.9) 145 (4.6) 
 
   
   
Depression  
(n = 3064) 
Yes 359 (11.7) 271 (8.8) 242 (7.9) 92 (3.0) 79 (2.6) 
No 2378 (77.6) 2553 (83.3) 2524 (82.4) 2691 (87.8) 2734 (89.2) 
NA/Unsure 327 (10.7) 240 (7.8) 298 (9.7) 281 (9.2) 251 (8.2) 
NA, not applicable 
3.3.2 Differences Between Bipolar Subtypes 
Episodes of High Mood 
Bipolar diagnosis (BD-I or BD-II) was associated with self-reports of sleep loss triggering 
episodes of high mood (χ2(2)=96.189, p <.001). As shown in Figure 3-1A, individuals with a 
diagnosis of BD-I were more likely than those with BD-II to report that sleep loss had 
triggered episodes of high mood (24.7% vs. 10.8%). Partitioned chi-square analyses 
comparing ‘Yes’ and ‘No’ responses (n=2952) revealed that BD-I participants were 2.81 times 
more likely than those with BD-II to report that sleep loss had triggered episodes of high 
mood (χ2(1)=90.808,p <.001, OR=2.81, 95% CI 2.26-3.50).  
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Episodes of Major Depression 
Initial chi-squared tests for independence across all response options  (i.e. Yes, No, Unsure) 
suggested that diagnostic subtype (BD-I or BD-II) was significantly associated with 
participants’ responses on whether sleep loss had triggered episodes of depression 
(χ2(2)=17.050, p <.001). As shown in Figure 3-1B, there was a trend for participants with BD-II 
to be more likely than those with BD-I to report that sleep loss had triggered episodes of 
depression (13.6% vs. 10.7%) but this difference did not meet criteria for statistical 
significance in subsequent partitioned chi-square analyses comparing only ‘Yes’ and ‘No’ 
responses (χ2(1)=3.716, p =.054, OR=1.25, 95% CI 0.99-1.57, n=2737).  
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Figure 3-1. Percentage of individuals with bipolar disorder who report that sleep loss has triggered episodes of (hypo)mania (Panel A) or depression (Panel B) split by 
bipolar subtype. Error bars represent 95% confidence intervals. 
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3.3.3 Gender Differences 
Episodes of High Mood 
As shown in Figure 3-2A, I found an association between gender and reports of sleep loss 
triggering episodes of (hypo)mania (χ2(2)=12.739, p =.002), with women being more likely 
than men to report that sleep loss had triggered episodes of high mood (21.7% vs. 16.3%). A 
partitioned chi-square analysis comparing only ‘Yes’ and ‘No’ responses (n=2952) showed 
that this difference was statistically significant (χ2(1)=12.668, p <.001) with the odds of 
women reporting manic or hypomanic episodes triggered by sleep loss being 1.43 times 
greater than men (OR=1.43, 95% CI 1.17-1.75). 
 
Episodes of Major Depression 
Gender was significantly associated with self-reports of episodes of depression triggered by 
sleep loss (χ2(2)=7.297, p =.026). A partitioned chi-square analysis comparing only ‘Yes’ and 
‘No’ responses (n=2737) showed that this difference was statistically significant (χ2(1)=6.133, 
p =.013) with women being more likely than men (12.7% vs. 9.5%, respectively, see Figure 
3-2B) to report that sleep loss had triggered episodes of depression (OR=1.37, 95% CI 1.07-
1.77) 
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Figure 3-2. Percentage of individuals with bipolar disorder who report that sleep loss has triggered episodes of (hypo)mania (Panel A) or depression (Panel B) split by 
gender. Error bars represent 95% confidence intervals. 
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3.3.4 Multivariate Binary Logistic Regression Models  
When adjusting for potential confounders (age, number of episodes of (hypo)mania, and 
method of recruitment), a multivariate logistic regression with (hypo)mania triggered by 
sleep loss as the outcome and including both bipolar diagnosis and gender as predictors 
found that the associations with (hypo)mania triggered by sleep loss remained significant for 
BD-I (OR=2.81, 95% CI 2.23-3.53, p <.001) and female gender (OR=1.30, 95% CI 1.05-1.61, p 
=.015. In contrast, the association between female gender and episodes of depression 
triggered by sleep loss was not significant when controlling for age, number of episodes of 
depression, and method of recruitment (OR=1.29, 95% CI 0.99-1.68, p =.06).  
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3.4 Discussion 
Sleep loss has been proposed as a potential trigger of mood episodes (particularly high mood) 
in individuals with bipolar disorder (Wehr et al. 1987). Despite support from experimental 
research in animals (Gessa et al. 1995) and in healthy human populations (Kahn et al. 2013; 
Van Someren et al. 2015), longitudinal studies of clinical populations have not always found 
that reduced sleep predicts subsequent mania in all individuals with a bipolar diagnosis 
(Perlman et al. 2006; Talbot et al. 2012). It is possible, therefore, that some individuals with 
BD have increased vulnerability to experiencing high mood following sleep disruption 
whereas others may be unaffected or become depressed. If so, this would be consistent with 
research in healthy populations which finds individual differences in vulnerability to the 
neurocognitive effects of sleep loss (Van Dongen et al. 2004; Banks and Dinges 2007). 
This study provides further evidence that some but not all individuals with BD experience 
sleep loss as a trigger of mania, with 20% of the sample reporting that sleep loss had 
triggered episodes of mania. Sleep loss was less commonly reported as a trigger of 
depression, with 11% of the sample who had experienced depressive episodes reporting that 
they had been triggered by sleep loss.  Nonetheless, sleep loss was the most commonly 
reported trigger of (hypo)manic and depressive episodes (Table 3-2). It is difficult to compare 
these results to other literature, as few studies have reported the percentage of individuals 
with BD who report sleep loss as a trigger. Research to date has primarily focused on early 
symptoms of mood episodes (Jackson et al. 2003) or has explored the proportion of 
individuals with bipolar disorder who become manic or hypomanic following sleep 
deprivation therapy for depression. The proportion of individuals who become manic or 
hypomanic in these contexts is reported to range from 4.85% to 29% (Plante and Winkelman 
2008). The aforementioned study on triggers of mood episodes by (Proudfoot et al. 2012) 
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does not report the percentage of individuals who endorsed a particular trigger, but the 
authors report that sleep loss was more frequently reported as a trigger of depression than 
mania. However, other triggers that the authors found were specific to mania (or common to 
both mania and depression) included events that are characterised by sleep loss, such as 
‘partying all night’ or ‘jet lag’.  
A key finding of this study was that individuals with BD seem to differ in their tendency for 
sleep loss to trigger mood episodes depending on their gender and bipolar subtype.  
Specifically, I found that participants who were female or had a diagnosis of BD-I were more 
likely to report that sleep loss had triggered episodes of high mood than male participants or 
those with a BD-II diagnosis. In contrast, sleep loss triggering episodes of depression was 
more commonly reported by women and individuals with BD-II than men or those with BD-I, 
respectively. However, for sleep loss triggering depressive episodes, (1) the differences 
between BD-I and BD-II did not reach statistical significance, and (2) the differences for men 
and women did not persist when controlling for potential confounders.  
3.4.1 Bipolar Subtype 
In this sample, individuals with BD-I were significantly more likely than those with BD-II to 
report that sleep loss had triggered episodes of high mood, with 1 in 4 individuals with BD-I 
reporting this compared to around 1 in 10 individuals with BD-II. Differences between bipolar 
subtypes in the tendency for sleep loss to trigger high mood may reflect clinical and 
underlying neuroanatomical (and associated functional) differences between BD-I and BD-II 
that have been highlighted elsewhere (Liu et al. 2010; Baek et al. 2011; Caseras et al. 2013). 
One possibility is that the emotion regulation systems that are disrupted by sleep loss (Kahn 
et al. 2013) and have been found to vary between BD-I and BD-II subtypes (Caseras et al. 
2015) are responsible for the different responses to sleep loss in BD-I and BD-II.  
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Alternatively, it is possible that fewer participants with BD-II reported sleep loss triggering 
high mood because they were generally less able to identify triggers of their episodes. 
However, analysis of the ‘unsure’ responses for this question revealed that 4.7% of 
participants with a BD-II diagnosis responded ‘unsure’ compared to 6.7% of those with BD-I (p 
=.029). 
3.4.2 Gender 
The results also suggest that women may be more susceptible than men to mood 
dysregulation following sleep loss, with women being significantly more likely than men to 
report that sleep loss had triggered episodes of high mood. These findings may have been 
due to women being more likely to over-report triggers, women generally being better at 
identifying triggers of mood episodes than men, or men being more likely to underreport 
triggers. However, when I examined responses for other triggers that participants were asked 
at interview (i.e. medication, antidepressants, alcohol or non-prescription drugs) I found that 
women did not consistently endorse triggers more than men (see Appendix D). In addition, 
analysis of ‘unsure’ responses revealed that men were not significantly more likely than 
women to respond ‘unsure’ when asked about triggers of high mood (5.8% vs. 6.1%, 
respectively, p = .807) or depressive episodes (11.6% vs. 10.3%, respectively, p = .274). 
The findings are in agreement with previous research that has also found women to be at 
greater risk than men of mood disturbances following sleep loss (Saunders et al. 2015; Short 
and Louca 2015) and may partly explain why women with BD are at high risk of experiencing 
mania following childbirth(Jones et al. 2014), which is associated with sleep deprivation. 
Furthermore, there is evidence that women with BD-I are more likely to become manic 
following childbirth compared to those with BD-II (Di Florio et al. 2013) which is concordant 
with the results for BD subtype. 
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These gender differences provide interesting avenues to explore underlying mechanisms by 
which gender and sleep may interact to influence bipolar disorder phenotypes. For example, 
it has been suggested that ovarian hormones may interact with the circadian system to 
influence the sleep-wake cycle and responses to sleep deprivation (Bailey and Silver 2014). 
3.4.3 Episodes of Depression Triggered By Sleep Loss 
It is possible that the association between sleep loss and mania has been attenuated in some 
studies by the inadvertent inclusion of individuals who, following sleep loss, are more likely to 
experience shifts in mood towards the opposite polarity (i.e. depression). Therefore, I 
examined whether bipolar subtype and/or gender were associated with an increased 
likelihood of reporting episodes of depression triggered by sleep loss.  
First, I found some evidence that individuals with BD-II were more likely than those with BD-I 
to report that sleep loss had triggered episodes of depression (14% vs. 11%, respectively) but 
this difference did not meet criteria for statistical significance (p =.054). Of note is that fewer 
participants reported sleep loss triggering episodes of depression (n=359, 11%) compared to 
high mood (n=627, 20%) and more participants responded ‘unsure’ when asked whether 
sleep loss had triggered episodes of depression (10.7%) compared to episodes of 
(hypo)mania (6.0%). The reasons for this are unclear, however, Jackson and colleagues (2003) 
reported that individuals with BD found it easier to identify early symptoms of mania than 
depression. Therefore, if the onset of depressive episodes is less noticeable than manic 
episodes, it may be more difficult for individuals to identify triggers. 
Second, I found that women were more likely than men to report that sleep loss had 
triggered episodes of depression. This concurred with previous research finding that women 
are more likely than men to experience depressed mood following sleep loss (Saunders et al. 
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2015; Short and Louca 2015). These findings may be due to women being at a greater risk of 
experiencing insomnia, which has been associated with subsequent depressive episodes 
(Ohayon 2002). However, the association between gender and sleep loss triggering 
depression did not remain significant when controlling for potential confounding factors. This 
may be because rates of insomnia have been found to increase with age in both sexes 
(Ohayon 2002) and the sample included a wide age-range (median = 46 years, range = 18-86). 
3.4.4 Strengths and Limitations 
At the time of writing, this is the largest study to date reporting on the prevalence of sleep 
loss as a trigger of both manic and depressive episodes in individuals with BD. There are, 
however, studies that have examined this relationship using objective rather than subjective 
measures of sleep and mood, such as nurse observations (Wehr et al. 1982; Barbini et al. 
1996) or have imposed sleep deprivation as part of treatment (e.g. Barbini et al. 1998). These 
studies have provided convincing evidence that sleep loss can trigger mood episodes, 
however, the labour-intensive nature of such studies results in relatively small sample sizes 
(typically fewer than 100 participants). This makes it difficult to ascertain what proportion of 
individuals with bipolar disorder may be vulnerable to the sleep loss trigger, and means there 
is limited power to make comparisons between bipolar subtypes and genders. The less-
intensive nature of the self-report measure ensured that data were available on a large 
sample of individuals and therefore allowed comparisons of responses from men and women, 
as well as bipolar subtypes.  
A further strength is that participant diagnoses were derived from rich clinical data. The only 
other study to date that has examined triggers of mood episodes relied on self-reported 
bipolar diagnoses that were reported online (Proudfoot et al. 2012). In contrast, in this study, 
information on diagnoses and other key clinical variables (e.g. age at illness onset) were 
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derived using a well-validated standardised psychiatric interview (Wing et al. 1990) and 
combined with information from case notes.  
 However, this study is limited by the retrospective nature of the data, hence there is a 
possibility that participants over- or underestimated the role of sleep loss in triggering mood 
episodes. For instance, the bidirectional relationship between sleep and mood (Wehr et al. 
1987; Baglioni et al. 2010; Kahn et al. 2013) could have made it difficult for participants to 
judge whether sleep loss had been a trigger or prodrome of episodes (although participants 
had the option to respond ‘unsure’). However, multiple experimental studies have provided 
supporting evidence that sleep deprivation can perturb emotion regulation (Harvey et al. 
2009) and can be a risk factor for the development of BD in high-risk children (Levenson et al. 
2015). In addition, if sleep loss is a prodrome rather than a trigger, it could nevertheless be a 
clinically useful warning-sign of incipient mood episodes. Therefore, if women and those with 
BD-I are more likely to report sleep loss triggering mania, this strongly suggests that there 
should be a concerted effort to monitor sleep in these individuals, as a change in sleep 
pattern – whether prodromal or as a result of external factors – could still signal the onset of 
an impending mood episode.  
An additional limitation of the data used in this chapter is the representativeness of the 
dataset utilised for analysis. Participants in the sample used were highly educated and almost 
half of the sample had a professional occupation. Therefore the results may differ in more 
representative samples of individuals with BD. 
Furthermore, although the multivariate analyses controlled for confounding factors such as 
age, number of episodes of illness, and method of recruitment, it is possible that other 
variables influenced the relationship between sleep and mood that were not available in this 
dataset, such as medication use or (as discussed below) differences in the amount of sleep 
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loss individuals were exposed to. Other confounders that were not controlled for, but could 
influence the relationship between sleep and mood include alcohol or other substance 
misuse, stressors, and other sources of circadian rhythm disruption such as light exposure.  
3.4.5 Future Research 
The results of the present study should inform future research investigating associations 
between sleep and mood in BD, as samples containing a mix of genders and bipolar subtypes 
might obfuscate associations between sleep and mood. However, the results need to be 
validated in longitudinal studies using objective measures of sleep such as actigraphy, as I did 
not have objective data on whether participants experienced sleep loss prior to mood 
episodes or the type of sleep loss that they experienced (e.g. total or partial sleep 
deprivation). Such research may also inform the rapidly expanding field of ‘digital psychiatry’ 
that aims to aid management of mental health by utilising information from technology 
(Bidargaddi et al. 2016). However, much more remains to be understood about the 
progression of mood episodes following sleep disruption (e.g. on how the pattern or circadian 
timing of sleep loss affects risk of relapse) and how to distinguish between sleep loss as a 
trigger, prodrome or early symptom of episodes. I will discuss this theme further in the 
General Discussion (Chapter 7).  
It is unclear why some individuals become depressed following sleep deprivation and others 
become manic.  It is possible that other triggers associated with relapse in BD (e.g. stressful or 
exciting life events, medication use or interpersonal conflict) may have coincided with the 
sleep loss that participants reported. However, vulnerability to the negative cognitive and 
emotional effects of sleep loss has been studied more extensively in healthy populations, 
which provides further support that differential vulnerability to sleep loss is trait-like and 
potentially genetic (Banks and Dinges 2007). Some studies have explored this in participants 
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with bipolar disorder, however to date this has been limited to candidate gene studies (e.g. 
Benedetti et al. 2012). Future research could potentially use manic or depressive responses 
to sleep loss as a sub-phenotype for genome-wide analyses or examine whether individuals at 
high familial risk of BD are more prone to mood dysregulation following sleep loss. In 
addition, there is a need to explore what factors underpin the differences in response to 
sleep loss between BD-I and BD-II individuals and between men and women. 
Another intriguing avenue for future research is the relationship between sleep and 
pharmacology, as the data on medication use was limited in this dataset. For example, lithium 
is known to affect circadian rhythms (McCarthy and Welsh 2012) and there is preliminary 
evidence that patients are more likely to experience mood elevation following sleep 
deprivation therapy if they have single nucleotide polymorphisms in genes that encode 
enzymes targeted by lithium (Benedetti et al. 2004). Future research should explore the 
genetic underpinnings of this in genome-wide studies. 
3.4.6 Implications for Clinical Practice 
If replicated in subsequent research, the findings of this study may inform self-management 
strategies for bipolar disorder, particularly in light of recent attempts to engage patients with 
electronic self-monitoring tools, which aim to alert the individual of impending mood 
episodes based on their behaviour (e.g. Hidalgo-Mazzei et al. 2015).  If future research 
reliably demonstrates that some individuals are more affected by sleep loss than others, then 
these self-monitoring tools could, for example, be tailored to send alerts if sleep starts to 
become disturbed. Clinicians should therefore discuss the importance of this trigger with 
patients, including encouraging a regular sleep pattern and considering the potential impact 
of specific situations such as shift work and long-haul travel.  
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However, additional research on burden to patients, clinicians and services will be required 
before the results of this study could be applied to clinical practice. One example of how 
research might take these results forward would be to use objective, longitudinal data on 
sleep and mood as a means of exploring the sensitivity, specificity, positive predictive value 
and negative predictive value of responding positively to whether sleep loss has triggered 
episodes of high mood. 
The results of this study suggest that up to 1 in 4 individuals with BD at some point in their 
lifetime, have reported an episode of high mood that they attributed to sleep loss, with 
women and those with a bipolar-I diagnosis particularly at risk. Caution should be employed 
when interpreting this figure, however, due to the fact that this was a lifetime measure of 
triggers, could be referencing acute rather than chronic sleep loss, and this estimate may be 
higher or lower in more representative samples of individuals with BD. 
3.4.7 Summary 
In summary, I found that bipolar subtype and gender influence susceptibility to relapse 
following sleep reduction. In particular, the strongest effects were observed for sleep loss 
triggering mania, with female gender and BD-I diagnosis associated with a greater tendency 
to report this.  
I also observed differences in the tendency to report that sleep loss had triggered episodes of 
depression, with this being associated with female gender and BD-II diagnosis. However, the 
effect for BD-II did not reach statistical significance, and the effect for gender was non-
significant following controlling for confounders. 
However, the results need to be interpreted with caution due to the limitations of the data 
(self-report, retrospective) and representativeness of the sample. These factors mean it is not 
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possible to determine whether sleep loss definitely triggered episodes of high mood in 
participants who reported this. To be able to adequately answer this question will require 
large-scale longitudinal studies in randomly sampled individuals or population studies (e.g. 
registry studies). 
In the next Chapter, I will explore whether a tendency to report sleep loss triggering mania is 
associated with an increased risk of mania or psychosis in the postpartum period.  
 
 
 89 
4 SLEEP LOSS AS A TRIGGER OF MANIA AND SUSCEPTIBILITY TO 
POSTPARTUM PSYCHOSIS 
Reported by Lewis et al. (In Press) 
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4.1 Introduction 
As outlined in section 1.2.5 of Chapter 1, women with BD are at high risk of affective 
psychoses following childbirth, termed ‘postpartum psychosis’ (PP) (Jones et al. 2014). 
Although research has explored a number of factors that may explain this increased risk, 
sleep disruption during the perinatal period remains an understudied area of research. 
Sleep disruption is a plausible candidate for triggering PP, as it has been associated with the 
onset of mania (Wehr et al. 1982; Wehr et al. 1987; Wehr 1989; Wehr 1991) and is 
characteristic of the perinatal period (Parry et al. 2006). Few studies have examined the 
association between perinatal sleep loss and PP (Ross et al. 2005; Lawson et al. 2015), 
however, one study suggested that women who develop PP may experience more sleep loss 
during labour than those who remain well; Sharma and colleagues (Sharma et al. 2004) 
derived information on length of labour and time of delivery from medical records of 42 
women (21 PP, 21 healthy controls) who gave birth at three hospitals in Ontario, Canada 
between 1990-2000. Sharma et al. found that women who developed PP were more likely 
compared to healthy controls to give birth at night, and had longer durations of labour.  
However, an important aim for clinicians is to be able to individualise risk within women who 
are at high risk of PP (i.e. women with BD or a history of PP). Within this high-risk group, it is 
possible that women who develop PP are more sensitive than average to the sleep 
disturbances that typify the perinatal period. This hypothesis is plausible for two reasons. 
First, research examining responses to sleep deprivation finds that there is considerable 
variation within healthy populations, with some individuals showing more pronounced 
neurobehavioural sequelae than others (Rupp et al. 2012) and emerging evidence suggests 
that this might be moderated by genetic factors (Groeger et al. 2008; Kuna et al. 2012). 
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Second, although it is thought that individuals with psychiatric disorders are more vulnerable 
to the negative effects of sleep disturbance than healthy populations, there is evidence of 
variation in response to sleep deprivation within the BD population. For example, Benedetti 
and colleagues have found that an antidepressant response to sleep deprivation in individuals 
with BD is associated with genetic factors (Benedetti and Smeraldi 2009; Benedetti et al. 
2012). This variation within the BD population in how individuals respond to sleep loss may 
extend to women in the perinatal period, with some women with BD being more sensitive to 
perinatal sleep disturbance and therefore potentially more susceptible to PP.  
In light of the above literature, and given that episodes of PP typically have a manic 
presentation (Brockington et al. 1981), I hypothesised that women with BD who report 
episodes of mania being triggered by sleep loss would be more likely to experience PP than 
those who do not report sleep loss as a trigger for manic episodes.  
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4.2 Method 
4.2.1 Recruitment and Inclusion Criteria 
Participants in this study were parous women who had been recruited to the BDRN and asked 
about triggers of mood episodes at interview. Evidence suggests that risk of PP is greatest for 
women with bipolar-I disorder (BD-I) (Di Florio et al. 2013), therefore I limited the current 
analyses to women with a lifetime DSM-IV diagnosis of BD-I.  For further information on 
sample recruitment, see Chapter 2, section 2.2. 
4.2.2 Assessments and Definition of Postpartum Episodes 
Research psychologists or psychiatrists administered all assessments and diagnostic 
procedures. Data collected on all the pregnancies of each parous woman were used to make 
lifetime ratings of postpartum episodes. PP was defined as a lifetime DSM-IV manic, mixed, 
psychotic depression or other psychotic episode occurring within 6 weeks of delivery. 
Postpartum depression (PD) was defined as a lifetime DSM-IV episode of non-psychotic 
depression with onset within 6 weeks of delivery, with no lifetime episodes of PP. The 
temporal association of episodes to childbirth was chosen as 6 weeks based on previous 
research indicating that the majority of postpartum episodes occur within this time-frame 
and to include both DSM-IV and ICD-10 definitions of the postpartum period (Di Florio et al. 
2013). Women were assigned to PP or PD categories in a hierarchical manner so that in 
instances where women had experienced both PP and PD, they were assigned to the PP 
group.  
Information on triggers of past manic and depressive episodes was derived at interview, 
where participants were asked about triggers of their episodes of mania and depression, with 
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specific questions about sleep loss, physical illness, medication and alcohol. For these 
analyses, I focused on whether women had reported that sleep loss had triggered manic or 
depressive episodes. Responses were used to group women into (i) those who reported that 
their episodes of mania were triggered by sleep loss versus those who did not (i.e. ‘sleep loss 
triggering mania’) and (ii) those who reported that their episodes of depression were 
triggered by sleep loss versus those who did not (i.e. ‘sleep loss triggering depression’). As 
data were retrospective, it is possible that women who reported sleep loss as a trigger of 
mood episodes were referring solely to episodes that had occurred in the postpartum period. 
To reduce the likelihood of this, I excluded women who had only experienced mood episodes 
in relation to childbirth.  
4.2.3 Statistical Analysis 
All analyses were conducted using SPSS version 20 (IBM 2011). In primary analyses, I used chi-
square tests for independence to examine associations between sleep loss triggering mania 
and lifetime PP. Specifically, I compared the rates of PP in women who did or did not report 
that sleep loss had triggered episodes of mania. Significant associations were followed with 
multivariate logistic regression analyses that examined the association between sleep loss 
triggering mania (predictor) and lifetime PP (outcome) whilst controlling for number of 
deliveries, age, marital status, number of manic episodes experienced and method of 
recruitment. Data from other triggers of mood episodes (e.g. physical illness, medication, 
non-prescription drug use and alcohol use) were not included as covariates due to (1) low 
numbers of participants endorsing these triggers and (2) many people responding “not 
applicable” for trigger questions such as non-prescription drug use, thus including these as 
covariates would have increased missing data.  
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4.3 Results 
4.3.1 Sample Characteristics and Perinatal Episodes 
Within the BDRN cohort, 870 women met the inclusion criteria described in section 4.2.1. 
Within the sample, 23.5% of women had experienced a lifetime episode of postpartum 
psychosis (n = 204) and a further 21.2% (n = 184), while not experiencing PP, had experienced 
non-psychotic depression within 6 weeks of delivery. The remaining women who did not 
meet criteria for PP or PD within 6 weeks of delivery had experienced (i) no perinatal episodes 
despite giving birth (n = 207, 23.8%) or (ii) while not meeting the criteria for PP or PD, had 
experienced an affective episode in pregnancy or later in the postpartum period, or there 
were insufficient data to reach a conclusion on perinatal episodes (n = 275, 31.6%). 
Demographic and clinical information on the sample is presented in Table 4-1. 
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Table 4-1. Sample clinical and demographic information for 870 parous women with 
bipolar-I disorder. 
Demographic/clinical characteristics (n=870) 
Age at interview in years, median (range) 49 (21-80) 
Number of deliveries, median (range) 2 (1-8) 
Number of episodes of mania 
Median 
Range 
  
7 
1-100 
Number of episodes of depression 
Median 
Range 
 
10 
0-100 
Age at illness onset, mean (SD) 22.53 (8.93) 
Systematic recruitment, n (%) 261 (30.0) 
Highest educational achievement, n (%)* 
No secondary education qualifications  
CSE/O-level/GCSE  
A-level/AS-level  
Degree 
Postgraduate degree 
Unknown 
 
93 (10.7) 
215 (24.7) 
184 (21.1) 
218 (25.1) 
96 (11.0) 
64 (7.4) 
Highest occupational attainment, n (%) 
Professional 
Non-professional 
Never worked 
Unknown 
 
385 (44.3) 
416 (47.8) 
15 (1.7) 
54 (6.2) 
* Grades of UK secondary education are specified as GCSE, General Certificate of Secondary 
Education; O-level, ordinary level; A-level, advanced level; AS-level, advanced subsidiary level. 
 
4.3.2 Mania Triggered by Sleep Loss and Postpartum Psychosis 
Within the sample of 870 women, 25.3% (n = 220) reported that sleep loss had triggered 
mania, 68.4% reported that sleep loss had not triggered mania (n = 595), and 6.3% of women 
reported that they were unsure whether sleep loss had triggered mania (n = 55). Subsequent 
analyses were conducted on women who had responded ‘Yes’ or ‘No’ to the sleep trigger 
question and had information on puerperal episodes, resulting in a sample of 732 for analysis. 
Figure 4-1 shows the proportion of perinatal episodes within this sample, split according to 
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whether women had or had not reported sleep loss triggering mania. I found that women 
who reported sleep loss triggering mania were significantly more likely to experience PP than 
those who did not report this  (χ2(1)=17.191, p < 0.001, 36.8% vs. 21.8%, respectively). 
Compared to women without a manic response to sleep loss, women who reported sleep loss 
triggering episodes of mania had more than twice the odds of experiencing a lifetime episode 
of PP (OR=2.09, 95% CI = 1.47-2.97). The association remained significant when controlling 
for number of episodes of mania, age at interview, number of deliveries, marital status and 
method of recruitment (OR=2.09, 95% CI=1.43-3.04, p < 0.001).  
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Figure 4-1. Proportion of women with perinatal episodes split by manic response to sleep 
loss. Abbreviations: PP, Postpartum Psychosis; PD, Postpartum Depression; no PD/PP, 
includes: no perinatal episode, any other psychiatric illness occurring in the perinatal 
period up to 6 months postpartum, or onset of PP or PD outside of 6 weeks of delivery. 
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4.3.3 Specificity of Findings  
To examine the specificity of the findings for the trigger, namely mania triggered by sleep 
loss, and the outcome, namely episodes of PP, I conducted follow-up analyses examining (i) 
the association between reporting a depressive response to sleep loss (i.e. sleep loss 
triggering episodes of depression) and PP, and (ii) the association between depression or 
mania triggered by sleep loss and PD.  
Depression Triggered by Sleep Loss and Postpartum Psychosis 
Some women in the sample had not experienced depressive episodes, and therefore 
responded ‘Not applicable’ to whether sleep loss had triggered episodes of depression. The 
following analyses were conducted on the 669 women in the sample who had responded 
‘Yes’ or ‘No’ to the sleep trigger question. As shown in Figure 4-2, in contrast to the findings 
for sleep loss triggering high mood, women who reported that sleep loss had triggered 
episodes of depression did not demonstrate higher rates of PP than women who did not 
report this (22.8% vs. 26.1%, respectively, χ2(1)= 0.401, p = 0.526). 
Mood Episodes Triggered by Sleep Loss and Postpartum Depression 
Compared to the rest of the women in the sample (i.e. those who had experienced no 
perinatal episodes or perinatal episodes that did not meet criteria for postpartum 
depression), women who experienced postpartum depression within 6 weeks of delivery 
were not more likely to report sleep loss triggering episodes of depression (25.3% vs. 25.6%, 
respectively, χ2(1)=0.004, p = 0.948) or sleep loss triggering episodes of mania (25.7% vs. 
20.9%, respectively, χ2(1)=1.797, p = 0.180). 
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Figure 4-2. Proportion of women with perinatal episodes split by depressive response to 
sleep loss. Abbreviations: PP, Postpartum Psychosis; PD, Postpartum Depression; no 
PD/PP, includes: no perinatal episode, any other psychiatric illness occurring in the 
perinatal period up to 6 months postpartum, or onset of PP or PD outside of 6 weeks of 
delivery. 
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4.3.4 Analyses to Address Potential Recall Bias  
I conducted further analyses to address the likelihood that reporting sleep loss as a trigger of 
mania was due to recall bias (i.e. due to women assuming that their postpartum episodes 
were caused by sleep loss they may have experienced in the perinatal period).  
Episodes of Mania ‘Usually’ Triggered by Sleep Loss 
First, I repeated the analyses on a sample of women who had said that sleep loss ‘usually’ 
triggered episodes of mania. This question was only asked to women who had experienced at 
least 3 episodes of mania (n = 547), reducing the likelihood that they were referring primarily 
to episodes that had occurred in the postpartum period. Among these women, those who 
reported that sleep loss had ‘usually’ triggered episodes of high mood were more likely to 
experience PP than women who did not report this (χ2(1)=7.157, p = 0.001, OR=2.00, 95% 
CI=1.20-3.36). This association remained significant when controlling for number of episodes 
of mania, age at interview, number of deliveries, marital status and method of recruitment 
(OR=1.99, 95% CI=1.16-3.41, p = 0.012). 
Parous vs. Nulliparous Women 
I compared the rates of reporting sleep loss triggering mania in parous and non-parous 
(nulliparous) women. If experiencing childbirth leads to an increased tendency to report that 
sleep loss triggers mood episodes, then I would expect parous women to be more likely to 
report this than nulliparous women (i.e. women who have not given birth). Parous women did 
not have higher rates of sleep loss triggering mania than nulliparous women – in fact, the 
opposite was true – with 30.7% of the non-parous BD-I women in the BDRN sample (n = 
158/515) reporting that sleep loss had triggered episodes of mania compared to 25.3% of 
parous women (n = 220/870) (χ2(1)=4.495, p = 0.034, OR=0.77, 95% CI=0.60-0.98).  
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4.4 Discussion 
I examined rates of lifetime postpartum mood episodes in parous women with BD-I according 
to self-report of sleep loss triggering episodes of mania or depression. Compared to those 
who did not report sleep loss as a trigger of mania, women who reported that sleep loss had 
triggered episodes of mania were more than twice as likely to have experienced PP. This 
effect remained significant when controlling for potential confounders.  
The association between sleep loss and postpartum episodes was specific to (i) a vulnerability 
to sleep disturbance triggering mania rather than depression, and (ii) experiencing PP rather 
than PD. This suggests that a vulnerability to the mania-inducing qualities of sleep loss 
increases the risk of experiencing PP, and is consistent with previous research suggesting that 
PP is frequently a manifestation of manic or mixed episodes triggered by childbirth 
(Brockington 1996; Jones et al. 2001). Importantly, the results suggest that women with BD-I 
who report manic episodes triggered by sleep loss could be more vulnerable to developing 
PP, although this needs further investigation in prospective studies.   
In contrast, I found that a lifetime history of depressive episodes being triggered by sleep loss 
was not associated with an increased rate of PD in this sample. Other research has found an 
association between perinatal sleep loss and PD (Skouteris et al. 2009; Khazaie et al. 2013), 
therefore it is perhaps surprising to find no significant lifetime associations between PD and 
depression triggered by sleep loss. It is worth noting, however, that fewer women in this 
sample reported depressive episodes triggered by sleep loss (n = 93) compared to mania 
triggered by sleep loss (n = 220), which will impact on power to detect a difference between 
the groups. In addition, it is possible that the mechanisms involved in triggering PD in BD 
women are different to women with unipolar depression.  Finally, PD may be more likely to 
develop after exposure to chronic rather than acute sleep loss, which may not have time to 
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have its impact within the 6 weeks specified in the current study. In fact, previous studies 
examining the association between sleep and PD have used a broader onset criterion 
(Montgomery-Downs et al. 2010; Okun et al. 2011; Dørheim et al. 2014). However, expanding 
the definition of PD to include episodes that occurred within 6 months of birth did not result 
in significant associations between a depressive response to sleep loss and rate of PD (χ2(1)= 
0.006, p = 0.937).  
4.4.1 Strengths and Limitations 
The strengths of this study are similar to those presented in Chapter 3, specifically the ability 
to analyse data from a large sample of parous women with BD with detailed clinical 
phenotype data. However, a major limitation is that the data on sleep loss triggering mood 
episodes were collected retrospectively at interview. It is possible that women with a history 
of PP over-reported that sleep loss had triggered mania due to attributing their postpartum 
episode(s) to sleep disruption that is typical in the perinatal period. However, I excluded 
women from the analyses if they had experienced manic episodes solely in relation to 
childbirth. Furthermore, secondary analyses provided support that this was not the major 
driver of the association I observed. First, if this were the case, women with PD may also over-
report a depressive response to sleep loss. However, in this study, women who reported that 
sleep loss had triggered episodes of depression were no more likely to experience PD than 
those who did not report sleep loss triggering depression. Second, I performed additional 
analyses on a subsample of women who reported their manic episodes had usually been 
triggered by sleep loss, as opposed to on a single occasion, with the requirement that women 
had experienced at least three episodes of mania. This increased the likelihood that I selected 
a group of women with an underlying susceptibility to sleep loss triggering non-puerperal 
episodes of mania rather than those that occurred primarily in relation to PP. In this 
subsample, the association between reports of sleep loss triggering mania and PP remained, 
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even when controlling for potential confounders. Finally, if childbirth increases the likelihood 
of reporting that sleep loss triggers mood episodes, then one would expect parous women to 
report this more frequently than nulliparous women. However, I found that nulliparous 
women actually had higher rates of reporting sleep loss triggering mania than parous women. 
Despite controlling for number of deliveries, age, marital status, number of manic episodes 
experienced and method of recruitment, it is possible that other factors which were not 
controlled for affected the results. These include (but are not limited to) social class, levels of 
family support, medication and substance use. I did not have available data on medication, 
substance use and levels of family support during perinatal episodes. Educational attainment 
and occupation could have been used as a proxy for social class but preliminary analyses 
revealed that these covariates were not significantly associated with reporting sleep loss as a 
trigger. 
Another limitation is that I did not objectively measure sleep loss and relied on retrospective 
self-reporting. This means it is not possible to determine what level of sleep disruption 
women experienced around childbirth or at any other time. In addition to obtaining more 
detailed subjective measures of sleep, future prospective studies of pregnant women with BD 
should include objective measures of sleep such as actigraphy. Such prospective designs will 
be instrumental in establishing whether a history of sleep disruption triggering episodes of 
mood disorder is a clinically useful predictor of developing severe postpartum episodes.  
4.4.2 Vulnerability to the Mania-Inducing Qualities of Sleep Loss  
Further research on individual differences in vulnerability to sleep disturbance may provide 
markers of increased sensitivity to sleep loss in BD, thus allowing clinicians to predict 
vulnerable individuals prior to significant exposures to sleep loss. A particularly promising 
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area of interest is whether genetic variation (for example in circadian rhythm genes) predicts 
an individual’s response to acute sleep loss (Benedetti et al. 2008; Benedetti and Terman 
2013; Bunney and Bunney 2013). It will be of particular interest to determine whether 
genetic factors for vulnerability to mania following sleep loss overlap with those that predict 
episodes of PP in women with bipolar disorder. 
4.4.3 Clinical Implications 
If the findings of this study are replicated in prospective studies, a history of manic episodes 
triggered by sleep loss could be a potential screening question to identify pregnant women 
with BD at heightened risk of PP. This could help to individualise the risk of severe postpartum 
episodes in women with BD and potentially help with difficult decisions regarding the use of 
medication during the perinatal period. Furthermore, it may identify women for whom 
obstetric management may need to pay particular attention to sleep disruption in labour and 
for whom specific measures to protect sleep in the postpartum period may be indicated. 
It could be argued that identifying women with BD for whom sleep loss has previously 
triggered episodes of mania is of limited clinical utility, given that these women are 
considered high risk of developing PP by virtue of having BD. However, estimates of the risk 
of PP vary within women with BD (Wesseloo et al. 2016) therefore the results of this study 
offer an opportunity to individualise risk within this group. In light of this, the finding that 
sensitivity to sleep loss could be associated with a two-fold increased risk of PP represents a 
moderate difference in risk. Understanding more about which factors can individualise risk 
may be helpful for women and clinicians when considering the risks and benefits of 
medication during pregnancy and postpartum. The finding that sensitivity to sleep loss could 
be associated with a two-fold increased risk further emphasises the need for services to 
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minimise sleep loss in this group and suggests that interventions that target sleep loss may be 
particularly beneficial for some women.  
Nonetheless, further work is required in order to establish whether the results of this study 
would be helpful clinically and, if so, whether the method of assessing sensitivity to sleep loss 
that was used in this study would be applicable to clinical practice. For example, examination 
of case notes or more detailed questions on sleep and mood may be better measures of 
sensitivity to sleep loss. In addition, further research is required to determine whether 
interventions for improving sleep in women at high risk of PP are associated with decreased 
risk of relapse. There is preliminary evidence that cognitive behavioural therapy for insomnia 
(CBT-I) in pregnancy may help reduce symptoms of depression in pregnant women (Tomfohr-
Madsen et al. 2017) and that CBT-I is preferred by pregnant women to medication as a 
treatment option for insomnia (Sedov et al. 2017). However, it remains to be seen whether 
this could be an option for pregnant women with BD. These issues will be discussed further in 
Chapter 7. 
4.4.4 Future Studies 
Future research needs to explore these findings further in samples with prospective data on 
sleep and postpartum episodes, in addition to multiple objective and subjective measures of 
sleep. Another important variable that was not available in this dataset was the use of 
medication in pregnancy and postpartum, which may have influenced the relationship 
between sleep and mood. Finally, future studies may also extend these findings by examining 
whether sleep loss triggering mania is associated with genetic factors, and whether these 
factors overlap with those implicated in risk for PP.   
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4.4.5 Summary 
In summary, the results suggest that individual differences in vulnerability to mood 
dysregulation following sleep loss in BD may be a promising marker for identifying women at 
heightened risk of PP.  
However, data were cross-sectional therefore may be subject to recall bias. I also did not 
have objective data on sleep disruption that had occurred during the postpartum period or 
prior to mood episodes. In Chapter 6, I further explore the relationship between sleep and 
postpartum episodes in a prospective study of pregnant women at high risk of developing PP 
using actigraphy (an objective measure of sleep loss). 
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5 TRAJECTORIES IN INSOMNIA PRIOR TO EPISODES OF HIGH MOOD: 
RESULTS FROM AN ONLINE MOOD MONITORING SYSTEM  
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5.1 Introduction 
As outlined in Chapter 1, there are numerous lines of evidence suggesting an association 
between sleep and mood in bipolar disorder (see section 1.6.1, Chapter 1). Seminal research 
in this area began with the work of Thomas Wehr and colleagues (Wehr et al. 1982; Wehr 
1989; Wehr 1991) during which Wehr proposed the ‘sleep reduction model of mania’ (Wehr 
et al. 1987). 
 
Figure 5-1. The sleep reduction model of mania (Wehr et al. 1987). 
This model (Figure 5-1) proposed that the relationship between sleep and mania was bi-
directional, such that sleep reduction as a result of insomnia or exogenous sleep deprivation 
could precipitate manic symptoms, and manic symptoms could, in turn, induce sleeplessness. 
The authors argued that this relationship culminates in a vicious cycle that explains the 
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tendency for manic episodes to escalate. Of note is that this model suggests that sleep loss 
can act as both a trigger and prodrome in the genesis of mania. 
 Evidence from (i) sleep deprivation experiments in animals and humans, and (ii) cases of 
mania following sleep deprivation therapy lend credence to the proposition that sleep 
deprivation via exogenous factors may trigger mania (e.g.Gessa et al. 1995; Colombo et al. 
1999). In observational studies, however, it is more difficult to determine whether reduced 
sleep prior to an episode of mania is evidence of sleep loss acting as a trigger or prodrome. 
Regardless of whether sleep reduction does or does not ‘cause’ manic episodes, a pattern of 
sleep reduction prior to episodes of mania could be relatively easy to monitor by individuals 
and clinicians, and thus aid illness management.  
To date, however, there are mixed findings from observational research, as some studies 
have found sleep reduction to be associated with subsequent depressive rather than manic 
symptoms (Perlman et al. 2006; Gruber et al. 2011; Talbot et al. 2012). One explanation for 
these findings is that, as the causes of BD are multifactorial, individuals will vary in how they 
respond to sleep loss; some individuals will become manic, some depressed, and others will 
remain euthymic. This is corroborated by research finding that only a subset of depressed 
bipolar patients become euthymic following total sleep deprivation therapy, whereas another 
subset become manic or hypomanic (Colombo et al. 1999). Likewise, if sleep reduction is a 
prodrome of mania, it is plausible that it may not be a prodrome for all individuals, and for 
some it may instead be a sign of an impending depressive episode.  
This theory was supported in Chapter 3, in which I found that 20% of individuals with BD 
reported that sleep loss had triggered episodes of high mood, and that this was significantly 
more likely to be reported by women and those with BD-I (compared to those with BD-II). In 
addition, being female was associated with an increased likelihood of reporting that sleep loss 
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had triggered depression, however this finding did not persist following adjustment for 
confounders.  
As shown in Figure 5-1, Wehr et al. (1987) also propose that sleep reduction can precipitate 
mania as a result of insomnia. This means that, in theory, some individuals will experience 
insomnia prior to episodes of mania. I explored the sleep deprivation aspect of the sleep 
reduction model of mania in Chapter 3, therefore in this chapter I present analyses examining 
the insomnia aspect of the model.  In addition, as the research described in the previous 
chapter was limited by the use of retrospective data, in this chapter I examine these 
associations prospectively in individuals who completed weekly measures of their mood using 
an online mood-monitoring system, True Colours.  Specifically, I examined whether there 
were different trajectories in sleep loss that can be observed prior to the development of 
mania. Specifically, this chapter aims to answer the following questions: 
1: Are there groups of individuals with bipolar disorder who display different trajectories 
of insomnia prior to the onset of manic episodes? 
The previous chapters and literature I have outlined suggest that there should be a group of 
individuals who experience disrupted sleep prior to episodes of mania. In the study described 
in this chapter, I hypothesised that a subgroup of individuals in the BDRN sample would show 
increasing insomnia symptoms prior to the onset of manic episodes. 
2: If present, are particular insomnia trajectories associated with clinical characteristics 
such as bipolar subtype and gender? 
In Chapter 3, I found evidence suggesting that women and individuals with BD-I are more 
likely to report that sleep loss triggers episodes of mania than men or individuals with BD-II. 
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Therefore in this chapter I aimed to explore whether gender and bipolar subtype were 
associated with different trajectories in insomnia prior to episodes of mania. 
In addition, I examined any resultant classes for differences in the following characteristics: 
 Age: Evidence suggests that the prevalence of insomnia increases with age (Ohayon 
2002). Therefore, as there was a wide age range in the BDRN sample who completed 
True Colours, I examined whether individual differences in insomnia trajectories could be 
explained by age. 
 Symptoms of mania during the pre-illness period: Although scores from participants 
were included only if they were euthymic during the pre-illness period, it is possible that 
reduced sleep during this time could have been the result of residual manic symptoms. 
 Symptoms of depression and presence of depressive episodes during the pre-illness 
period: It is possible that insomnia symptoms occurring prior to the onset of a manic 
episode are the result of depressive episodes occurring during this time. This observation 
has previously been raised by Wehr et al: 
 ‘…insomnia associated with depression should precipitate mania in bipolar patients. 
In fact, as many as half of all manic episodes are preceded by depressive episodes’ 
(Wehr et al. 1987 p.203). 
Therefore any resulting differences in insomnia trajectories prior to episodes of mania were 
compared on depression symptoms in subsequent analyses. 
3: Is the trajectory of insomnia symptoms prior to depressive episodes different to the 
trajectory observed prior to manic episodes? 
Previous research has found that insomnia can increase the risk of depression in healthy 
individuals, and that persistent insomnia can increase the risk of depressive episodes in 
individuals with MDD (Franzen and Buysse 2008; Suh et al. 2013). There has been less 
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research examining this in individuals with BD, however, evidence to date would suggest that 
increasing insomnia symptoms would precede episodes of depression (Jackson et al. 2003; 
Perlman et al. 2006; Eidelman et al. 2010; Talbot et al. 2012). 
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5.2 Method 
5.2.1 The True Colours Online Mood Monitoring System 
True Colours is an online mood monitoring system that is an online version of the text based 
Oxford University Symptom Monitoring System (Bopp et al. 2010) developed by Professor 
John Geddes and colleagues at the Oxford University Department of Psychiatry 
(https://oxfordhealth.truecolours.nhs.uk), with the aim of allowing patients with BD to 
monitor mental wellbeing and aid illness management. The system was initially used by NHS 
patients within Oxford Health Foundation Trust, and was adapted for use in research settings 
in 2014-2015. From March 2015, participants enrolled in the Bipolar Disorder Research 
Network (BDRN, described in Chapter 2) were also invited (via newsletters and emails) to 
enrol in this version of True Colours (bdrn.org/research/true-colours/). 
When enrolled in the True Colours system, participants are sent a weekly reminder email to 
complete two questionnaires on mood: the Altman Mania Scale (AMS) and Quick Inventory of 
Depressive Symptoms (QIDS) scale. These are described in detail below. 
The Quick Inventory for Depressive Symptoms (QIDS) 
The Quick Inventory for Depressive symptomatology (QIDS, Appendix B) is a questionnaire 
consisting of 16 items which correspond to the nine DSM-IV symptom criteria for major 
depressive episodes (low mood, poor concentration, self-criticism, suicidal ideation, 
anhedonia, low energy/fatigue, sleep disturbance, decrease/increase in appetite/weight, and 
psychomotor agitation/retardation) (Rush et al. 2003). Each item is measured on a 0-3 scale, 
with total scores ranging from 0-27 (see Appendix B for the algorithm used to calculate the 
total score). Total QIDS scores indicate varying levels of depression symptom severities based 
on the following ranges: ‘mild’ 6-10, ‘moderate’ 11-15, ‘severe’ 16-20, and ‘very severe’ 21-
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27. The self-report version of the QIDS has demonstrated good psychometric properties and 
has been validated for use in bipolar samples (Rush et al. 2003; Trivedi et al. 2004; Bernstein 
et al. 2009). As shown in Figure 5-2, participants completed the QIDS based on how they had 
felt over the past week (see Appendix B for the full questionnaire).  
 
 
Figure 5-2. Welcome screen and example question from the Quick Inventory for 
Depression Symptomatology (QIDS) used in the True Colours online mood monitoring 
system. 
The Altman Mania Rating Scale (AMS) 
The Altman self–rating Mania Scale (AMS) (Altman et al. 1997) is a 5-item questionnaire that 
assesses each of 5 major symptoms of mania outlined in the DSM-IV (elevated mood, inflated 
self-esteem or grandiosity, decreased need for sleep, pressured speech, and increased goal-
directed activity, American Psychiatric Association 2000). The individual items for the AMS are 
shown in Appendix C). Each item is scored on a scale of 0 to 4, with total scores ranging from 
 115 
0 to 20. Scores greater than 5 have been associated with 85.5% sensitivity and 87.3% 
specificity for detecting mania or hypomania (Altman et al. 1997). 
 
 
Figure 5-3. Welcome screen and example question from the Altman Mania Scale used in 
the True Colours online mood monitoring system. 
Participants were able to view their current and previous answers to the QIDS and AMS 
online. Appendix E shows screenshots of True colours and the example graphs available to 
participants.  
5.2.2 Sample 
The sample presented in this chapter were participants with a diagnosis of type 1 or type 2 
bipolar disorder (BD-I or BD-II, respectively) who were enrolled in the Bipolar Disorder 
Research Network (BDRN). Recruitment and assessment of this sample has been described in 
Chapter 2. The analyses presented in this chapter were conducted on data from BDRN 
participants who were enrolled in True Colours from 4 March 2015 to 3 February 2017. 
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During this time, 692 participants with a diagnosis of BD-I (n=429, 62%) or BD-II (n=263, 38%) 
completed the online mood monitoring system. This resulted in an initial dataset of 39,749 
observations made over an average of 56 weeks (range 1 to 100 weeks).  
5.2.3 Data Preparation 
Data were downloaded from the True Colours server in February 2017. Initial data processing 
was conducted using a script prepared in R version 3.2.2 (R Core Team 2017), which was 
prepared with the help of Dr Katherine Tansey (Cardiff University). 
Participants were sent a reminder email to complete the questionnaires each week, however, 
participants were able to log on to the system and complete the questionnaires at any time. 
This meant that some participants had responses in close succession (i.e. 1 or 2 days after the 
previous entry). To ensure that responses related to at least the majority of a preceding 
week, the R script specified that responses had to be a minimum of 4 days apart. This 
resulted in excluding 1.94% of the 39,749 responses, resulting in a final dataset of 38,994 
responses. Out of the remaining responses, the average interval between responses was 7.13 
days (SD = 1.16) with a range of 4-28 days. As shown in Table 5-1, 88% of responses occurred 
6 to 8 days after the previous response, and 94% of all responses occurred 5-9 days after the 
previous response.  
Table 5-1. Number of days between participant entries on the True Colours system. 
Interval between 
entries 
Percentage of responses in dataset 
 (n = 38,994) 
7 days 67.3 
6 - 8 days 88.1 
5 - 9 days 94.4 
4 - 10 days 97.9 
> 10 days 2.0 
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5.2.4 Identifying Mood Episodes 
The presence of mood episodes was estimated based on two criteria: 
(1) A weekly summary score that was above a specified threshold, and 
(2) A specified duration for the above threshold score. 
These criteria are described in more detail below.  
Thresholds for Mood Episodes 
The score thresholds for episodes of high and low mood were chosen based on the 
psychometrically validated threshold scores for the AMS and QIDS outlined in section 5.2.1 
and previous work by the Oxford University True Colours research team (Bopp et al. 2010; 
Palmius et al. 2016). Specifically, AMS total scores that exceeded 5 were chosen as an index 
of hypomania or mania, and scores of 11 or more on the QIDS were chosen as indicators of 
moderate to very severe depression.  
Duration of Episodes 
The weekly scores for the AMS and QIDS do not assess duration, therefore to increase the 
probability that the duration criteria for an episode of (hypo)mania had been met (i.e. at least 
4-7 days), AMS scores had to be above threshold for a minimum of two consecutive weeks. 
This increased the probability that symptoms had been present for at least one week. 
Likewise, as the DSM-IV duration criteria for major depressive episodes is at least 2 weeks, 
the total QIDS score had to be above-threshold for a minimum of 3 consecutive above-
threshold weeks. 
5.2.5 Extracting Data Prior to Episode Relapse 
Once an episode that met the aforementioned criteria was identified, the R script extracted 4 
weeks of data that had occurred prior to the episode onset, in order to allow examination of 
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trajectories in insomnia symptoms.  To ensure that participants were euthymic during this 
time, participants whose scores were above threshold (i.e. had an AMS score greater than 5 
or QIDS score greater than 10) for any duration in the weeks prior to mood episode were 
excluded. Out of the 692 participants enrolled in True Colours, 153 participants met these 
criteria for episodes of high mood, and 94 met these criteria for episodes of low mood. 
Descriptives of the participants who met these criteria is detailed in Table 5-2. 
Table 5-2. Descriptives of participants enrolled in True Colours who met symptom and 
duration criteria for likely episodes of high mood or low mood. 
 High Mood Low Mood 
Total N who met criteria 153 94 
Diagnosis, n (%) BD-I: 91 (59.5) 
BD-II: 62 (40.5) 
BD-I: 53 (56.4) 
BD-II: 41 (43.6) 
Gender, n (%)   
Male 50 (32.7) 24 (25.5) 
Female 103 (67.3) 70 (74.5) 
Age, years Mean 52.81 (SD 10.03) 
Median 53.00 
Range 30-78 
Mean 51.89 (SD 11.02) 
Median 52.00 
Range 26-80 
Response interval, mean 
(SD) 
7.3 days (1.6 days) 7.0 days (1.1 days) 
Response interval  (% of 
responses) 
7 days (60.3) 
6 – 8 days (84.4) 
5 – 9 days (91.5) 
4 – 10 days (95.1) 
7 days (64.3) 
6 – 8 days (90.1) 
5 – 9 days (97.0) 
4 – 10 days (98.5) 
5.2.6 Measuring Insomnia 
The QIDS includes 4 items that assess sleep disturbance: initial insomnia, middle insomnia, 
terminal insomnia and hypersomnia. As the main aim of this chapter was to examine changes 
in insomnia that occur prior to episode relapse, I analysed data on initial, middle and terminal 
insomnia. The questions on these items are shown in Table 5-3. 
  
 119 
 
Table 5-3. QIDS insomnia items and responses. 
Question Response (score) 
Q1. Falling asleep 
[initial insomnia] 
I never take longer than 30 minutes to fall asleep (0) 
I take at least 30 minutes to fall asleep, less than half the time (1) 
I take at least 30 minutes to fall asleep, more than half the time (2) 
I take more than 60 minutes to fall asleep, more than half the time (3) 
  
Q2. Sleep during 
the night [middle 
insomnia] 
I do not wake up at night (0) 
I have a restless, light sleep with a few brief awakenings each night (1) 
I wake up at least once a night but I go back to sleep easily (2) 
I awaken more than once a night and stay awake for 20 minutes or 
more, more than half the time (2) 
  
Q3. Waking up too 
early [terminal 
insomnia] 
Most of the time, I awaken no more than 30 minutes before I need to 
get up (0) 
More than half the time, I awaken more than 30 minutes before I 
need to get up (1) 
I almost always awaken at least one hour or so before I need to, but I 
go back to sleep eventually (2) 
I awaken at least one hour before I need to, and can’t go back to 
sleep (3) 
QIDS, Quick Inventory of Depressive Symptomatology questionnaire (Rush et al. 2003) 
Cross-product correlations between the insomnia items within the sample revealed that they 
were significantly correlated, with spearman correlation coefficients greater than 0.3 (see 
Table 5-4) and a Cronbach’s alpha of 0.90.  
Table 5-4. Correlations between QIDS insomnia items. 
  
Initial 
Insomnia 
Middle 
Insomnia 
Terminal 
Insomnia 
Initial Insomnia 1.00 
  
Middle Insomnia 0.33*** 1.00 
 
Terminal Insomnia 0.40*** 0.44*** 1.00 
***p < .001, QIDS, Quick Inventory of Depressive Symptomatology questionnaire 
(Rush et al. 2003) 
 
Given these associations, the items were summed to provide a total ‘insomnia’ score with 
possible scores ranging from 0 to 9. The insomnia score was calculated for each of the four 
weeks identified prior to the onset of mood episodes. 
 120 
5.2.7 Statistical Analysis: Latent Growth Mixture Modelling 
Following extraction of the relevant data using the methods described above, Growth 
Mixture Modelling (GMM) was used to examine trajectories in insomnia observed in the 
month prior to relapse. GMM is a statistical technique in which individuals are 
probabilistically assigned to categories (i.e. latent classes) based on intraindividual change 
over time (Jung and Wickrama 2008). Differences between individuals can then be explored 
based on class membership. Therefore, GMM is a person-centred statistical approach (in 
contrast to more traditional variable-centred approaches, Jung and Wickrama, 2008). 
Determining the number of classes is an iterative process, in which a k-class model is tested 
(i.e. a model with one class) followed by models with k+1 classes. Each model is assessed by 
examining the following statistics (Berlin et al. 2014):  
 Log-likelihood: values closer to 0 indicate a better model fit. 
 Bayesian information criterion (BIC): lower values indicate better model fit. 
 Entropy: an index of classification accuracy ranging from 0 to 1. Values of at least 
0.80 are preferable. 
Models are also compared using likelihood ratio tests and bootstrapping procedures to 
determine whether a k+1 class solution provides a significantly better model fit than a k-class 
solution. The Vuong-Lo-Mendell-Rubin likelihood ratio test (VLMR-LRT) and Bootstrap 
likelihood ratio test (BLRT) were used in these analyses. 
The optimum number of classes was informed by the statistics described above, theory and 
model parsimony (Bauer and Curran 2003). Missing data were handled using full information 
maximum likelihood estimation and all GMM analyses were conducted in Mplus version 7 
(Muthén and Muthén 2012). 
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Differences Between Classes 
Upon identifying an optimal class solution, differences between classes were tested in Mplus 
using pseudo-class Wald tests of equality of means. These tests use posterior probability-
based multiple imputation in order to account for the fact that each individual will have a 
different probability of belonging to each of the resultant classes (Asparouhov and Muthén 
2014).   
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5.3 Results 
5.3.1 Insomnia Trajectories Prior to Episodes of High Mood 
Out of the 153 participants, 8 had data missing at all 4 pre-illness weeks, therefore the final 
analysis was conducted on 145 participants. Figure 5-4 outlines the average insomnia 
trajectory in the sample prior to the onset of an episode of high mood.  
 
Figure 5-4. Mean insomnia score in weeks prior to episode of high mood. Error bars 
represent 95% confidence intervals. 
 
Table 5-5 outlines the model fit statistics for each of the k class models that were tested using 
growth mixture modelling. The information in Table 5-5 (combined with assessment of the 
classes based on theory and parsimony) indicated that a 3-class solution of insomnia 
trajectories represented the best model fit, with the following model fit indicators: 
 Classification accuracy (i.e. entropy) greater than 0.80 (0.85). 
 Bayesian Information Criterion = 1963.477 
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 Vuong-Lo-Mendell-Rubin likelihood ratio test, p = 0.017 and Bootstrap likelihood 
ratio test, p < .001 compared to a 2-class solution. 
Table 5-5. Model selection criteria to determine trajectory classes of insomnia prior to 
episodes of high mood. 
Model Log likelihood BIC VLMR-LRT BLRT Entropy 
1-class -977.000 1978.883 --- --- --- 
2-class -964.435 1973.660 0.2711 < .001 0.873 
3-class -949.390 1963.477 0.0174 < .001 0.845 
4-class -941.378 1967.361 0.4438 0.020 0.845 
BIC, Bayesian Information Criterion, VLMR-LRT, Vuong-Lo-Mendell-Rubin likelihood ratio test, BLRT, 
Bootstrap likelihood ratio test. 
In addition, as shown in Table 5-5, the 4-class solution did not appear to represent a better 
model fit than the 3-class solution, as evidenced by: 
 A higher Bayesian Information Criterion value (1967.361) than the 3-class solution. 
 Vuong-Lo-Mendell-Rubin likelihood ratio test, p = 0.44 compared to the 3-class 
solution. 
As shown in Figure 5-5, the classes identified for the 3-class solution were: (1) low insomnia (n 
= 113, 78%) in which insomnia scores were consistently low throughout in the euthymic 
period,  (2) high insomnia (n = 24, 17%) in which insomnia score were consistently high during 
the euthymic period and (3) increasing insomnia, in which symptoms were initially low but 
increased throughout the pre-illness period (n = 8, 6%). 
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Figure 5-5. Mean insomnia scores prior to episodes of high mood, split by class. Error bars 
represent 95% confidence intervals. 
 
5.3.2 Predictors of Insomnia Class Membership Prior to Episodes of High Mood 
Bipolar Diagnosis and Gender 
Results from Chapter 3 suggested that individuals with BD-I and women may be more likely to 
experience disturbed sleep prior to episodes of high mood, therefore I tested the groups to 
determine whether the increasing or high insomnia groups were more likely to include 
women and individuals with BD-I. 
Pseudo-class Wald Chi-square tests revealed no significant differences between the classes in 
bipolar diagnosis (χ2(2)= 1.98, p = 0.372, see Figure 5-6) or gender (χ2(2)= 0.566, p = 0.754, 
see Figure 5-7). 
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Figure 5-6. Insomnia trajectory class split by bipolar diagnostic subtype (BD-I, bipolar-I 
disorder, BD-II, bipolar-II disorder). 
  
Figure 5-7. Insomnia trajectory class split by gender. 
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Age 
 As shown previously in Table 5-2, there was a wide age range in this sample and, given that 
old age is associated with a higher likelihood of insomnia, it is possible that the high or 
increasing insomnia classes were more likely to include older participants. However, a 
Pseudo-class Wald Chi-square test revealed no significant differences in age (χ2(2)= 4.726, p = 
0.094) across the classes (see Table 5-6). 
Table 5-6. Descriptives of age split by insomnia trajectory class. 
 Class 
 
Increasing (n=8) Low (n=113) High (n=24) 
Mean (SD) 56.86 (10.30) 51.53 (9.89) 56.45 (9.98) 
Median 52.00 52.00 58.50 
Range 43-70 30-78 32-70 
 
AMS Summary Scores in the Pre-Illness Period 
It is possible that participants in the high or increasing insomnia classes were also more likely 
to display increasing residual manic symptoms during this time, therefore I compared the 
classes on AMS symptom scores during the pre-illness weeks. Figure 5-8 shows the AMS 
symptoms in the pre-illness weeks, split by class. 
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Figure 5-8. Mean Altman Mania Scale (AMS) scores prior to episodes of high mood. Error 
bars represent 95% confidence intervals. 
A pseudo-class Wald test revealed that there were no significant differences in AMS summary 
scores between the classes  (χ2(2)= 1.43, p = 0.489). 
AMS Reduced Need for Sleep Score in the Pre-Illness Period 
Despite there being no significant differences in AMS summary scores, it is possible that the 
insomnia groups showed corresponding differences in the ‘reduced need for sleep’ item of 
the AMS (see Appendix C). Figure 5-9 illustrates average scores for the ‘reduced need for 
sleep’ item of the AMS (with a score ranging from 0 to 3) during the pre-illness period 
according to class membership. A pseudo-class Wald test revealed that there were no 
significant differences in AMS ‘reduced need for sleep’ scores in the pre-illness period (χ2(2)= 
4.98, p = .083). 
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Figure 5-9. Average scores on the ‘reduced need for sleep’ item of the AMS. Error bars 
indicate 95% confidence intervals. 
 
QIDS Total Scores in the Weeks Prior to an Episode of High Mood 
A pseudo-class Wald test revealed that the distribution of QIDS summary scores (minus 
insomnia items) in the pre-illness period were significantly different across classes (χ2(2) = 
10.356, p = .006), with a significant difference between Class 2 (‘Low insomnia’) and Class 3 
(‘High insomnia’) (χ2(1) = 10.441, p = .001). 
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Figure 5-10. Average QIDS summary scores (minus insomnia items) by class during 4 weeks 
prior to an episode of high mood. Error bars indicate 95% confidence intervals. 
Examination of the QIDS total scores in the weeks prior to the episodes revealed that 21.4% 
of the sample met criteria for an episode of low mood (i.e. reported QIDS scores > 10 for at 
least 3 consecutive weeks) during the 4 weeks prior to the episode of high mood.  
A pseudo-class Wald test revealed that the proportion of participants who met criteria for a 
depressive episode during the pre-illness period was significantly different across classes 
(χ2(2)= 8.76, p = .013), with a significant difference between Class 2 ‘Low insomnia’ and Class 
3 ‘High insomnia’ (χ2(1)= 8.89, p = .003), with 46% of the ‘high insomnia’ class meeting criteria 
for a depressive episode compared to 16% in the ‘low insomnia’ class.  
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5.3.3 Insomnia Trajectories Prior to Episodes of Low Mood 
Of the 94 participants who met the criteria outlined in section 5.2.5, 12 had missing data at all 
4 weeks prior to episode onset, therefore the analysis was conducted on the 82 participants. 
Figure 5-11 outlines the average insomnia trajectory in the sample prior to the onset of 
episodes of low mood.  
 
Figure 5-11. Average trajectory in insomnia severity over 4 weeks preceding episodes of 
low mood. Error bars represent 95% confidence intervals. 
 
As shown in Table 5-7, the model fit statistics for each of the k+1 models did not appear to 
provide better solutions to the data than a 1-class solution. Specifically, (1) the BIC value 
increased for each additional class, (2) the 3-class and 4-class solutions did not show 
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significantly better fit than a 2-class or 3-class solution, respectively, and (3) although the 
VLMR-LRT and BLRT tests were significant, inspection of the 2 classes revealed that one class 
consisted of only one individual. 
Table 5-7. Model selection criteria to determine trajectory classes of insomnia prior to 
episodes of low mood. 
Model Log likelihood BIC VLMR-LRT BLRT Entropy 
1-class -538.341 1098.716 --- --- --- 
2-class -529.754 1099.169 0.0017 0.0000 0.989 
3-class -525.948 1109.184 0.3528 0.2500 0.883 
4-class -522.736 1120.386 0.7431 0.6667 0.760 
BIC, Bayesian Information Criterion, VLMR-LRT, Vuong-Lo-Mendell-Rubin likelihood ratio test, BLRT, 
Bootstrap likelihood ratio test. 
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5.4 Discussion 
The aim of this chapter was to examine the prospective association between sleep 
disturbance and episode relapse in individuals with bipolar disorder. Specifically, I examined 
trajectories in symptoms of insomnia prior to episodes of high mood and low mood. The 
three questions that I aimed to address are discussed below. 
Are there different trajectories in insomnia prior to the onset of manic episodes? 
The results indicate that individuals with bipolar disorder can be grouped into three classes 
based on their insomnia trajectories: ‘low insomnia’, where insomnia symptoms remain low 
(e.g. low scores on insomnia questions in the weeks prior to episodes); ‘high insomnia’, where 
insomnia symptoms are consistently high prior to episodes; and ‘increasing insomnia’ where 
insomnia symptoms start low but increase in the weeks prior to manic episodes. The majority 
of individuals were in the ‘low insomnia’ class (78%), with 6% in the ‘increasing insomnia’ 
class and 17% in the ‘high insomnia’ class.  These results suggest that there are 
distinguishable patterns in sleep disturbance prior to episodes of mania. 
Few other studies have reported on the proportion of bipolar individuals who experience 
sleep disturbance prior to episodes of high mood. In a systematic review, which comprised 
over 1100 participants, Jackson et al. (2003) reported that a median of 77% of bipolar 
individuals report sleep loss as a prodromal symptom of mania. This figure is considerably 
higher than that observed in the present study, however the authors conceded that the 
studies included in the systematic review varied considerably in methodologies and relied 
primarily on retrospective data (Jackson et al. 2003). In addition, ‘sleep loss’ is a broad term 
that can encompass both symptoms of insomnia and sleep loss incurred through other 
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factors (e.g. shift work), whereas the results of the present study consider only symptoms of 
insomnia. 
In studies which have examined the rates of mania and hypomania in individuals receiving 
total sleep deprivation therapy for depression, the rates of switching from depression into 
hypomania or mania range from 5-29% (Wu and Bunney 1990; Kasper and Wehr 1992; 
Colombo et al. 1999). These figures are more consistent with the results of the present study, 
but the studies are not directly comparable, given that they assessed rates of switching into 
mania that occurred following sleep deprivation, and in these cases all patients were 
depressed. Furthermore, prodromal insomnia may have different psychological and 
physiological sequelae to sleep deprivation imposed in a therapeutic setting.  
An additional point that warrants further exploration is the characteristics of the ‘high 
insomnia’ group. It is possible that, for these participants, high levels of insomnia signalled 
the impending onset of episodes of high mood. Conversely, it is possible that these 
individuals always experienced this level of sleep disturbance and continued to do so after the 
episode of high mood abated. Sleep disturbance for longer periods before and after episodes 
could be explored in future work on these data. 
Chapter 3 of this thesis found that 20% of individuals with BD reported that sleep loss had 
triggered episodes of high mood, therefore the results of this chapter, in which 6% report 
increasing insomnia symptoms prior to episodes of high mood, could be interpreted as 
weaker evidence for the role of sleep loss as a pathway to mania. Whilst this may be correct, 
it is also worth considering that the results of Chapter 3 considered lifetime triggers of mania, 
whereas the results of this chapter examine sleep loss occurring prior to one episode. 
Therefore, one would expect a lower proportion of participants to report sleep loss prior to 
episodes of high mood when examining one mood episode compared to all those 
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experienced in a participant’s lifetime. Furthermore, the definition of a ‘mood episode’ 
differed in this study, and subsequent research might wish to use more robust measures of 
mood episodes than scores on questionnaires. 
Are particular insomnia trajectories associated with clinical characteristics such as bipolar 
subtype and gender? 
The insomnia classes did not differ according to bipolar subtype, gender, age or AMS 
symptom scores during the pre-illness period. However, the classes significantly differed on 
QIDS symptom scores, with individuals in the high insomnia group demonstrating significantly 
higher QIDS symptom scores compared to individuals in the low insomnia group, even when 
removing insomnia items from the QIDS summary score. Further examination of these scores 
revealed that the high insomnia group were also more likely than those in the low insomnia 
group to meet criteria for a depressive episode during this time. 
This is in accordance with the sleep reduction model of mania, in which Wehr hypothesises 
that insomnia that occurs as a result of depressive symptoms could precipitate mania in some 
bipolar individuals (Wehr et al. 1987). Future analyses could aim to delineate whether 
insomnia predicts episodes of mania over and above depressive symptoms within this 
sample, as has been done in studies of patients with MDD (Franzen and Buysse 2008). 
However, the ‘low’ and ‘increasing’ insomnia subgroups had small sample sizes, which 
compromised power to detect differences between the subgroups, therefore these results 
need to be replicated in larger samples before conclusions can be made.  
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Is the trajectory of insomnia symptoms prior to depressive episodes different to the 
trajectory observed prior to manic episodes? 
In contrast to episodes of high mood, the analyses did not suggest more than one insomnia 
trajectory prior to episodes of low mood. This trajectory was consistently low, with an 
average of 3 out of a possible 9 on the insomnia scale during the pre-illness period. This 
finding is in contrast to research finding that reduced sleep duration is associated with 
subsequent depression (Perlman et al. 2006; Talbot et al. 2012; Gershon et al. 2017). 
However, it should be noted these analyses were conducted on a sample of 82 participants, 
therefore were likely underpowered. Future analyses could aim to rerun the analyses in a 
larger sample. 
5.4.1 Strengths and Limitations 
There are a number of strengths of this study. First, this is one of the first studies to examine 
prospective associations between insomnia and relapse in bipolar disorder. Despite evidence 
that sleep loss is both a prodromal symptom and trigger of mania (Wehr et al. 1987; Jackson 
et al. 2003), few studies have examined the relationship between sleep and mood in a 
prospective sample. Second, data were collected over an extensive period, spanning an 
average of 56 weeks, with mood ratings collected at weekly intervals. Third, the findings 
highlight the importance of recognising heterogeneity in sleep loss that may occur prior to 
episodes of high mood. Specifically, the analysis lent credence to the theory that only a 
subgroup of individuals display sleep loss as a pathway to mania. Finally, although weekly 
mood symptoms were completed online, information on diagnoses were derived from rich 
clinical data collected via diagnostic interviews and case notes. 
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However, the findings of this chapter need to be considered in light of the following 
limitations. First, the option for participants to answer the mood questionnaires at any time 
point resulted in unequal intervals between entries, which will have introduced additional 
error within the analyses. However, the rate of compliance with providing weekly mood 
ratings was high, with 94% of all responses occurring 5-9 days after the previous response. 
Future analyses in large samples may attempt to model this variation through the use of a 
latent variable.  
Second, a major limitation of secondary analyses which compared classes is the small sample 
sizes within the derived classes (e.g. n=8). This means that the results for class comparisons 
need to be interpreted with caution, as they are likely to be underpowered to detect 
differences between the classes. Power calculations indicate that a larger sample size would 
be required in order to make adequately powered comparisons between the classes. For 
example, based on the effect size achieved in this study, analyses with 80% power to detect 
whether individuals with BD-I (or BD-II) are overrepresented in particular classes would 
require a minimum sample size of 62 participants in each class (see Appendix F for the 
method used to calculate sample sizes). Until this is achieved it is not possible, therefore, to 
reliably interpret the results of class comparisons. 
Third, the AMS may not be the optimum measure of ‘high mood’ episodes, as it does not 
assess other symptoms of mania such as irritability, racing thoughts, distractibility, and 
excessive involvement in pleasurable activities with high potential for painful consequences. 
In addition, the threshold of a score of 5 or more may have been too liberal a criterion for 
manic episodes. This may explain why, using this criterion, more participants in the sample 
met criteria for (hypo)manic episodes than depressive episodes (see Table 5-2).  
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Finally, of note is that the sample consisted of a wide age range, with an average age of 52-53 
in both samples. Although further analyses did not reveal significant differences in age 
between the samples, it would be prudent to attempt to replicate the results in younger 
samples. In addition, it was not possible to adjust results for the effects of medication, as 
these data were not collected as part of this version of the True Colours system. However, a 
study by Sylvia and colleagues (Sylvia et al. 2012) on the relationship between sleep duration 
and course of illness in BD found that only anticonvulsants were associated with reduced 
sleep duration, with no significant associations found with other medications such as lithium 
or atypical antipsychotics. Nevertheless, routine collection of medication via the True Colours 
system would be beneficial for disentangling the relationship between sleep and mood. 
5.4.2 Future Research 
Aside from the aforementioned recommendations, future research could improve upon the 
current study through the following: 
1. Increasing the sample size: Aside from recruiting more participants or waiting for 
more participants to experience episode recurrence, other methods to increase the 
sample size might involve using less stringent criteria for mood episodes (e.g. 
requiring only one week instead of two weeks above threshold) or the pre-illness 
period.  
2. Further exploration of the insomnia classes: It is possible that individuals in the ‘high 
insomnia’ class experienced high levels of insomnia both prior to and following the 4-
week pre-illness period. It would be interesting to explore whether these individuals 
experience persistently high sleep disturbance prior to, during and following episodes 
of high mood. 
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3. Utilising other statistical methods: Selecting data prior to one episode per 
participant may be limited due to not being able to make use of the full data for each 
participant – other statistical methods for intensive longitudinal data may provide 
additional insight into the relationship between sleep and mood (e.g. multilevel 
modelling, cross-lagged panel models, dynamic structural equation models).  
4. Frequency and characteristics of sleep and mood measures: In this study, ratings 
for insomnia symptoms and mood were made on a weekly basis. Previous research 
suggests that the time lag between sleep and mood may be best observed using daily 
measures (Leibenluft et al. 1996; Bauer et al. 2006). Furthermore, other types of 
sleep disturbance in addition to insomnia may display different relationships with 
subsequent mood episodes (e.g. hypersomnia for depression, acute versus chronic 
sleep deprivation). 
5.4.3 Conclusions 
In summary, the results in this chapter support the theory that only a subgroup of individuals 
with BD will display sleep disturbances prior to the onset of manic episodes. The results 
suggest that high or increasing levels of insomnia may be a more useful prodrome for 
detecting the onset of manic, rather than depressive episodes. However, the analyses 
presented here are of limited statistical power to examine the characteristics of the identified 
subgroups, and need to be further explored in larger samples that include at least 62 
participants in each subgroup. Nonetheless, the results highlight the importance of 
considering both intra- and interindividual variation in sleep prior to episodes of high mood. If 
replicated in larger samples, further characterisation of individuals who are at a heightened 
risk of relapse following sleep disturbance may help illness management and prevention. 
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6 USING ACTIGRAPHY TO MEASURE SLEEP DISTURBANCE IN PREGNANT 
WOMEN AT HIGH-RISK OF POSTPARTUM PSYCHOSIS  
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6.1 Introduction 
Previous chapters highlighted the relevance that sleep research may have for predicting and 
preventing postpartum psychosis (PP). In Chapter 4, I analysed data from the Bipolar Disorder 
Research Network (BDRN) sample on parous women with bipolar disorder (BD). These results 
suggest that a history of sleep loss triggering episodes of high mood (i.e. sensitivity to sleep 
loss) may indicate increased risk of developing PP. However, these results were limited by the 
retrospective nature of data collection, therefore may have been subject to recall bias. 
Furthermore, as measures of sleep loss were not available for these data, it was not possible 
to determine what level of sleep loss women in this sample had been exposed to.  
The next step in this area of research, therefore, is to explore these findings using prospective 
measurements of sleep and subsequent mood episodes in the perinatal period. In this 
chapter, I will first outline existing research in this area, followed by a description of the use 
of actigraphy for this area of research. I will end this section by describing the aims for this 
chapter. 
6.1.1 Prospective Studies of Sleep and Risk of Postpartum Psychosis 
To date, only two studies have examined the prospective relationship between perinatal 
sleep and PP. First, Sharma and colleagues compared the obstetric records of 21 women 
admitted to hospital with PP to matched controls (Sharma et al. 2004). They found that 
women with PP had experienced significantly longer labours and were also more likely to give 
birth at night (defined by the authors as a delivery occurring between 12:30am and 7:30am). 
However, this study inferred sleep loss based on the timing and duration of labour, and did 
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not measure sleep directly. It also did not consider sleep patterns in the days or weeks 
preceding labour.   
Second, Bilszta and colleagues (Bilszta et al. 2010) asked 23 women at high-risk of PP (i.e. with 
a history of BD and/or PP) and 15 healthy controls to record their sleep during pregnancy and 
the postpartum period using sleep diaries. The authors reported no significant differences in 
sleep parameters between the high-risk and control groups, but reflected that 80% of women 
in the high-risk group were taking medication, and that this group’s past experiences with PP 
may have made them hyper-vigilant to minimise any potential triggers of mood episodes.  
There is evidently a need for more studies in this area and the existing studies have a 
combined sample size of 80 women (44 with PP), thus limiting power and generalisability. 
Furthermore, both studies used healthy controls as the comparison group, therefore are of 
limited use for individualising risk within women who are already at high risk of developing PP 
(i.e. women with a history of PP or diagnosis of BD). It was not possible for Bilszta and 
colleagues to compare sleep parameters between women who did and did not relapse in the 
high-risk group because only 3 out of 23 women in this group relapsed). Comparing women 
who do and do not experience episode recurrence is crucial for understanding what factors 
precipitate PP in high-risk women. It is therefore necessary to examine whether changes in 
sleep patterns could be used as a risk marker within women at high risk of PP. 
Furthermore, neither study used objective measures of sleep. The study by Sharma and 
colleagues inferred sleep loss based on the timing and length of labour, whereas the study by 
Bilszta et al. used sleep diaries. Currently available objective measures of sleep may be less 
prone to recall-bias or poor compliance than sleep diaries.  
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In summary, the above studies highlight the need for further research on sleep and PP that 
(a) compares the perinatal sleep of high-risk women who develop PP to those who remain 
well, and (b) complements subjective measures of sleep with objective measures.  
The two main methods for objectively measuring sleep are polysomnography (PSG) and 
actigraphy. PSG is considered the gold standard method for assessing sleep and combines 
information from multiple sensors to elucidate sleep stages. These generally include electrical 
brain activity, eye movements, and muscle activation, but may also use information from 
oxygen saturation sensors, video recordings and other sensors (Sadeh 2015). However, PSG 
involves high participant burden, high costs, and the requirement to sleep in an unnatural 
environment, thereby making it a questionable assessment of normal sleep patterns (Millar et 
al. 2004; Sadeh 2015). In contrast, actigraphy provides a cost-effective and non-invasive 
method to assess sleep over long periods of time in naturalistic settings (Millar et al. 2004; 
Sadeh 2011; Miller et al. 2012; Sadeh 2015). Actigraphy is described in further detail in the 
next section. 
6.1.2 Actigraphy and Sleep 
The term ‘actigraphy’ (also referred to as actimetry or activity monitoring) refers to the use of 
electromechanical devices, typically worn on the wrist, which monitor and analyse movement 
(Sadeh 2011). Collected data is then analysed via validated algorithms to estimate sleep 
parameters such as sleep onset, total sleep time and sleep efficiency. The first use of 
actigraphy was documented in the 1950s (Tryon 1991), with subsequent development in the 
1970s (Littner et al. 2003) and was approved by the American Academy of Sleep Medicine for 
research purposes in 1995 (Thorpy et al. 1995). Actigraphy has previously been successfully 
used to measure sleep patterns in women in pregnancy and the postpartum period (Insana 
and Montgomery-Downs 2010; Montgomery-Downs et al. 2010; Insana et al. 2011; Insana 
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and Montgomery-Downs 2013; McBean and Montgomery-Downs 2013) and in individuals 
with BD (e.g. Gershon et al. 2012; Jones et al. 2005). 
Actigraphy enables non-invasive long-term monitoring of sleep, which is advantageous for 
research on sleep loss occurring due to childbirth. This is because delivery dates may vary 
significantly from due dates, with only 27% of births in the UK occurring at gestational week 
40 (Moser and Hilder 2008). This variation means that devices need to monitor sleep for a 
sufficient period of time in order to capture sleep loss occurring around childbirth. Recent 
technological advances mean that monitoring periods of several weeks are now possible with 
some actigraph models. However, the extended monitoring period of the newer actigraph 
models currently cannot capture the entire gestational period; therefore it is still necessary to 
limit actigraphy monitoring to a specific period of interest. The available literature suggests 
that the most crucial timeframe to measure the association between sleep patterns and PP is 
the immediate perinatal period (i.e. the week prior to, including, and following labour). This is 
because the greatest degree of sleep loss occurs in this period (Hedman et al. 2002; Beebe 
and Lee 2007), and the first symptoms of PP often emerge in the first postpartum week 
(Heron et al. 2007; Heron et al. 2008). Evidence from sleep deprivation studies mentioned 
previously (e.g. Kasper and Wehr, 1992) suggest that acute sleep deprivation (i.e. total sleep 
deprivation or sleep deprivation in the latter half of the night) can trigger mania after one 
night. It is plausible, therefore, that the acute sleep loss often experienced during labour 
(Sharma et al. 2004; Beebe and Lee 2007) and in the early postpartum days, may trigger PP in 
some women. 
At the time of writing, there were no published studies using actigraphy to measure sleep in 
women at high risk of developing PP. This could be due to a confluence of factors. First, this 
might reflect difficulties of recruiting clinical populations (particularly, women at high-risk of 
PP) as well as asking individuals to partake in research during a significant life event. Second, 
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this may be due to difficulties capturing sleep at a particular stage of pregnancy and 
postpartum that can be difficult to coordinate within the limits of actigraphy battery life and 
memory storage. Although allowing relatively long-term measurements of sleep, until 
recently, the length of time that actigraphy was able to measure was limited to around 1-2 
weeks. This means traditionally it has been logistically difficult to measure sleep continuously 
during the weeks immediately before and after birth.  
6.1.3 Aims  
In summary, the results presented in Chapter 4 were limited by the lack of direct data 
examining sleep, and there is a dearth of research that has used objective measures of sleep 
to examine sleep patterns in women at high risk of developing PP. Therefore, the aim of this 
study was to pilot the use of assessing sleep using actigraphy in pregnant women at high-risk 
of developing PP. Specifically, I aimed to measure changes in sleep that occurred during the 
time of parturition which has been associated with the greatest disruption to sleep; the 
weeks immediately before and after childbirth. 
Initially, I also aimed to use the prospective sleep data to investigate whether changes in 
sleep patterns during pregnancy and postpartum could be used as a marker for developing 
PP. However, difficulties with recruitment meant that this project was not able to progress 
beyond the pilot stage. This chapter will therefore describe the process of designing and 
conducting the pilot study, followed by recommendations for future research based on the 
experiences of conducting this study and examining preliminary results. 
In particular, I will discuss: 
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1. Whether it is feasible to collect actigraphy data in this population and, if so, to 
identify which indicators of sleep disturbance may be useful to target in larger 
studies. 
2. The barriers to conducting this type of research, and what could be done to facilitate 
this research in the future. 
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6.2 Method 
The study described in this chapter formed part of the ongoing programme of research 
conducted by the BDRN. Specifically, this study prospectively investigated the factors 
associated with postpartum mood episodes in pregnant women at high risk of PP (i.e. women 
with a lifetime diagnosis of BD or a history of PP). Women enrolled in this study were given 
the option to monitor their sleep patterns using an actigraph and sleep diary. The following 
sections describe the main study from which participants were recruited, followed by the 
methods specific to the sleep monitoring aspect of the study. The study had UK National 
Health Service (NHS) Ethics Committee approval (West Midlands Multi-Centre Research 
Ethics Committee, Ref MREC97701) and local R&D approval in NHS Trusts and Health Boards 
throughout the UK (described below). 
6.2.1 Recruitment 
Participants were primarily recruited systematically via specialist psychiatric perinatal services 
and community mental health teams. Trusts and Health Boards approached included: 
Abertawe Bro Morgannwg; Aneurin Bevan; Birmingham and Solihull; Derbyshire; Devon; East 
London; Glasgow; Greater Manchester; Hampshire; Leeds; Lothian; Northumberland; 
Nottinghamshire; Sheffield; South Staffordshire and Shropshire; Tyne and Wear; West Hub 
and Bath; and Worcestershire. Participants received an invitation letter and information sheet 
from their perinatal psychiatrist and contacted the research team if they wished to 
participate. In addition, individuals referred to the Cardiff University second opinion clinic run 
by Professor Ian Jones were informed of the study and referred if they wished to participate.  
Participants were also recruited non-systematically via websites and social media relating to 
postpartum psychosis and mental health (e.g. www.app-network.org, www.ncmh.info, 
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www.bdrn.org, and www.bipolaruk.org). Written informed consent was obtained from all 
participants prior to enrolment in the study.  
6.2.2 Inclusion and Exclusion Criteria  
In addition to general inclusion and exclusion criteria for inclusion to the BDRN research 
programme (described in Chapter 2, section 2.3), participants in the prospective pregnancy 
study had to meet the following criteria: 
 Be at least 12 weeks pregnant 
 Have a lifetime diagnosis of bipolar disorder (BD-I, BD-II or schizoaffective disorder 
bipolar type) according to DSM-IV or DSM-5 criteria (American Psychiatric Association 
2000; American Psychiatric Association 2013) or a history of PP (defined according to 
the same criteria described in Chapter 4, section 4.2.2). Diagnoses were ascertained 
by participant interview and case notes (described below). 
6.2.3 Antenatal Interview 
The antenatal assessment occurred during the second or third trimester (depending on time 
of recruitment). In this assessment, trained research psychologists interviewed participants 
using the Schedules for Clinical Assessment in Neuropsychiatry interview (SCAN, Wing et al. 
1990), a psychiatric interview used to ascertain lifetime psychiatric history. This interview 
included questions regarding any history of mood episodes occurring in relation to childbirth 
and any previous and currently prescribed medication use during pregnancy. 
6.2.4 Sleep Monitoring 
During the antenatal interview, participants were given the option to monitor their sleep 
patterns during late pregnancy, birth and postpartum using an actigraph and sleep diary. This 
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aspect of the study was not mandatory in order to safeguard against overburdening 
participants. Participants who expressed interest were referred to myself to be given further 
details on what the sleep monitoring would involve. 
Sleep Disorder Screening Questions 
For participants who decided to monitor their sleep, at approximately 36 weeks gestation I 
conducted a brief phone interview (see Appendix G) containing five screening questions to 
ascertain the potential presence of sleep disorders such as obstructive sleep apnoea or 
periodic limb movement disorder (Wilson et al. 2010). These sleep disorders are common in 
pregnancy (Pien and Schwab 2004; Parry et al. 2006; Facco et al. 2010; Hutchison et al. 2012) 
and may influence subjective and objective sleep estimates.  
Actigraphy 
From week 37 of pregnancy until two weeks postpartum, sleep-wake patterns were 
measured objectively using the Actiwatch Spectrum Plus actigraph by Philips Respironics 
(shown in Figure 6-1). This model of actigraph was chosen based on the following features: 
 Extended monitoring period (up to 60 days) 
 Off-wrist detection feature 
 Waterproof 
 Ability to function as a watch 
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Figure 6-1. Actiwatch Spectrum Plus Actigraph (Philips Respironics). 
Each actigraph was set to record data from 37-weeks gestation for 56 days (8 weeks) in 60-
second epochs as recommended by American Academy of Sleep Medicine practice 
parameters for actigraphy (Littner et al. 2003). Participants were advised that they were able 
to adjust or remove the device if they found it uncomfortable. 
In order to remove artefacts from actigraphy data (i.e. distinguish periods of wakeful 
inactivity from periods where the individual is resting and attempting to sleep), it is 
recommended that actigraphy research is complemented with sleep diaries (Littner et al. 
2003). Therefore, participants were asked to complete a daily (paper-based) ‘sleep grid’ to 
record their sleep times, rise times, and nap times (Beebe and Lee 2007), Figure 6-2) whilst 
wearing the actigraph. Actigraphs, sleep diaries and instructions were sent to participants by 
post (Appendix H). 
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Figure 6-2. Example sleep diary. Shaded regions indicate sleep, vertical lines indicate bed 
times and rise times. 
Following the expected due date, participants were sent freepost envelopes to return the 
actigraph and diaries. Participants also had the option to return the materials via courier. 
6.2.5 Postnatal Interview 
Approximately 8 weeks following the expected delivery date, the participant’s GP and 
psychiatrist were sent a questionnaire pack which asked for information regarding the 
participant’s pregnancy outcome and postpartum symptoms or treatment (Appendix I). 
Providing that the patient’s clinicians did not indicate that the pregnancy had resulted in an 
adverse outcome (e.g. miscarriage, still birth), research psychologists conducted a telephone 
interview 12 weeks after the expected due date. This interview included: 
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 Questions relating to delivery (e.g. length of labour, method of delivery, pain relief, 
birth complications). 
 Questions relating to the postpartum period (e.g. medication prescribed) and 
relevant sections of the SCAN to determine whether the participant experienced a 
postpartum mood episode. 
Figure 6-3 provides a brief summary of the assessment measures used in the pilot study. 
6.2.6 Lifetime Diagnoses and Postpartum Episodes 
Lifetime Diagnosis and History of PP 
Following initial interview, GP and/or psychiatric records were requested to gather further 
information on psychiatric history. Information from the interview and case notes was then 
collated into a written vignette for each participant and used to determine lifetime diagnoses 
and whether participants had a history of PP. The procedure for rating diagnoses was the 
same as for other participants recruited to BDRN (described in Chapter 2, section 2.4) and the 
criteria for postpartum episodes that occurred prior to the prospective study were the same 
as outlined in Chapter 4, section 4.2.2. 
Mood episodes occurring during the prospective pregnancy study 
Mood episodes that occurred during the course of the prospective study were rated using the 
same methods described in previous chapters. Specifically, trained research psychologists 
independently rated psychiatric symptoms from participant interviews, clinician reports, and 
case notes, and these were used to determine the presence of DSM-IV and DSM-5 (American 
Psychiatric Association 2000; American Psychiatric Association 2013) episodes of mania, 
hypomania and depression. Episodes of ‘baby blues’ (which are not defined by DSM-IV or 
DSM-5) were defined as an episode of self-limiting mood symptoms (e.g. tearfulness, 
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dysphoric mood, fatigue) lasting no longer than one week, with onset in the first postpartum 
week (Robertson et al. 2004; Heron et al. 2005). 
 
Figure 6-3. Brief summary of assessments used in the prospective pregnancy study. 
6.2.7 Preparation of Actigraphy Data 
Prior to analysis, actigraphy data were imported into proprietary software (Actiware version 
6.0, Philips Respironics). Data were cleaned by setting ‘rest intervals’ in the software, which 
were informed by information from participants’ sleep diaries. This is a requirement for 
actigraphy data analysis as actigraphy is not reliable for distinguishing periods of wakeful 
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inactivity (e.g. reading, watching television) from periods where the individual is resting and 
attempting to sleep (Littner et al. 2003). The protocol applied for correcting actigraphy is 
outlined in Appendix J. In cases where there were discrepancies between participant’s self-
reported bed/rise times and activity data, I made informed judgements on where to allocate 
rest intervals in the program based on: 
1. the general level of concordance between each participant’s diary entries and 
activity. 
2. the level and persistence of activity (i.e. high  and persistent vs. low and fragmented). 
3. examination of activity around previously reported bed/rise times to determine 
whether participants showed a common ‘activity signature’ during these times. 
I applied the actigraphy data cleaning protocol to the actigraphy data for each participant. 
When correcting and analysing the actigraphy data, I was blind to participants’ diagnoses and 
psychiatric outcomes in the prospective pregnancy study. 
 
6.2.8 Analysis 
Following data cleaning, actigraphy data were analysed using the proprietary software 
(Actiware version 6.0) to calculate ‘activity counts’. The criteria used to identify sleep were (i) 
a 40-activity count wake threshold and  (ii) at least 10 minutes of immobility. 
Once corrected, the Actiware software was used to derive the following sleep parameters: 
 Sleep onset latency: Number of minutes to fall asleep 
 Number of awakenings per night: Number of nocturnal awakenings after sleep onset 
 Time awake after sleep onset: Total minutes awake per night after sleep onset 
 Total Sleep Time: Number of hours asleep whilst in bed 
 Sleep Efficiency: Percentage of time asleep whilst in bed 
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The resulting sleep parameters were extracted from the software and analysed using R 
version 3.2.2 (R Core Team 2017).  
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6.3 Results 
6.3.1 Recruitment and Retention 
 
Figure 6-4. Recruitment chart for actigraphy study. 
As shown in Figure 6-4, during the course of the pregnancy study, 65 women were given the 
option to record their sleep during pregnancy and postpartum. Of these 65 women, 28% (n = 
18) expressed interest. Characteristics of the 18 women who expressed interest in monitoring 
sleep are shown in Table 6-1. All women had a partner at the time of recruitment.  
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6.3.2 Retention and Acceptability 
As shown in Figure 6-4, out of the 18 women who initially expressed interest in recording 
their sleep, one woman later declined due to personal circumstances and another was unable 
to be contacted. Of the remaining 16 women: 
 One woman was unable to partake in sleep monitoring due to giving birth before 
receiving the study materials. 
 Two women did not complete sleep monitoring but did not provide a reason. 
 Three women did not complete sleep monitoring due to anxiety about monitoring 
sleep and/or finding the watch uncomfortable.  
Two of the three women who withdrew from sleep monitoring due to anxiety or 
discomfort voluntarily provided written correspondence outlining their reasons for 
withdrawing (full quotes from written correspondence are provided in Appendix K. The 
key reasons for withdrawing reported by these two women were: 
 Finding the actigraph hot and uncomfortable to wear at night. 
 Becoming anxious about tracking sleep times on the diary or not having the time 
to complete the sleep diary. 
 Worry that the anxiety and restlessness caused by being ‘aware’ of sleep patterns 
would have a detrimental effect on their mental health. 
6.3.3 Women who Completed Sleep Monitoring 
Of the original 18 who expressed interest in sleep monitoring, 10 (56%) wore the actigraph 
and completed a sleep diary during pregnancy and postpartum. Demographic and clinical 
characteristics of these women are provided in Table 6-1. 
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Table 6-1. Demographic and clinical characteristics of women who expressed interest in 
sleep monitoring. 
 Expressed interest in 
sleep monitoring 
(n = 18) 
Completed sleep 
monitoring 
(n = 10) 
Did not complete 
sleep monitoring 
(n = 8) 
Age, median (range) 34.5 (18-43) 34.5 (32-40) 35 (18-43) 
Method of recruitment, n (%)    
Systematic 9 (50) 3 (30) 6 (75) 
Non-systematic 9 (50) 7 (70) 2 (25) 
Gestational week at 
recruitment, mean (range) 
25 (14-38) 21 (14-27) 30 (16-38) 
Primiparous, n (%) 4 (22) 2 (20) 2 (20) 
DSM-V diagnosis    
Bipolar-I 16 (89) 8 (80) 8 (100) 
Bipolar-II 1 (6) 1 (10) 0 (0) 
Bipolar NOS 1 (6) 1 (10) 0 (0) 
    
History of postpartum 
psychosis, n (%) 
5 (28) 2 (20) 3 (38) 
Illness onset in the postpartum 
period, n (%) 
2 (11) 2 (20) 0 (0) 
Time since last mood episode, 
n (%) 
   
Currently unwell 0 (0) 0 (0) 0 (0) 
Less than 1 month 4 (22) 2(20) 2 (25) 
1-3 months 2 (11) 1 (10) 1 (13) 
4-6 months 2 (11) 1 (10) 1 (13) 
7-12 months 4 (22) 2 (20) 2 (25) 
More than 1 year 5 (28) 3 (30) 2 (25) 
More than 5 years 0 (0) 0 (0) 0 (0) 
Unknown 1 (6) 1 (10) 0 (0) 
    
Age at first contact with 
secondary services, median 
(range) 
26 (15-37) 29 (19-34) 25 (15-37) 
Highest educational 
attainment, n (%) 
   
CSE/O-level/GCSE 1 (5.6) 0 (0) 1 (13) 
A-level/AS-level 4 (22.2) 1 (10) 3 (38) 
Degree 9 (50.0) 7 (70) 2 (25) 
Postgraduate Degree 4 (22.2) 2 (20) 2 (25) 
    
Highest occupation, n (%)    
Professional 15 (83) 8 (80) 7 (88) 
Non-professional 1 (6) 1 (10) 0 (0) 
Never worked 2 (11) 1 (10) 1 (13) 
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Sleep Disorder Screening 
The sleep disorder screening questions did not indicate the presence of narcolepsy, sleep 
breathing disorder, or restless legs syndrome in any of the 10 women who completed sleep 
monitoring. One participant screened positive for delayed sleep phase disorder and 
parasomnia, however, the actigraphy data for this woman were not analysed due to the 
actigraph malfunctioning and corrupting the data. 
6.3.4 Actigraphy 
As shown in Figure 6-4, 3 out of the 10 actigraphs returned by women who completed sleep 
monitoring malfunctioned. This resulted in data from 7 women (11% of the original 65 
approached) available for analysis. An example actogram for one participant is shown in 
Figure 6-5. As shown in this figure, each actogram plots activity (black lines) over time. For 
reference, the participant’s self-reported bed times and rise times were added to the 
actogram within the Actiware program, shown as horizontal blue lines. 
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Figure 6-5. Example actogram of one participant during the postpartum period. Day 
numbers indicate days of monitoring.  
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The sleep parameters outlined in section 6.2.8 (sleep onset latency, number of awakenings 
per night, time awake after sleep onset, total sleep time, and sleep efficiency) were plotted 
for each participant (Appendix L) using R. An example is shown in Figure 6-6.  
 
 
Figure 6-6. Example sleep parameters derived from actigraphy for one participant during 
pregnancy and the postpartum period. The yellow shaded region indicates the week prior 
to delivery, the blue shaded region indicates the week following delivery. 
The sleep parameter of most relevance to research on sleep and postpartum episodes is the 
total number of hours slept per night. Figure 6-7 shows the total sleep time for each 
participant, centred on delivery date with psychiatric outcomes and onset labelled.  
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Figure 6-7. Total number of hours slept per night two weeks before and after delivery date 
in 7 women, measured using actigraphy. Onset of DSM-5 psychiatric episodes is labelled if 
women became unwell. 
This figure illustrates that:  
 6 of the 7 women experienced a marked decrease in sleep one or two nights 
preceding or on the night of delivery. 
 Some women have more variable antepartum sleep than others (cf. participant 6 vs. 
participant 1). 
 Some women appear to have more variable sleep durations in the postpartum vs. 
antepartum period (e.g. participant 7). 
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  Excluding the days immediately surrounding childbirth, some women’s sleep 
duration remains relatively similar in the postpartum to antepartum period (e.g. 
participant 3), whereas others experience more marked changes (e.g. participant 4). 
6.3.5 Psychiatric Sequelae and Sleep Duration 
As shown in Figure 6-7 and Table 6-2, four women experienced episodes of mood disturbance 
following childbirth, and three women remained well. Of the three women who remained 
well, participant 3 and 5 both showed relatively similar sleep patterns before and after 
childbirth. Of note is that participant 5 had a night-nurse to feed the baby for the first few 
weeks postpartum, and was given prophylactic olanzapine and Zopiclone following delivery. 
In contrast, participant 6 also remained well but her sleep was more disturbed in pregnancy 
compared to the postpartum period. This participant’s medication remained stable before 
and after birth. 
As shown in Figure 6-7 and Table 6-2, four of the seven women who completed sleep 
monitoring experienced some form of psychiatric disturbance during the two weeks following 
delivery. A summary of these women’s sleep patterns that can be derived from Figure 6-7 is 
provided below: 
Participant 1 – ‘Baby blues’ 
 Antepartum: experienced relatively consistent sleep duration ranging between 7 and 
9 hours each night. 
 Delivery: 0 hours sleep (emergency caesarean section) 
 Postpartum: sleep duration returned to pre-delivery levels on the night following 
delivery and first two nights postpartum. From the third to fifth postpartum night, 
sleep duration reduced to 5-7 hours, which was followed by an episode of ‘baby 
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blues’ lasting one week. During this time, her sleep duration ranged between 4 and 7 
hours. 
Participant 2 – Major depression 
 Antepartum: Sleep duration of approximately 8-10 hours that decreased to 
approximately 6 hours in the two nights preceding delivery. 
 Delivery: Approximately 6 hours sleep (elective caesarean section) 
 Postpartum: sleep duration became more variable, ranging from 5-8 hours, followed 
by an episode of major depression lasting 4 weeks. Sleep duration during this episode 
(that overlapped with sleep monitoring) ranged between 6 and 9 hours.   
Participant 4 - Mania 
 Antepartum: Sleep duration initially ranged from 7-10 hours then decreased in the 4 
nights prior to delivery (0-5 hours). 
 Delivery: 1 hour of sleep (emergency caesarean section). 
 Postpartum: Apart from approximately 8 hours sleep on postpartum nights 6 and 7, 
sleep duration ranged from 2-4 hours on postpartum nights 1-9. The participant 
became manic on day 10, at which point she completed sleep monitoring for a 
further two nights (sleep duration ranging from 3-4 hours).  
Participant 7 - Mania 
 Antepartum: Sleep duration on average around 7.5 hours per night until the night 
prior to delivery, in which sleep reduced to 0.80 hours.  
 Delivery: 7.1 hours sleep (emergency caesarean section after a 14 hour labour) 
 Postpartum: 5 hours sleep on the first night after delivery. Participant became manic 
the following day (which lasted 6 weeks).  Sleep duration becomes more variable at 
this point, ranging from 3-8 hours.  
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Further information on obstetric and psychiatric outcomes, medication use and diagnosis is 
provided in Table 6-2. 
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Table 6-2. Additional information on medication, delivery and psychiatric sequelae of women who completed sleep monitoring. 
N Diagnosis Medication (Pregnancy) Medication (Postpartum) Delivery Psychiatric Sequelae 
1 BD-I  SertralineP 
 QuetiapineP 
 
 SertralineP 
 QuetiapineP 
 Delivered at 6:00 AM 
 6 hour labour 
 Emergency C-section 
Baby blues 
Onset: 7 days after delivery 
Duration: 1 week 
2 BD-II  LamotragineP (stopped at 5 weeks 
gestation) 
 QuetiapineP  
 MirtazapineP  
 QuetiapineP  
 MirtazapineP  
 SertralineT (postpartum day 7) 
 Elective C-section Depression 
Onset: 5 days after delivery 
Duration: 4 weeks 
3 BD-I No medication. No medication.  24 hour labour 
 Vaginal delivery 
Remained well. 
4
  
 
BD-I  LithiumP 
 DuloxetineP (changed to 
OlanzapineP at 6.5 weeks 
gestation) 
 LithiumP  
 OlanzapineT (postpartum day 
10) 
 Delivered at 12:41 
AM 
 24 hour labour 
 Emergency C-section 
Mania  
Onset: 10 days after delivery 
Duration: 4 weeks 
5 BD-I No medication. 
 
 OlanzapineP (postpartum day 1) 
 ZopicloneP (start date 
unknown) 
 Delivered at 10:17 
AM 
 7 hour labour 
 Vaginal delivery 
Remained well. 
6 BD NOS  VenlafaxineP 
 QuetiapineP 
 VenlafaxineP 
 QuetiapineP 
 Delivered at 12:00 
PM 
 40 hour labour 
 Forceps delivery 
Remained well. 
7 BD-I  ZopicloneP (late in 3rd trimester 
for poor sleep) 
 OlanzapineP (postpartum day 
1) 
 ZopicloneT (postpartum day 4) 
 DiazepamT (postpartum day 4) 
 Delivered at 08:06 
AM 
 Emergency C-section 
Mania 
Onset: 2 days after delivery 
Duration: 6 weeks 
P Prophylactic, T Treatment 
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6.4 Discussion 
This study aimed to pilot the use of actigraphy to obtain longitudinal objective measures of 
sleep in pregnant women at high risk of developing PP. In particular, I aimed to use this 
method during the latter weeks of the third trimester and initial postpartum weeks. 
Findings from this study suggest that actigraphy is a challenging methodology for measuring 
sleep in women at high risk of PP. Specifically, this study demonstrated that recruitment was 
difficult, with only 28% (n=18) of the women approached expressing interest in monitoring 
sleep patterns. Of this sample, issues with acceptability and technical failures meant that data 
were available on 7 of the 18 women who expressed interest (11% of total sample 
approached). This suggests that, for the majority of women at high-risk of PP, it is not possible 
to use actigraphy to measure sleep loss during the perinatal period (although feasibility 
studies are needed in order to adequately assess this), and that to obtain large enough 
samples for statistical analysis would require multi-site collaboration.  
However, this study also demonstrates that, in women who opt to monitor their sleep, 
actigraphy was a useful method of measuring sleep. In these cases, actigraphy was well 
tolerated for multiple weeks and allowed the derivation of multiple sleep parameters (e.g. 
sleep efficiency, total number of hours slept per night). Closer examination of sleep duration 
for each woman revealed particular characteristics that may be of interest to explore in larger 
samples. These are outlined in further detail below. 
6.4.1 Sleep Deprivation in the Perinatal Period 
Although the small sample size precluded statistical analyses, the women’s sleep patterns 
unveiled interesting features that could be explored in larger samples. First, in line with 
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previous research (e.g. Hedman et al. 2002; Beebe and Lee 2007), the majority of women in 
this sample experienced the most sleep deprivation on the night before or of delivery. 
However, this was not the case for all women; one participant, who became depressed 5 days 
postpartum (Participant 2), appeared to have the least sleep deprivation in the nights 
surrounding delivery compared to the other women (of note is that Participant 2 was the only 
woman in the sample who had an elective caesarean section). These findings demonstrate 
that not all women will experience dramatic decreases in sleep during childbirth, therefore 
the day immediately before or after delivery will not necessarily be associated with the most 
sleep loss in the perinatal period. 
Second, the actigraphy data highlighted the potential role of intra-individual sleep variability 
and its relationship with postpartum mood episodes. The three women in this sample who 
experienced major affective episodes (1 major depression, 2 mania) demonstrated marked 
variability in sleep duration in the nights preceding episode onset. Intra-individual variability 
in sleep has previously been associated with BD and mood dysregulation (Jones et al. 2005; 
Kalmbach et al. 2014; Bei et al. 2016). Research in larger samples may therefore wish to 
explore sleep variability in the pre- and postpartum period and its relationship with mood 
episodes.   
In concordance with literature on sleep and mood (Wehr et al. 1987; Wehr 1989), the two 
women who became manic did show short total sleep durations in the nights preceding 
episodes onset (i.e. 0-2.5 hours). Surprisingly, however, both women also showed increased 
sleep durations (~ 7.5 hours) in the nights preceding mania. As mentioned above, this may 
reflect the effects of sleep variability on mood, and requires further examination in larger 
samples.  
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In addition, the women in this study who had disturbed sleep did not always relapse, and 
some women had more variable sleep patterns than others in the antepartum and/or 
postpartum period in general.  It would therefore be of interest in future studies to explore 
additional factors that may contribute to more or less disturbed sleep in pregnancy and 
postpartum, such as medication and symptoms of anxiety. Future research could also explore 
which variables are associated with resilience to sleep loss in the perinatal period. 
Finally, although the initial aim was to examine sleep loss one week either side of delivery, the 
long monitoring time of the actigraph model allowed examination of a slightly larger time 
span of 2 weeks either side of delivery, which provided useful additional information on sleep 
patterns and postpartum mood episodes. Therefore it is important for future research to 
utilise these data if they are available. 
6.4.2 Barriers to Using Actigraphy in Women at High Risk of Postpartum Psychosis 
This study highlighted the following factors that may limit the ability to estimate sleep 
disturbance via actigraphy in this population.  
Recruitment 
An area of concern in this study was the low recruitment rate. During a recruitment period of 
2 years, 18 of the 65 women approached expressed an interest in sleep monitoring (28%). 
One reason for this low recruitment rate could have been due to the timing of when women 
were approached about sleep monitoring; women were approached after they had 
completed a long research interview, by which point they may have been reluctant to commit 
to additional research demands. Women may also have been less likely to commit to sleep 
monitoring during this time due to the burden of pregnancy. Future research should assess 
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this systematically (e.g. via focus groups or questionnaires) to determine the barriers to 
recruitment.   
Discussion with research psychologists suggested that women declined because (a) they 
thought they would forget to wear the actigraph and/or complete the diary, or (b) did not 
normally wear a watch and would therefore find it uncomfortable to wear an actigraph. 
Future research might conduct a feasibility study to systematically record reasons for 
declining this and explore whether women who are less likely to partake in sleep monitoring 
are more likely to become unwell in the postpartum period and/or differ in other 
characteristics (e.g. illness severity, socioeconomic status, primiparity). 
Retention/Acceptability of Sleep Monitoring  
Of women who opted to monitor their sleep, a subsequent barrier was the acceptability of 
wearing the actigraph and tracking their sleep using a diary. Three out of the 16 women who 
opted to complete sleep monitoring (19%) later discontinued due to finding the actigraph 
uncomfortable to wear at night and/or finding that keeping a sleep diary disturbed their 
sleep. An approach to minimise these issues in the future might be to use smaller actigraph 
models and emphasise to women that they do not have to keep a sleep diary if it disturbs 
their sleep. One alternative to keeping a sleep diary is to record bed times and rise times 
using an event-logging button, which is available on some actigraph models.  
Technical Issues 
Technical issues also compromised this study. Out of the 10 actigraphs worn throughout 
pregnancy and the postpartum period, three did not record data. A 30% failure rate is 
particularly problematic in this area of research, given the difficulties with recruitment and 
time-dependent nature of data collections (i.e. during late-pregnancy and postpartum). These 
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problems may have been confined to this study, as the actigraph model that I used was a 
newly developed version and, in the initial stages of the study, the devices malfunctioned 
primarily due to problems with the new software and firmware.  
6.4.3 Strengths 
Despite the small sample size, this study has several strengths. First, the study provides a 
starting point for understanding the barriers to conducting actigraphy research in women at 
high-risk of PP. Second, the preliminary data from this pilot study highlight which indices of 
sleep may be most useful to examine in larger samples. Third, the prospective design using an 
objective measure of sleep offers an advantage over retrospective designs using self-report 
measures of sleep, which are subject to participant attributions and recall bias. 
Fourth, the model of actigraph used in this study allowed sleep monitoring to be conducted 
over an extended period (up to 60 days), thus ensuring the continuous measurement of sleep 
from late-pregnancy to postpartum. This is one of the first studies to date that has used 
actigraphy to monitor sleep during this period in women at high-risk of PP. Finally, in line with 
the data from previous chapters in this thesis, this study utilised detailed clinical information 
on women both before and after delivery (derived from case notes and interview). 
6.4.4 Limitations 
The limitations of this study are first, due to the sensitive nature of the data collection period, 
there was a greater need to ensure that participants were not over-burdened or contacted 
too frequently. This meant that, although participants were able to contact me if they had 
any problems with the actigraph or sleep diary, I did not contact them once sleep monitoring 
had begun. This may have contributed to some women discontinuing sleep monitoring (e.g. if 
they required additional support using the actigraph or completing the sleep diary). 
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Second, the results of this chapter and future work in this area may not be generalizable, as it 
is possible that women who opted to do sleep monitoring are not the most representative of 
women at high-risk of PP. An extension of the work presented in this chapter might compare 
demographic and clinical information on the women who opt to monitor sleep and those who 
do not, to determine which women are more likely to take part in this type of research. 
Finally, although referred to as an ‘objective’ measure of sleep, actigraphy is the measure of 
movement, not sleep, and the final data processing requires researchers to use judgments to 
remove artefacts from the data and interpret inconsistencies between participants’ diary data 
and activity data (Littner et al. 2003). These procedures are not widely reported in actigraphy 
literature and vary in literature that does report them, leading to some researchers to call for 
standardised procedures to be published (Sadeh 2011). This issue will be discussed in further 
detail in the General Discussion. In this study, I used a procedure for processing actigraphy 
data based on the protocol used by the Sleep and Circadian Neuroscience Institute at Oxford 
University (shared with permission from Dr Katharina Wulff). However, a key part of this 
protocol involves regular reliability checks between researchers who process actigraphy data, 
which would need performed on these data in future work.  
6.4.5 Future Research 
In addition to the suggestions for future research outlined above, further work in this area 
might explore the following topics: 
Feasibility of Using Actigraphy in Pregnant Women at Risk of PP 
An important limitation of this study was the inability to adequately assess the feasibility of 
using actigraphy in this population. Future research should systematically assess this through 
conducting a feasibility study. This would include qualitative interviews and focus groups with 
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stakeholders, in addition to systematic assessment of acceptability and efficacy (Bowen et al. 
2010). 
Sleep Loss in Women who Develop PP 
In sufficiently large samples, it might be possible to compare the sleep of women who 
develop PP to those who remain well. In addition to measures of total sleep duration, 
additional sleep parameters should be considered, such as intra-individual variability in sleep 
that occurs in pregnancy and postpartum (Mezick et al. 2009), sleep fragmentation, and 
circadian timing of sleep loss (Sack et al. 1988). For example, it has been proposed that sleep 
loss at particular phases of circadian timing (e.g. from 1am-4am) might increase risk of mania 
more than sleep loss at other times (9pm-12am) (Kasper and Wehr 1992; Wehr 1992). It is 
possible, therefore, that women who are kept awake from 1am-4am during childbirth are 
more likely to develop PP than those who are sleep deprived at earlier stages in the night. 
Other indices of disrupted circadian function may also be important, such as temperature and 
hormonal circadian rhythms (Parry et al. 2006). 
Individual Differences in Sensitivity to Sleep Loss 
Previous research and the results of previous chapters in this thesis suggest that only a subset 
of individuals with BD experience manic episodes in response to sleep loss, hence, some 
individuals may be more sensitive to the effects of sleep loss than others. This appeared to be 
the case in the data in this study, as some women experienced disturbed sleep but did not 
relapse. Future research might explore clinical characteristics that may modify any association 
between sleep disruption and PP, such as diagnostic category, chronotype, or a history of 
manic episodes being triggered by sleep loss.  
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Women at Risk of Other Postpartum Episodes 
The present study examined women at high risk of PP, therefore all women in the sample had 
a history of BD or PP. However, other groups of women may also experience an increased risk 
of mental illness in the postpartum period that is exacerbated by sleep loss, such as women 
with major depressive disorder (MDD, Okun et al. 2011). A further avenue to explore using 
this methodology might be to compare perinatal sleep in women with MDD or BD who 
develop postpartum depression to those with BD who develop PP. 
Fathers 
A related research question is whether the effects of postpartum sleep loss extend to fathers, 
who have also been reported to suffer sleep loss once the infant is born (Insana and 
Montgomery-Downs 2013). Examining males provides an opportunity to examine the effects 
of sleep loss in a population that is not experiencing the same hormonal fluctuations in 
response to childbirth, an avenue of research that has also been explored as a possible cause 
of PP, although with mixed results. Fathers with bipolar disorder have rarely been examined, 
although a case study (Stevens et al. 2014) reported that a father had became manic after his 
sleep was repeatedly disturbed by his newborn daughter. 
Alternative Measures of Sleep Loss 
Finally, the fact that the majority of women approached in this study did not want to monitor 
their sleep on a daily basis suggests that less-intensive measures of sleep may be more 
amenable to this population. These might include online questionnaires (such as the 
Pittsburgh Sleep Quality Index (Buysse et al. 1989) administered at weekly or monthly 
intervals during pregnancy, or the option to only use a sleep diary instead of wearing an 
actigraph.  
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6.4.6 Clinical Implications 
It should be noted that although a prospective design does not allow researchers to infer a 
causal role between sleep disruption and PP, identifying characteristics of sleep loss (whether 
causal or prodromal) that are important in the pathogenesis of PP could inform postpartum 
relapse prevention plans. If followed up in larger samples, the findings of this study could 
ultimately inform prevention strategies for pregnant women at heightened risk of postpartum 
psychosis. These might include night time help with infant feeding, improving sleep hygiene in 
pregnancy and postpartum, CBT-I, or pharmacological interventions that improve sleep 
(Reichner 2015; Wesseloo et al. 2016). 
In addition, understanding more about which indices of sleep are likely to signal the onset of 
a postpartum episode, and which women will be most vulnerable to these, could help 
perinatal teams make the best use of resources to treat and prevent postpartum episodes.  
6.4.7 Conclusions 
In conclusion, the findings from this study suggest that actigraphy is a challenging 
methodology for measuring sleep in women at high risk of PP due to low levels of recruitment 
(28%) and feasibility studies are required in order to further explore barriers to recruitment. 
Whether women who opted to monitor their sleep using actigraphy are representative of the 
population of interest needs to be determined, and larger samples are needed in order to 
statistically determine which indices of sleep (if any) can be used to predict the onset of 
postpartum episodes. If this is achieved, there is opportunity to derive in-depth information 
on sleep parameters, which may inform prevention strategies for PP and aid understanding of 
the role of sleep disturbance in the pathway to mania more generally. 
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7 GENERAL DISCUSSION 
 
 
  
7.1 Introduction 
In this chapter, I will summarise the main findings of each of the studies presented in this 
thesis and discuss how they addressed the primary thesis aims. I will then discuss the 
strengths, limitations, and themes that emerged during the course of this thesis. I will end 
this chapter with suggestions for future research and the clinical implications of the findings. 
The broad aim of this thesis was to examine the association between sleep disruption and 
mania in individuals with bipolar disorder (BD). In Chapter 1, I outlined the following thesis 
aims: 
1. To explore whether there is a subgroup of individuals who experience sleep 
disruption as a pathway to mania and, if present, to examine individual differences 
associated with this phenotype. 
2. To determine whether experiencing sleep disruption as a pathway to mania is 
associated with vulnerability to postpartum psychosis (PP).  
3. To pilot the use of actigraphy to measure perinatal sleep in pregnant women at high 
risk of PP. 
4. Within aims 1 and 2, to compare results for sleep disruption as a pathway to mania to 
those experiencing sleep loss as a pathway to depression. 
I investigated these research aims in the studies presented in Chapters 3, 4, 5 and 6. In the 
following sections, I outline the findings from each chapter in relation to the research aims, 
followed by limitations and suggestions for future research. A summary of the findings from 
each chapter is provided in Table 7-1. 
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Table 7-1. Summary of main findings of studies described within this thesis. 
Chapter number and 
title 
Main findings and thesis aims addressed 
3. Sleep loss as a trigger 
of mood episodes in 
bipolar disorder: 
Individual differences 
based on diagnostic 
subtype and gender. 
In 3140 individuals with BD, 20% reported that sleep loss has 
triggered episodes of mania, and 11% reported that sleep loss 
has triggered episodes of depression. 
Individuals with BD-I were more likely than those with BD-II to 
report that sleep loss had triggered episodes of mania. In 
addition, women were more likely than men to report that 
sleep loss had triggered episodes of mania. Comparison of 
other triggers did not suggest that females consistently over-
reported other triggers of mood episodes, although the 
possibility of female over-reporting cannot be excluded.  
Being female was associated with an increased likelihood of 
reporting that sleep loss had triggered depression, however 
this finding did not persist following adjustment for 
confounders. Differences between BD-I and BD-II did not reach 
statistical significance. 
Study design: Retrospective 
Thesis aims addressed: Aim 1, Aim 4 
4. Sleep loss as a trigger 
of mania and 
susceptibility to 
postpartum psychosis. 
Parous BD-I women who reported that sleep loss had triggered 
episodes of mania were more likely to experience postpartum 
psychosis (PP) compared to BD-I women who did not report 
sleep loss as a trigger.  
Reporting sleep loss as a trigger of manic or depressive episodes 
was not significantly associated with experiencing postpartum 
depression. 
Study design: Retrospective 
Thesis aims addressed: Aim 2, Aim 4 
5. Trajectories in 
insomnia prior to 
episodes of high mood: 
results from an online 
mood monitoring system. 
Within BD individuals who had used an online mood-monitoring 
system, latent class analysis revealed that individuals could be 
grouped into three classes based their trajectories in insomnia 
prior to episodes of high mood.  
Individuals could not be split into subgroups based on their 
insomnia trajectories prior to episodes of depressed mood. 
Study design: Prospective 
Thesis aims addressed: Aim 1, Aim 4 
6. Using actigraphy to 
measure sleep 
disturbance in pregnant 
women at high-risk of 
postpartum psychosis. 
Actigraphy is a challenging methodology to employ in women at 
high risk of PP, but can procure informative indices of sleep 
parameters during the perinatal period.  
Study design: Prospective 
Thesis aims addressed: Aim 3 
BD, bipolar disorder; BD-I, bipolar-I disorder, BD-II, bipolar-II disorder; PP, postpartum psychosis 
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7.2 Thesis Aims 
7.2.1 Aim 1 
To explore whether there is a subgroup of individuals who experience sleep disruption as a 
pathway to mania and to examine individual differences associated with this phenotype. 
The first aim of this thesis was to explore whether there is a subgroup of individuals with BD 
who experience sleep disruption as a pathway to mania. The term pathway, in this instance, 
may refer to a trigger or prodrome of impending illness. This was addressed in Chapter 3 and 
Chapter 5. In Chapter 3, I examined data from 3,140 participants recruited to the BDRN who 
were asked about triggers of mood episodes. The results of this chapter revealed that 20% of 
individuals with BD reported that sleep loss had triggered episodes of high mood, and that a 
tendency to report this was more likely among individuals with BD-I compared to those with 
BD-II, and more commonly reported by women. This was consistent with existing estimates of 
the proportion of individuals who become manic or hypomanic following sleep deprivation 
therapy (Colombo et al. 1999; Plante and Winkelman 2008), and findings that women may be 
more susceptible to mood dysregulation following sleep loss than men (Saunders et al. 2015). 
However, the results were limited by the retrospective nature of data collection and a lack of 
direct measures of sleep occurring prior to episode onset. Furthermore, it was not possible to 
account for all possible confounders that may have influenced the results and the results 
need to be replicated in more representative samples of individuals with BD. 
In Chapter 5, I examined data from 692 BDRN participants who had used an online system to 
monitor their mood. Specifically, I used growth mixture modelling to examine whether 
individuals who had episodes of high mood when using the system (n=145) could be grouped 
into latent categories based on their trajectories in insomnia symptoms in the weeks prior to 
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episode onset.  The results indicated that participants could be grouped into three classes 
based on their insomnia symptom trajectories: those with consistently high levels of insomnia 
(17%), those with consistently low levels of insomnia (78%) and participants whose symptoms 
of insomnia were initially low but increased in the weeks preceding episode onset (6%). This 
suggests that disturbances in sleep are only observed in a subset of individuals with BD prior 
to episodes of high mood. Subsequent comparisons did not reveal significant differences 
between the insomnia classes in BD diagnosis, gender, age or other symptoms of mania. 
However, compared to participants in the low insomnia class, individuals in the high insomnia 
class had higher levels of depressive symptoms (other than insomnia) and were more likely to 
be in an episode of low mood. This finding supports a previous hypothesis by Wehr et al. who 
suggested that insomnia associated with depressive symptoms might trigger mania (Wehr et 
al. 1987). However, these results require further exploration in a much larger sample, as the 
subgroups were not large enough to have adequate power to compare differences between 
the groups. Future research using more robust measures of mood episodes (e.g. clinical 
observations or interview measures rather than questionnaires) is also required. 
In summary, the results described in Chapters 3 and 5 suggest that there is a subgroup of 
individuals who experience sleep loss as a pathway to mania. Results from the larger study 
presented in Chapter 3 suggest that gender and BD diagnostic subtype may influence 
susceptibility to this phenotype, whereas the results of Chapter 5 highlight the importance of 
considering the role of sleep loss during depression as a potential pathway to mania.  
These findings have implications for future research, as studies examining the relationship 
between sleep and mania in BD should consider the potential effect of gender and BD 
subtypes on this relationship. If replicated in prospective (Chapter 3) and larger samples 
(Chapter 5), the results of these studies also have potential implications for clinical practice. 
For example, the results of Chapter 3 suggest that interventions should focus in particular on 
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individuals who appear to be at higher risk of relapsing following periods of sleep deprivation 
(e.g. women with BD-I through childbirth). This could be done by additional efforts to monitor 
the sleep of these individuals, to encourage healthy sleep behaviours and to offer therapies 
to improve sleep such as CBT-I. The results of Chapter 5 suggest that clinicians should pay 
particular attention to symptoms of insomnia, as for some individuals these may herald the 
onset of (hypo)manic episodes. However, there is a need for more research in larger samples 
of more representative individuals with BD before it will be possible to gauge clinical utility of 
these findings. 
7.2.2 Aim 2 
To determine whether experiencing sleep disruption as a pathway to mania is associated with 
vulnerability to postpartum psychosis.  
The second research aim was to use knowledge of individual differences in response to sleep 
loss to guide investigations into the role of sleep loss in postpartum psychosis (PP). The role 
of sleep disruption in PP is of key interest given that the perinatal period is associated with 
heightened sleep disturbance and high risk of relapse for women with BD (Sharma and 
Mazmanian 2003; Beebe and Lee 2007). 
In Chapter 4, I analysed data from 870 parous women recruited to BDRN and compared the 
rates of PP among women who reported that sleep loss had triggered episodes of mania and 
those who did not report this. The main finding of this chapter was that that women who 
reported that sleep loss had triggered episodes of mania were more likely to experience PP 
than women who did not report this. This effect remained statistically significant when 
controlling for potential confounding factors and was of a sufficient magnitude to potentially 
be clinically significant (OR=2.09, 95% CI=1.43-3.04). 
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These results have important implications for research on the aetiology of PP. First, few 
studies have examined the role of sleep loss in PP (Ross et al. 2005; Lawson et al. 2015), and 
none to date have examined whether sensitivity to the effects of sleep loss increases risk of 
PP. This study is therefore the first to suggest that women with this phenotype (i.e. with a 
history of manic episodes triggered by sleep loss) may have a heightened risk of experiencing 
PP. However, the data analysed in this chapter were retrospective, therefore to estimate risk 
would require replication in a prospective sample. If replicated, these results may have 
implications for individualising risk within women at high risk of PP, however these findings 
need to be explored further using objective, longitudinal measures of sleep (which was 
explored in Chapter 6 of this thesis) before it will be possible to determine what clinical 
recommendations (if any) should be made). 
7.2.3 Aim 3 
To pilot the use of actigraphy to measure perinatal sleep in pregnant women at high risk of PP. 
The third thesis aim was to conduct a pilot study using actigraphy to measure the sleep of 
pregnant women at high risk of PP. In Chapter 6, I present results from a prospective study of 
pregnant women with BD or a history of PP who monitored their sleep from week 37 of 
pregnancy until the second postpartum week using actigraphy. This chapter highlighted that 
recruiting BD participants during pregnancy for actigraphy studies is difficult, with low uptake 
rates of BD women during pregnancy and issues with user acceptability of actigraphy during 
pregnancy. Of the ten women who completed the study, technical issues with three of the 
actigraphs meant that data were available on seven women. Despite these issues, this study 
revealed that actigraphy can offer detailed insights into perinatal sleep patterns, as there are 
numerous sleep parameters that can be obtained using this methodology (e.g. sleep 
fragmentation, intra-individual variability in sleep duration). The data from these women 
 183 
highlighted that there is significant variation in sleep patterns both within and between 
women during the perinatal period, and that this relationship is complicated by numerous 
factors such as medication, mode of delivery, and prophylactic admission or assistance with 
infant care.  
The low uptake during this study highlights that to obtain the sample sizes required for 
adequately powered analyses would take a substantial amount of time and resources. 
Recruitment for these studies could be facilitated by: (1) researchers collaborating with other 
research groups, and (2) including potential participants in the design of research studies to 
determine barriers to acceptability (e.g. via qualitative studies).  
In summary, measuring perinatal sleep using actigraphy in high-risk pregnant populations is 
compromised by recruitment issues, ensuring that participants are not overburdened, as well 
as technical issues that may arise. This may explain the lack of published studies to date that 
have used this methodology. Progress will likely require collaboration across multiple 
research centres to enable adequately sized (and powered) samples to be collected. 
7.2.4 Aim 4 
Within aims 1, 2 and 3, to compare results for sleep disruption as a pathway to mania to those 
examining sleep loss as a pathway to depression. 
The relationship between sleep and mania was compared to the relationship between sleep 
and depression in Chapters 3, 4 and 5. In each of these chapters, the association between 
sleep and mood differed according to illness polarity. Although there is some evidence 
implicating sleep loss as a trigger or early warning sign of manic episodes, less is known about 
the relationship between sleep loss and depression in BD. It is also possible that 
inconsistencies in research examining sleep and mania in BD (outlined in Chapter 1 section 
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1.6) are due to including individuals who experience a depressive rather than manic response 
to sleep loss. 
In Chapter 3, fewer participants reported that sleep loss had triggered episodes of depression 
compared to episodes of (hypo)mania (11% vs. 20%, respectively). In addition, participants 
who reported that sleep loss had triggered episodes of depression were more likely to have a 
diagnosis of BD-II, although this finding was not statistically significant. In accordance with the 
results for mania, women were also more likely than men to report that sleep loss triggered 
episodes of depression, however this association became non-significant when controlling for 
potential confounding factors. In Chapter 4, the results for postpartum psychosis differed to 
those observed for postpartum depression. Specifically, reporting that sleep loss had 
triggered episodes of depression did not appear to be associated with an increased risk of 
developing postpartum depression. In Chapter 5, the results suggested that there were no 
distinct categories in insomnia trajectories prior to episodes of low mood, which was in 
contrast to the results for high mood (described above). However, it is important to note that 
the sample size for these analyses was likely underpowered, as only 84 participants were 
included in the analysis.  
These results suggest that the relationship between sleep loss and mood is more likely to 
present as manic, rather than depressive, mood disturbances for individuals with BD. 
However, in each of the chapters that examined differences between sleep loss and illness 
polarity, the sample size for analyses on depression was always smaller than that for mania, 
which was usually because fewer participants reported an association between sleep loss and 
depression. An unexplored aspect of the sleep-mood relationship that is worth future 
consideration is the relationship between hypersomnia and depression. Individuals with BD 
are more likely than those with major depressive disorder to report hypersomnia during 
episodes of depression (Bowden 2005; Forty et al. 2008) and BD is characterised by high rates 
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of hypersomnia during periods of euthymia (Kaplan et al. 2011). Considering this and other 
factors that may influence the relationship between sleep and depression (e.g. alcohol use) 
will be important for understanding the factors involved in triggering depressive episodes in 
BD.  
 
7.3 Strengths and Limitations 
The main strength of the studies presented within this thesis was the use of a well-
characterised sample of individuals with BD. For each participant, information on diagnosis 
was obtained using standardised psychiatric assessments and information from case notes. In 
addition, Chapter 3 and Chapter 4 utilised large sample sizes, which allowed for comparisons 
between BD-I and BD-II, and between men and women. Furthermore, this thesis used a 
variety of research methods to explore the relationship between sleep loss and mania in BD, 
such as using retrospective and prospective data and using interview, questionnaire and 
actigraphy data to ascertain the relationship between sleep and mania. In contrast to the 
majority of existing research on the sleep-mania relationship, the studies in this thesis explore 
individual differences that may affect this relationship as well as the relationship between 
sleep and depression in BD.  
There are also a number of limitations in relation to the studies presented within this thesis. A 
key issue in Chapter 5 related to the smaller sample size, which meant that analyses were 
underpowered to detect differences between the insomnia classes identified through growth 
mixture modelling. This finding therefore needs to be explored in larger samples. Another 
issue was the low rate of recruitment to the sleep monitoring study in Chapter 6. This 
precluded analyses comparing the sleep of those women who relapsed in the postpartum 
period to those women who remained well.  
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There are three overarching issues that are relevant to all chapters in this thesis: (1) the 
assessment of sleep; (2) difficulties determining whether sleep acts as a prodrome, early 
warning sign, or symptom of mania; and (3) the assessment of other variables that may 
impact on sleep and mood (e.g. medication). These issues are discussed in the following 
sections. 
7.4 The Role of Sleep Loss in the Genesis of Mania: Trigger, Prodrome 
or Symptom? 
A recurring issue with interpreting the results presented in this thesis is the precise role of 
sleep loss in the genesis of mania, that is, whether sleep loss is a trigger, prodrome or early 
symptom of manic episodes. For example, in Chapter 3, participants reported whether sleep 
loss had previously triggered episodes of (hypo)mania. As the data were self-report and 
retrospective, it is possible that participants thought that sleep loss had been a trigger, when 
it had actually been a prodromal symptom. Likewise, the analyses in Chapter 4 also used 
retrospective data on sleep triggering mood episodes. In this instance, it was possible that 
women with PP thought that sleep loss had triggered episodes of mania due to misattributing 
the sleep loss that is common in the perinatal period as a cause of the postpartum episode. 
Chapter 5 tried to disentangle the temporal relationship between sleep and mood, as data 
were collected prospectively and analyses were conducted only on data from the euthymic 
period prior to episodes of high mood. Nonetheless, data on sleep loss were subjective and 
did not specify the source of the sleep loss (i.e. whether participants’ insomnia symptoms 
were due to endogenous or exogenous factors) and it was not possible to determine whether 
symptoms of sleep disturbance occurring in the ‘euthymic’ period prior to the onset of 
(hypo)manic episodes were prodromal, early symptoms, or a trigger. This is also true of the 
data from Chapter 6; even if changes in sleep occur prior to episode onset recorded by the 
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clinician or participant, it is not possible to disentangle whether those changes in sleep were a 
trigger, prodrome or early symptoms of the episode. 
Each of the chapters highlights the difficulties of determining whether sleep loss is a trigger or 
prodrome of manic episodes. However, a broader question is whether sleep disruption is 
instrumental to the aetiology of BD or an epiphenomenon (e.g. the heat from a light bulb). It 
is difficult to determine whether changes in sleep observed during mania are part of the 
manic episodes per se or merely an epiphenomenon of other manic symptoms, such as 
increased activity (Plante and Winkelman 2008). It was not possible to determine this in this 
thesis, as the available data were observational, however, as discussed in Chapter 1, sleep 
deprivation studies provide more compelling evidence that sleep loss can trigger mania, by 
demonstrating that some bipolar individuals become manic following enforced wakefulness. 
Nevertheless, as outlined Wehr’s sleep reduction model of mania, the relationship between 
sleep and mood is bidirectional (Wehr et al. 1987). This means that, in theory, a unidirectional 
relationship between the two is transient.  
The clinical implications of distinguishing whether sleep loss is a trigger, prodrome or early 
symptom of illness will depend on the level of personalised care to which clinicians aspire. For 
example, in a discussion of detecting prodromal vs. early warning signs of schizophrenia, 
Bustillo et al. argue that, ‘The clinician is concerned not with the conceptual problem of 
whether the observed change precedes exacerbation or is merely the first indication of this 
process, but rather with detection and intervention’ (Bustillo et al. 1995, p. 555). Therefore, 
knowing that sleep loss may signal the ascent into mania could alert clinicians to adjust 
patient care regardless of whether sleep loss did or did not cause (or precede) the episode. 
However, understanding if sleep loss acts as a trigger versus a prodrome or early symptom 
could be beneficial, as this would obviate the need for patients to avoid sleep-disrupting 
scenarios (e.g. night shifts) if these do not trigger their episodes. Therefore, understanding 
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more about the mechanisms by which sleep loss affects mood may inform more nuanced 
recommendations and treatments for some patients. For example, some research has 
suggested that patients who respond to sleep deprivation therapy for depression are also 
more likely to respond to lithium (Benedetti et al. 2014).  
In summary, this thesis is not able to determine whether sleep loss is a trigger, prodrome, or 
early symptom of mania, but much evidence suggests that disturbances in sleep occur prior 
to or in the early stages of mania, thus providing an important signal of impending illness. 
Clinically, therefore, this could be a useful signpost for both clinicians and patients, and 
understanding more about which patients are more prone to experiencing sleep as a pathway 
to mania will ultimately improve illness management.  This will be discussed in further detail 
in section 7.8. 
7.5 Subjective vs. Objective Measures of Sleep Disruption 
Another theme arising in each of the chapters in this thesis surrounds the appropriate 
measure of sleep. Measures of sleep can be broadly categorised as either subjective or 
objective. Subjective measures of sleep include interview questions, questionnaires and sleep 
diaries. The two main ‘objective’ measures of sleep used in research settings are actigraphy 
and polysomnography (Sadeh 2015).  
Subjective measures of sleep are advantageous as they allow data to be collected on large 
samples and, if validated and replicated, can provide an affordable and efficient way to 
impact on clinical practice. However, these measures are limited by reliance on retrospective 
recall. This was primarily an issue in Chapters 3 and 4, which relied on retrospective data on 
whether sleep loss had triggered episodes of mania. These chapters attempted to address 
this issue via other analyses (e.g. controlling for number of mood episodes experienced). In 
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Chapter 5, the data on sleep prior to episodes of high mood were collected prospectively, 
however at each time point participants had to recall what their sleep had been like over the 
preceding week. In contrast, objective measures such as actigraphy and polysomnography 
(PSG) (described in Chapter 6) are not subject to participant recall biases. However, these 
techniques also have limitations. For example, although PSG provides the most 
comprehensive assessment of sleep, it is expensive, intrusive, and usually cannot be 
administered for more than a few consecutive nights (Sadeh 2015). There is also evidence 
that PSG can negatively affect sleep (Lee and Gay 2004). 
As discussed in Chapter 6, actigraphy is less intrusive and expensive than PSG, and can 
monitor sleep over extended periods of time (Miller et al. 2012). However, as actigraphy 
relies on activity to estimate sleep, it cannot distinguish motionless wakefulness from sleep, 
and thus overestimates sleep durations (Sadeh 2011). Furthermore, at present, PSG and 
actigraphy data both require researcher input during data processing (e.g. scoring stages of 
sleep in PSG data currently has to be performed by researchers who are trained in 
interpreting these data) (Sadeh 2015). Therefore even objective measures of sleep involve an 
element of subjectivity in their interpretation. 
In spite of the limitations outlined above, it is important to recognise that subjective 
measures of sleep are not always less useful than objective measures of sleep. For example, 
Bei and colleagues found that the subjective perception of sleep predicted subsequent 
postpartum depression but did not find a significant association between objectively 
measured sleep (via actigraphy) and postpartum mood (Bei et al. 2010). Furthermore, 
subjective measures could be an easier and more cost-effective option to implement in 
routine clinical practice. 
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This thesis has also highlighted that utilising ‘objective’ measures of sleep generates 
additional challenges, such as interpreting the deluge of data that results from such 
measures, the necessity to make subjective judgements on the data, and determining which 
of the many parameters derived are most useful to examine in future research. 
In summary, assessing sleep is complex and each measure of sleep has distinct advantages 
and disadvantages, which have been highlighted in the process of this thesis. The results of 
this thesis are in line with recommendations to, where possible, triangulate data from a 
combination of objective and subjective sleep measures (Harvey et al. 2006), therefore this 
should be a consideration in future research examining the relationship between sleep and 
mood in BD. 
7.6 Additional Influences on Sleep and Mood 
As outlined in Chapter 1, the sleep-wake cycle is a product of interactions with the 
environment and circadian rhythms. A number of authors have highlighted that the 
relationship between sleep and mood does not operate in isolation, and can be affected by a 
myriad of factors such as light exposure, atypical patterns of social behaviour, medication, 
and substance misuse (Wulff et al. 2010; Foster and Kreitzman 2014). It is possible, therefore, 
that any sleep disturbances that participants observed prior to episodes of mania were an 
epiphenomenon of other triggers or prodromes of mania, such as stress, alcohol or other 
substance misuse, and medication. The results of Chapters 3, 4, and 5 were not able to 
examine medications that were taken during the period of sleep loss, and as shown in 
Chapter 6, operationalizing medication use in BD for statistical analyses can be complex due 
to the substantial variation between participants in types and dosages of medication taken. 
However, one option that has been used in other studies is to quantify medication via rubrics 
such as the Somatotherapy Index (Bauer et al. 1997). An additional influence on sleep in BD 
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women is the menstrual cycle, which has also been implicated in disturbed sleep (Parry et al. 
1989; Parry et al. 2006; Shechter and Boivin 2010). Therefore, future research into the 
relationship between sleep and mood must attempt to consider other influences on the 
sleep-wake cycle, where possible, before we are able to make conclusions on how sleep loss 
could act as a pathway to mania. 
7.7 Future Research 
Suggestions for future research have been described in previous sections, however there are 
a number of additional avenues for future research to explore. Examples include: 
1. Determining the extent to which sleep disturbances prior to mood episodes are trait-
like or state-like (Harvey 2008b). For example, further analyses could explore 
whether participants in the ‘high insomnia’ class described in Chapter 5 always 
display high levels of sleep disruption or whether this emerges only prior to illness 
onset. 
2.  Considering how disruption to the circadian system impacts on sleep and mood – for 
example, changes in light exposure or social rhythms (Le Strat et al. 2008) – or how 
circadian preferences (i.e. chronotype) may affect course of illness or risk of 
developing BD (Etain et al. 2014; Abreu and Bragança 2015). 
3. Delineating which characteristics of sleep increase risk of relapse. This could include 
comparing the effects of chronic vs. acute sleep loss or sleep fragmentation vs. total 
sleep duration (Montgomery-Downs et al. 2010; Philip et al. 2012). 
4. Exploring whether information on genetic variation (e.g. variation in clock genes, or 
polygenic risk scores) can be used to predict which individuals are most vulnerable to 
sleep loss. For example, mutations in the gene CLOCK have been associated with a 
manic phenotype in mice (Roybal et al. 2007), and other studies have associated 
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single nucleotide polymorphisms with how individuals respond to sleep deprivation 
(Benedetti et al. 2004). 
As discussed in the preceding chapters, a limitation of the datasets used in this thesis is that 
participants recruited to research studies may not be representative of all individuals with BD. 
Research using more representative samples of individuals with BD is therefore needed. In 
addition, the results of Chapter 5 and Chapter 6 will require further exploration in larger 
sample sizes in order to achieve adequate power to detect effects. Another limitation relates 
to the measures of sleep and mood, which were primarily based on subjective, retrospective 
accounts. Future work should therefore attempt to use more robust measures of sleep and 
mood.  Finally, future research using methodologies that account for possible confounders of 
the relationship between sleep and mood regulation outlined above are necessary to 
delineate the effects (if any) of sleep on subsequent mood.  
7.8 Clinical Implications 
As outlined above, further research is needed before it will be possible to make definite 
recommendations for clinical practice. If the results in this thesis are replicated in larger, 
more methodologically sound studies, they might inform clinical practice via two avenues. 
First, by advancing understanding of the relationship between sleep and mood in BD, and 
second, by improving knowledge on which individuals are most likely to experience sleep loss 
as a pathway to mania.  
7.8.1 The Relationship Between Sleep and Mood in BD 
The results of this thesis may inform current knowledge of how sleep loss can act as a 
pathway (i.e. trigger or prodrome) of mania in BD. In particular, the results presented in this 
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thesis suggest that up to 1 in 4 individuals with BD report that sleep loss has triggered 
episodes of high mood at some point in the course of their illness, and that high or increasing 
levels of sleep disturbance over a 4-week period may signal the onset of (hypo)manic 
episodes in some individuals. These results highlight the importance of monitoring sleep for 
illness management. If sleep loss is a trigger or sign of impending relapse, identifying sleep 
disruption could allow clinical care teams to intervene by providing additional support, 
providing closer monitoring, or adjusting medication. However, further replication in larger 
samples that account for other influences on sleep and mood is required. 
In perinatal settings, clinicians might offer additional support in improving sleep for women 
with BD using cognitive behavioural therapy for insomnia (CBT-I). This has been reported to 
be preferred by pregnant women as a treatment for insomnia compared to using 
pharmacotherapy (Sedov et al. 2017) and is associated with improvements in sleep and 
depression symptoms (Tomfohr-Madsen et al. 2017). However, this would need to be 
adapted for use in individuals with BD (as described in Harvey et al. 2015), as standard CBT-I 
includes sleep restriction.  
In order for clinicians and patients to be aware of disrupted sleep requires effective 
monitoring. More recent technological advances could facilitate this, for example via online 
mood monitoring systems (such as ‘True Colours’, described in Chapter 5) or smartphone 
applications (Bhat et al. 2015; Torous and Powell 2015; Bidargaddi et al. 2016). A 2015 
systematic review of smartphone apps available for monitoring symptoms in BD revealed that 
less than 50% provided the option to monitor sleep (Nicholas et al. 2015). However, ethical 
issues regarding the use of this digital technology (e.g. privacy and validity) must be 
considered before recommending its use in clinical settings (Bidargaddi et al. 2016; Bauer et 
al. 2017). Such technology would also need to account for other triggers of mood episodes, 
such as medication, stressors, and substance use. 
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7.8.2 Individual Differences in Whether Sleep Loss Acts as a Pathway to Mania 
If replicated, the findings of this thesis may also be informative for clinical practice due to 
highlighting the importance of individual differences in how sleep loss may act as a pathway 
to mania. Identifying which individuals exhibit sleep disturbances as part of ‘relapse signature’ 
could be helpful for illness management and there are a number of ways in which this 
information could be utilised in clinical settings. For example, there is a version of the online 
mood monitoring system used in Chapter 5 that is currently used in clinical settings. In theory, 
clinicians using this system could examine whether some patients display increasing levels of 
insomnia prior to episodes of high mood, and use this information to modify these patients’ 
care if the system indicates that they are experiencing high or increasing sleep disturbance.  
Ideally, mood-monitoring systems would automatically learn from an individual’s data 
whether sleep disturbances signalled the onset of mood episodes, and would automatically 
notify patients and/or their clinicians of this information. However, whether it is possible to 
use information on sleep to predict and prevent mood episodes will only be ascertained 
followed substantial further research. 
In addition, if it is known that some individuals are more prone to relapse following exposure 
to sleep loss-inducing events (e.g. shift work, long-haul travel), care and medication could be 
adjusted during these times of increased risk. These individuals could also be a focus for 
interventions that aim to improve sleep. For example, a pilot randomised control trial found 
that cognitive behavioural therapy for insomnia that was modified for use in bipolar 
individuals (CBTI-BP) was associated with a reduced risk of relapse at 6-month follow up 
(Harvey et al. 2015). For women with BD who are pregnant, clinicians could ask whether sleep 
loss has previously triggered episodes of mania. If so, perinatal teams could pay particular 
attention to the sleep loss in pregnancy and postpartum and introduce measures to minimise 
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this (e.g. help with night time nursing) or utilised other methods of improving sleep outlined 
above. 
7.9 Final Conclusions  
In 1609, Thomas Dekker extolled the virtues of sleep for physical and mental health, noting 
that too little ‘tumbles us into a Church-yard, and to use it but indifferently, throwes[sic] us 
into Bedlam’(Dekker 1609 p.10). Over 400 years later, Dekker’s observations have been 
corroborated in multiple clinical and scientific observations, but there is still much we do not 
understand about the relationship between sleep loss and mental health. Existing research 
has established an association between sleep loss and the genesis of mania in BD, but this 
research also suggested that there are individual differences in this relationship.  
This thesis extends previous research by first, providing further confirmation that only a 
subgroup of individuals with BD will experience sleep loss as a pathway to mania. Second, 
that this phenotype is potentially associated with female gender and BD-I diagnoses, and 
could potentially index risk for PP.  Third, this thesis highlights the methodological difficulties 
of measuring perinatal sleep objectively in women at high risk of PP, as well as identifying 
sleep parameters that may be useful to monitor in larger studies. Finally, the findings of this 
thesis suggest that sleep loss is less frequently observed as a trigger or early warning sign of 
depression than mania. 
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Appendix B - Quick Inventory of Depressive Symptomatology (Self-
Report) 
Please checkmark the one response to each item that is most appropriate to how you have 
been feeling over the past 7 days. 
Q1. Falling asleep 
0 I never take longer than 30 minutes to fall asleep. 
1 I take at least 30 minutes to fall asleep, less than half the time (3 days or less out of the 
past 7 days). 
2 I take at least 30 minutes to fall asleep, more than half the time (4 days or more out of the 
past 7 days). 
3 I take more than 60 minutes to fall asleep, more than half the time (4 days or more out of the 
past 7 days). 
Q2. Sleep during the night 
0 I do not wake up at night. 
1 I have a restless, light sleep, briefly waking up a few times each night. 
2 I wake up at least once a night, but I got back to sleep easily. 
3 I wake up more than once a night and stayed awake for 20 minutes or more, more than half 
the time (4 days or more out of the past 7 days). 
Q3. Waking up too early 
0 Most of the time, I woke up no more than 30 minutes before my scheduled time. 
1 More than half the time (4 days or more out of the past 7 days), I woke up more than 30 
minutes 
before my scheduled time. 
2 I almost always woke up at least one hour or so before my scheduled time, but I got back to 
sleep eventually. 
3 I woke up at least one hour before my scheduled time, and couldn’t get back to sleep. 
Q4. Sleeping too much: 
0 I slept no longer than 7-8 hours/night, without napping during the day. 
1 I slept no longer than 10 hours in a 24-hour period including naps. 
2 I slept no longer than 12 hours in a 24-hour period including naps. 
3 I slept longer than 12 hours in a 24-hour period including naps. 
Q5. Feeling sad: 
0 I didn’t feel sad. 
1 I felt sad less than half the time (3 days or less out of the past 7 days). 
2 I felt sad more than half the time (4 days or more out of the past 7 days). 
3 I felt sad nearly all of the time. 
Please complete either 6 or 7 (not both) 
Q6. Decreased appetite Q7. Increased appetite 
0 There was no change in my usual appetite. 0 There was no change in my usual appetite. 
1 I ate somewhat less often or smaller 
amounts of food than usual. 
1 I felt a need to eat more frequently than 
usual. 
2 I ate much less than usual and only by 
forcing myself to eat. 
2 I regularly ate more often and/or greater 
amounts of food than usual 
3 I rarely ate within a 24-hour period, and 
only by really forcing myself to eat or 
when others persuaded me to eat. 
3 I felt driven to overeat both at mealtime and 
between meals. 
Please complete either 8 or 9 (not both) 
Q8. Decreased weight (within the last 14 days): Q9. Increased weight (within the last 14 days): 
0 My weight has not changed. 0 My weight has not changed. 
1 I feel as if I’ve had a slight weight loss. 1 I feel as if I’ve had a slight weight gain. 
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2 I’ve lost 2 pounds (about 1 kilo) or more. 2 I’ve gained 2 pounds (about 1 kilo) or more. 
3 I’ve lost 5 pounds (about 2 kilos) or more. 3 I’ve gained 5 pounds (about 2 kilos) or more. 
Q10. Concentration/decision-making: 
0 There was no change in my usual ability to concentrate or make decisions. 
1 I occasionally felt indecisive or found that my attention wandered. 
2 Most of the time, I found it hard to focus or to make decisions. 
3 I couldn’t concentrate well enough to read or I couldn’t make even minor decisions. 
Q11. Perception of myself: 
0 I saw myself as equally worthwhile and deserving as other people. 
1 I put the blame on myself more than usual. 
2 For the most part, I believed that I caused problems for others. 
3 I thought almost constantly about major and minor defects in myself. 
Q12. Thoughts of my own death or suicide: 
0 I didn’t think of suicide or death. 
1 I felt that life was empty or wondered if it was worth living. 
2 I thought of suicide or death several times for several minutes over the past 7 days. 
3 I thought of suicide or death several times a day in some detail, or I made specific plans for 
suicide or actually tried to take my life. 
Q13. General interest: 
0 There was no change from usual in how interested I was in other people or activities. 
1 I noticed that I was less interested in other people or activities. 
2 I found I had interest in only one or two of the activities I used to do. 
3 I had virtually no interest in the activities I used to do. 
Q14. Energy level: 
0 There was no change in my usual level of energy. 
1 I got tired more easily than usual. 
2 I had to make a big effort to start or finish my usual daily activities (for example: shopping, 
homework, cooking or going to work). 
3 I really couldn’t carry out most of my usual daily activities because I just didn't have the energy. 
Q15. Feeling more sluggish than usual: 
0 I thought, spoke, and moved at my usual pace. 
1 I found that my thinking was more sluggish than usual or my voice sounded dull or flat. 
2 It took me several seconds to respond to most questions and I was sure my thinking was more 
sluggish than usual. 
3 I was often unable to respond to questions without forcing myself. 
Q16. Feeling restless (agitated, not relaxed, fidgety): 
0 I didn’t feel restless. 
1 I was often fidgety, wringing my hands, or needed to change my sitting position. 
2 I had sudden urges to move about and was quite restless. 
3 At times, I was unable to stay seated and needed to pace around. 
QIDS Scoring algorithm: The QIDS-SR16 total score is calculated by adding scores obtained for 
items: Sad mood, concentration/decision-making, outlook (self), suicidal ideation, general 
interest, energy/fatigability, the highest score on any of the four sleep items (sleep onset 
insomnia; midnocturnal insomnia; early morning insomnia; hypersomnia); the highest score 
on any one of the four appetite/weight change items (appetite increase; appetite decrease; 
weight increase; weight decrease); and the highest score on the two psychomotor 
agitation/retardation items (psychomotor slowing; psychomotor agitation) (total score range: 
0–27) (Rush et al 2000). 
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Appendix C - Altman Self-Rating Mania Scale  
There are 5 groups of statements in this questionnaire, read each group of statements 
carefully. You should choose the statement in each group that best describes the way you 
have been feeling for the past week. 
Please note: The word ‘occasionally’ when used here means once or twice; ‘often’ means 
several times or more and ‘frequently’ means most of the time. 
Q1. Happiness 
0 I do not feel happier or more cheerful than usual. 
1 I occasionally feel happier or more cheerful than usual. 
2 I often feel happier or more cheerful than usual. 
3 I feel happier or more cheerful than usual most of the time. 
4 I feel happier or more cheerful than usual all of the time. 
Q2. Confidence 
0 I do not feel more self-confident than usual. 
1 
I occasionally feel more self-confident than usual. 
2 I often feel more self-confident than usual. 
3 I feel more self-confident than usual. 
4 I feel extremely self-confident all of the time. 
Q3. Sleep 
0 I do not need less sleep than usual. 
1 
I occasionally need less sleep than usual. 
2 I often need less sleep than usual. 
3 I frequently need less sleep than usual. 
4 I can go all day and night without any sleep and still not feel tired. 
Q4. Talking 
0 I do not talk more than usual. 
1 
I occasionally talk more than usual. 
2 
I often talk more than usual. 
3 
 I frequently talk more than usual. 
4 
I talk constantly and cannot be interrupted. 
Q5.  Activity 
0 I have not been more active (either socially, sexually, at work, home or school) than usual. 
1  I have occasionally been more active than usual. 
2 I have often been more active than usual. 
3  I have frequently been more active than usual. 
4 
I am constantly active or on the go all the time. 
EG Altman, D Hedeker, JL Peterson, JM Davis. The Altman Self-Rating Mania Scale. 42: Biol 
Psychiatry 948-955. 1997. 
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Appendix D – Comparison of Triggers of Mood Episodes by Gender 
It is possible that women were more likely than men in general to report or notice triggers of 
their mood episodes. However, examining women’s responses to other trigger questions 
included in the interview did not suggest that they consistently report triggers more often 
than men. For example, as shown in Table 9-1, women are less likely than men to report that 
alcohol or non-prescription drugs have triggered episodes of  (hypo)mania. 
Table 9-1. Comparison between men and women in likelihood of reporting different 
triggers of mood episodes. 
 Female OR (95% CI), p value  
Sleep Loss 
Physical 
Illness 
Medication Antidepressants Alcohol 
Non-
prescription 
drugs 
Triggers of 
(hypo)mania 
(n = 3140) 
1.43 
(1.18-1.75) 
p <.001 
1.94 
(1.12-3.37) 
p =.019 
1.14 
(0.76-1.72) 
p =.528 
1.16 
(0.90-1.49) 
p =.245 
0.78 
(0.59-1.04) 
p =.085 
0.61 
(0.44-0.83) 
p =.001 
Triggers of 
depression 
(n= 3064) 
1.37 
(1.07-1.77) 
p =.013 
1.92 
(1.41-2.62) 
p <.001 
1.68 
(0.97-2.88) 
p =.063 
N/A 0.82 
(0.62-1.08) 
p =.158 
0.93 
(0.60-1.45) 
p =.756 
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Appendix E – True Colours Example Participant Summary Graph 
Example screenshot of summary graph available to participants using the True Colours mood 
monitoring system.
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Appendix F – Sample Size Calculations for Chapter 5 
Sample sizes for future studies were calculated in R using the method outlined in (Noordzij et 
al. 2011). Specifically, the sample size for a binary outcome is calculated as: 
𝑛 =  
[(𝑎 + 𝑏)2 (𝑝1 𝑞1 + 𝑝2 𝑞2)] 
𝑥2
 
Where: 
n = the sample size in each group 
p1 = proportion of participants with the outcome in Group 1  
q1 = proportion of participants without outcome in Group 1 
p2 = proportion of participants with the outcome in Group 2 
q2  = proportion of participants without the outcome in Group 2 
x = the expected difference in the event rate  
a = conventional multiplier for alpha = 0.05 
b = conventional multiplier for power = 0.80 
 
This calculation is based on a binary outcome, therefore the sample sizes required for each of 
the class comparisons were calculated in pairs (i.e. ‘Increasing’ vs. ‘Low’, ‘Increasing’ vs. 
‘High’, and ‘Low’ vs. ‘High’). In addition, the expected difference in event rate (x) was 
calculated as the observed difference between groups observed in this study. Sample size 
calculations for key variables of interest (bipolar diagnosis, gender, and presence of a 
depressive episode) are shown in Table 9-2. 
Table 9-2. Sample sizes per group for class comparisons (alpha = 0.05, power = 0.80) 
  Class Comparisons 
  
‘Increasing’ (1)  
vs. ‘Low’ (0) 
‘Increasing’ (1) 
vs. ‘High’ (0) 
‘Low’ (1) vs. 
‘High’ (0) 
Bipolar Diagnosis (BD-I vs. BD-II) 62 137 628 
Gender  259 1782 679 
Depressive Episode 47 311 23 
Classes: ‘Increasing’ (n=8),’Low’ (n=113), ‘High’ (n=24). BD-I, Bipolar Disorder type I; BD-II, Bipolar 
Disorder type II.
  
Appendix G – Sleep Disorder Screening Questions
 
1.   Narcolepsy 
a. Do you sometimes fall asleep in the daytime completely without warning? 
b. Is it literally impossible to resist ‘sleep attacks’ during the day?  
c. Do you have collapses or extreme muscle weakness triggered by extreme emotion?  
d. Do you have visual hallucinations, either just as you fall asleep or when you wake in the 
morning? 
e. Are you paralyzed and unable to move when you wake up from your sleep?  
 
[Possible narcolepsy: 1a = “TRUE” AND (1b OR 1c OR 1d OR 1e = “TRUE”)] 
 
2.   Sleep breathing disorder 
a. Are you a very heavy snorer? 
b. Does your partner say that you sometimes stop breathing?  
c. Do you often wake up gasping for a breath?  
d. Are you often excessively sleepy during the day or fall asleep without wanting to?  
 
[Possible sleep breathing disorder:  2a = “TRUE” AND (2b OR 2c OR 2d = “TRUE”)]  
 
3.   PLMS/ RLS 
a. Do your legs often twitch or jerk or can’t keep still in bed? 
b. Is it very difficult to get to sleep because of repeated muscle jerks?  
c. Do you frequently wake from sleep with sudden jerky movements or with a compulsion to 
move your legs? 
d. Do you simply have to get out of bed and pace around to get rid of these feelings?  
 
[Possible PLMS/ RLS:  3a = “TRUE” AND (3b OR 3c OR 3d = “TRUE”)] 
 
4.   Circadian Rhythm Sleep Disorder 
a. Do you tend to sleep well but just at the ‘‘wrong times’’? 
b. Can you sleep well enough, but only if you stay up very late?  
c. Are you in a very sound sleep at normal waking time and could sleep on for hours more?  
d. Can you sleep well enough, but only if you go to bed very early? 
e. Do you wake very early, bright and alert and no longer sleepy?  
 
[Possible CRSD:  4a = “TRUE” AND EITHER (4b AND 4c = “TRUE”) OR (4d AND 4e = “TRUE”)] 
 
5.   Parasomnia 
a. Do you have unusual behaviours associated with your sleep that trouble you or that are 
dangerous?  
b. Do you sleepwalk frequently and run the risk of injuring yourself or others?  
c. Do you have frequent night terrors when you are extremely distressed but not properly 
awake?  
d. Do you act out your dreams and risk injuring yourself or others? 
e. Do you have terrible recurring nightmares?  
 
[Possible parasomnia:  5a = “TRUE” AND EITHER (5b OR 5c OR 5d OR 5e= “TRUE”)] 
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Appendix H – Sleep Diary and Actigraphy Instructions 
(see overleaf) 
 
  
Actigraphy Instructions: 
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Sleep Diary Instructions: 
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Appendix I – GP and Psychiatrist Questionnaires 
GP Questionnaire: 
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 238 
Psychiatrist Questionnaire 
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Appendix J – Actigraphy Data Processing Protocol 
Protocol for processing actigraphy data once uploaded to Actiware software. 
1. Identify bed times (BT) and rise times (RT) from sleep diary 
2. Calculate automatic rest intervals. 
3. Increase visibility of actogram: change max activity level to 500 or 1000 and set 
actogram to show only 1 or 2 days at a time. 
4. If there are diary BTs and RTs, delete the automatic interval. Add diary bed times 
and rise times as a custom interval on the software.  
5. Add REST INTERVALS using the following method: 
a. BTs:  
i. Using the self-report BT as a guide, check ~30 mins before and after 
for a drop in activity  
ii. Set BT to begin 3 mins before drop in activity.  
b. RTs:  
i. Using the self-report RT as a guide, check ~30 mins before and after 
for the presence of continuous activity. 
ii. Set RT 3 minutes into presence of continuous activity 
6. If no diary information is available or there are large discrepancies between sleep 
diary and activity data, examine actogram for periods of inactivity based on: 
a. the general level of concordance between each participant’s diary entries 
and activity. 
b. the level and persistence of activity (i.e. high and persistent vs. low and 
fragmented). 
c. examination of activity around previously reported bed/rise times to 
determine whether participants showed a common ‘activity signature’ 
during these times. 
And apply steps 4-5 and note the decision made. 
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Appendix K – Participant Correspondence 
Participant correspondence 1: 
 ‘I really wanted to assist in this research but immediately found wearing the watch 
[actigraph] and trying to rate when I was awake actually disturbed my ability to go to 
sleep. Firstly, I don’t normally wear a watch and found it hot and uncomfortable; I was 
very conscious of how it felt on my wrist – preventing me fall[sic] asleep. I was even 
more conscious of (still) being awake when I knew that I should have been asleep. In 
the mornings, after having very little sleep, I asked my partner how he would have 
been able to track whether he was asleep or not – he said that he thought that 
tracking sleep patterns on the log was reasonable; for me I kept checking my watch 
through the night or wondering whether I was still truly awake or partially awake or 
on my way to sleep then wondering whether I would remember the next morning 
whether it had been half hour or more since I last check the watch. Being this 
conscious of my sleep patterns ‘caused’ me to have a very restless night and it 
reminded me of how my bipolarity is affected by poor sleep as well as how much sleep 
– or lack of it – is a feature of the days before a manic episode. As a result I decided to 
not continue wearing the watch as I didn’t want to jeopardise my mental health in my 
last trimester and certainly in the early postnatal weeks. Very sorry not to have helped 
more.’   
Participant correspondence 2: 
‘I apologise wholeheartedly but I am unable to continue with the Actiwatch 
[actigraph] – I am struggling to find the time to keep an accurate sleep diary and find 
sleeping whilst wearing it quite uncomfortable. I’m so sorry to have to return it, I 
really wish you all the best with your study. Good luck!’ 
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Appendix L – Participant Sleep Charts Derived From Actigraphy Data 
Participant 1 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28 35 42 49 56
0
10
20
30
40
0
25
50
75
100
0
25
50
75
0
3
6
9
12
0.0
2.5
5.0
7.5
10.0
0
50
100
150
Nights
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Participant 2 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28
0
10
20
30
40
0
25
50
75
100
0
20
40
60
80
0
4
8
12
0.0
2.5
5.0
7.5
10.0
0
50
100
150
Nights
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Participant 3 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28 35 42
0
20
40
60
0
25
50
75
100
0
50
100
150
0
4
8
12
0.0
2.5
5.0
7.5
0
100
200
Nights
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Participant 4 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28
0
10
20
30
40
0
25
50
75
100
0
30
60
90
0.0
2.5
5.0
7.5
10.0
12.5
0.0
2.5
5.0
7.5
10.0
0
100
200
300
Nights
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Participant 5 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28 35 42 49
0
20
40
0
25
50
75
100
0
30
60
90
0
5
10
0
3
6
9
0
50
100
150
Nights
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Participant 6 
 
  
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28 35 42 49
0
10
20
30
40
50
0
25
50
75
100
0
50
100
0
3
6
9
12
0.0
2.5
5.0
7.5
0
50
100
150
Nights
 250 
Participant 7 
 
 
 
Time Awake After Sleep Onset (mins)
Total Sleep Time (hrs)
Time in Bed (hrs)
Sleep Onset Latency (mins)
Sleep Efficiency (%)
Number of Awakenings per Night
1 7 14 21 28 35
0
10
20
30
40
0
25
50
75
100
0
20
40
60
0
5
10
0
3
6
9
12
0
50
100
150
Nights
